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A critical challenge in the design of biomaterials for tissue engineering relies on the 
development of tissue-specific biomimetic scaffolds capable of replacing cell-matrix 
interactions required for the repair of injured tissues. Further, such biomaterials with the 
additional capacity to prevent bacteria contamination can resolve issues surrounding surgical 
prosthesis infection. Fibrous micro- and nanostructures are extensively researched in tissue 
engineering due to their intrinsic similarities to decellularised human tissues. Among the 
several fibre-forming processes, electrospinning has drawn much attention due to its ability to 
produce scaffolds that morphologically resemble the native extracellular matrix (ECM) of 
human tissues. 
Electrospinning is a versatile method that uses electrohydrodynamic principles to produce 
fibres with diameters ranging from microns to tens of nanometres. By varying the chemistry 
and morphology of the fibres, it is feasible to attain different physiological and mechanical 
responses. The wide array of raw natural and synthetic materials – including polymers and 
complex molecules – that can be used to electrospin fibres can resolve well-documented 
problems associated with the inferiority of synthetic biomaterials and the limitations of 
biological tissues. 
In this thesis, electrospinning is utilised to contribute to the engineering of advanced ECM-
mimicking biomaterials. The work will focus on (1) improving the physicochemical and 
mechanical responses of skin substitutes and (2) preventing mesh-associated surgical site 
infection. 
The initial study of this thesis presents the design and construction of a nozzle-free 
electrospinning device, which is an economically viable method of scaling-up fibre production 
output. The equipment is then used to fabricate elastic skin-like composite nanofibres 
consisting of poly(vinylpyrrolidone) (PVP) and poly(glycerol sebacate) (PGS). The findings 
indicate that the mechanical properties of the electrospun mats could be tuned by varying the 
concentration of PGS and the molecular weight of PVP within the blends. Photocrosslinking 
the fibres prevented the rapid degradation of the composite mats due to the hydrophilic nature 
of PVP, making it feasible to assess the biological responses of the construct in vitro, 
displaying good viability and proliferation of human dermal fibroblasts. This study provides a 
different approach towards the development of skin substitutes, based on the fact that 
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mechanical stimuli influence the ability of dermal cells to adapt and reconstruct the ECM at an 
injured site; being able to adjust the mechanics to those of different anatomical sites of the 
body can have a positive effect on the overall outcome of a healing wound. 
Synthetic biomaterials tend to present suboptimal cell growth and proliferation, with many 
studies linking this phenomenon to the hydrophobicity of such surfaces. This thesis continues 
with the development of a protocol for silk fibroin extraction from Bombyx mori cocoons, which 
achieved significantly increased yields of the protein in a third of the time required by the 
conventional molecular cut-off extraction approach. The extracted silk fibroin was then used 
to produce electrospun membranes consisting of poly(caprolactone) (PCL) blended with 
variant forms of PGS. The main aim of this work was the development of fibre mats with 
tuneable hydrophobicity/hydrophilicity properties, depending on the esterification degree and 
concentration of PGS within each composite. By altering the surface properties of the 
electrospun membranes, the trinary composite biomaterial presented improved fibroblast 
attachment behaviour and optimal growth in comparison to PCL-only fibrous mats.  
The study continued with the development of an ultralight-weight nanostructured 
bicomponent antimicrobial construct with a similar microstructure to biologic meshes, which 
preserved the required mechanical integrity of synthetic mesh materials. A core/shell 
nanofibrous structure was developed, consisting of nylon-6 in the core and 
chitosan/polyethylene oxide in the shell. The bicomponent fibre structure comprised a binary 
antimicrobial system incorporating 5-chloro-8-quinolinol in the chitosan-shell, with the 
sustained release of poly(hexanide) from the nylon-6 core of the fibres. The antimicrobial 
nanofibres were found to elicit a robust bactericidal response, in vitro, against the two most 
commonly occurring pathogenic bacteria in deep incisional surgical site infections; 
Staphylococcus aureus and Pseudomonas aeruginosa. The results of this study advocate that 
the bicomponent nanofibres developed can be a promising alternative to biologic meshes, 
employed for hernia repair today, due to similar architecture and mechanics, but at the same 
time capable of actively protecting the patient from subsequent mesh-associated infections, 
thus tackling this life-threatening postoperative complication. 
Overall, the work in this thesis has expanded upon the fields of skin tissue engineering 








Tissue engineering is a rapidly evolving interdisciplinary field that applies the principles of 
engineering and life sciences to restore or replace tissue functions. It is among the major 
domains of biomedical engineering, where the goal is to develop advanced biomaterials with 
the ability to mimic complex tissues. This involves the integration of scaffold matrices with 
cells, which can then support their viability and promote growth. 
This thesis involves the use of a technique called electrospinning to advance the properties 
of such biomaterials. Electrospinning is an emerging fabrication technology that has attracted 
considerable attention in recent years in fields ranging from medicine and tissue engineering 
to energy and environmental science due to the ease of producing well-defined, fibrous woven 
or nonwoven materials. The process begins when a polymer solution or melt is exposed to a 
high electric field that causes it to deform and spin, which manipulates it to very fine meshes 
of micro-/nanostructured fibres. The constant advancement and unfolding of such material, 
along with the beneficial features of micro-/nanoscale structures, have made them eligible 
candidates for the progress and development of an array of therapies. 
The two key areas touched upon in this thesis encompass biomaterials for wound healing 
in the form of biocompatible dermal substitutes and the development of antimicrobial 
prostheses capable of preventing post-operative hernia mesh infection. 
Initially, a high-throughput free-surface electrospinning device was constructed, capable 
of solving issues associated with the meagre production rate of the traditional electrospinning 
process. This device permits the scaling-up of electrospinning by allowing for filaments to form 
from a wider surface rather than the conventionally used needle-tip. After this, a novel 
approach was employed to extract higher quantities of the silk fibroin protein in reduced 
processing time from silkworm cocoons. This was then used to produce a range of novel 
biocompatible skin-like constructs by integrating the properties of variant synthetic and natural 
polymers. By adjusting the chemistry and proportion of each material used, it was feasible to 
tune the mechanics and wetting properties of the developed constructs, ultimately attaining 
good biocompatibility and cellular proliferation required for wound healing and tissue repair. 
On a different note, post-surgical infections affect millions of people, and likewise cost 
billions; thus, making it a prevalent problem. While advances have been made in infection 
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control practices, surgical site infections remain a substantial cause of morbidity, prolonged 
hospitalisation, and death. In the case of hernia treatment, battling an infection that has settled 
on an implantable mesh is an arduous process. 
Surgical meshes are used to provide additional support to weakened or damaged tissue. 
However, when an infection occurs directly on the mesh, the bacteria can colonise the foreign 
material, where antibiotics cannot adequately defeat the infection due to the blood-mesh 
barrier. Thus, the only viable option is the removal of the hernia mesh – something that can 
significantly increase the chances of hernia reoccurrence, along with all the surgery-related 
implications. 
The hernia meshes available on the market today are textile-based products that provide 
good mechanics but lack any antimicrobial properties. Hence, part of this thesis focused on 
the development of a prosthetic mesh that can further protect patients from bacterial infections.  
A variation of the conventional electrospinning technique described earlier, referred to as 
co-axial electrospinning, was used, capable of formulating drug-containing fibres that present 
properties of different materials in a fibre-within-a-fibre format. The developed bicomponent 
nanofibrous construct was able to attain the sustained release of a dual antimicrobial system, 
capable of suppressing the growth of the pathogenic bacteria commonly associated with 
surgical site infections while presenting the suitable mechanical and physicochemical 
properties required for hernia repair. 
The work presented in this thesis advocates the significance of the electrospinning process 
towards the engineering of state-of-the-art nanofibrous biomaterials, by exploring new 
avenues of research for the advancement of skin substitutes and antimicrobial hernia meshes. 
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1.1 Problem statement and motivation 
The development of nanotechnology-enabled biomaterials is an accelerating field that has 
attracted considerable attention, with its hallmark relying on multidisciplinarity [1]. 
Nanotechnological approaches have had a substantial impact on the way we visualise 
biomaterials and their limitations today. Skin tissue engineering (TE) has been evolving since 
the idea of "tissue engineering" was first established in the 1960s, and the term 
"biocompatible" has come to distinguish "biomaterials" from other "materials" [2]. However, to 
progress further, the gap between the physicians' practical experience and the clinical 
translation of this knowledge needs to be addressed first. 
The perception of biomaterials surrounds the idea of mimicking nature's tissue template, 
the extracellular matrix (ECM). In tissue engineering and regenerative medicine, a biomaterial 
acts as a scaffold to provide the mechanical support and physiology in a similar manner to 
that of the intrinsic ECM [3]. Such an environment encourages biochemical signalling for 
modulating cell recruitment, attachment, and tissue regeneration, paving the way for 
reinstating homeostasis [3]. 
Methods for procuring ECM-based biomaterials from decellularised donor sources through 
physical (high hydrostatic pressure, dissection, agitation etc.), chemical (surfactants, ionic 
solutions etc.), and enzymatic approaches have to an extent expanded since the early 2000s 
[4]. Where measuring the amount of the double-stranded DNA remains the gold standard of 
evaluating the degree of decellularisation [4, 5]. Nevertheless, the question "how good is good 
enough?" raises issues regarding the limitations of decellularised ECM products. These 
limitations pertain to the materials (mechanics, adjusting the degradation etc.), the biology 
(induced immunological responses due to DNA fragments), donor limitations, and the 
complexity of obtaining these materials, as well as raising ethical issues [5, 6]. Products, such 
as Alloderm® (acellular human cadaveric-derived matrix), can be used for various applications 
ranging from dermal grafts and plastic surgery to transabdominal hernia repair, but in general, 
are not engineered to meet specific tissue requirements [7, 8]. To improve the medical 
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precision of biomaterials and to avoid a "one-size-fits-all" approach, ECM-mimicking 
technologies need to further advance and provide application-specific solutions. 
The skin is an interface that establishes a barrier between the body and the environment 
[9]. When the structural integrity of the skin is compromised, a wound occurs. This can be due 
to rupture of the tissue by trauma, burn, congenital anomalies, diseases imposing physical 
distress or chronic defects [10]. Upon injury, it is imperative to reinstate the skin's structural 
integrity. 
The World Health Organization (WHO) estimates that burns cause 180,000 deaths every 
year [11]. Although the majority of non-fatal wounds and burns heal through the self-
regenerative capacity of the skin, extensive injured lesions and chronic (non-healing) wounds 
are considered a leading cause of morbidity [11]. The rising proportion of the population living 
with diabetes is causing an alarming increase in the frequency of chronic wound diagnosis 
[12]. The current gold standard for handling wounds, depending on the severity, relies on 
varied types of wound dressings, gauzes, hydrogels, semipermeable films, and foams and in 
severe cases, skin substitute models [13–15]. Rather than initiating healing, the purpose of 
wound dressings is to protect the wound environment while retaining appropriate hydration of 
the wound bed [14]. By contrast, skin substitute products are based on autographing or 
acellularized tissues; they are expensive and difficult to obtain, can be of limited use if the 
affected area is extensive, and the body may have an adverse immune reaction to the 
transplant [16]. Consequently, the treatment and management of wound-related skin 
impairments pose significant challenges to the medical community.  
Skin TE requires the development of biomimetic scaffolds that play an active role in the 
wound healing process, prompting efficient tissue regeneration [16]. Many biodegradable 
polymers such as poly(caprolactone) (PCL), polyvinylpyrrolidone (PVP), poly(lactic-co-glycolic 
acid) (PLGA), polylactide-based and natural polymers such as collagen, cellulose, silk and 
hyaluronic acid among others have been extensively studied to develop bioinspired materials 
to advance wound care and wound healing [17–19]. Nonetheless, many requirements must 
be fulfilled to develop easily obtainable biomaterials that elicit the required properties and can 
be scaled up to a clinically relevant extent.  
Similarly, the use of biomaterials for prostheses to prevent hernia reoccurrence has 
progressed alongside dermal substitute products [20]. Hernia repair surgery is one of the most 
commonly performed elective operations. Every year, approximately 100,000 hernia repair 
surgeries are carried out in the UK, over 700,000 are performed in the US, and 1,100,000 
inguinal and abdominal wall hernia surgeries take place in China every year [21, 22]. Studies 
of large groups of patients undergoing hernioplasty (use of a polymer-based prosthetic mesh) 
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or herniorrhaphy (repositioning the hernia and suturing without the use of a mesh) have shown 
that the use of a mesh presents at least a 50% reduction in hernia recurrence risk [23]. 
However, there is uncertainty regarding the use of synthetic materials, such as 
polypropylene- and polyester-based meshes that are cost-effective and present good 
mechanics, compared to biologic (primarily collagen-based) meshes that are derived from 
decellularized tissues, resemble the native fascia, and can be partially bioabsorbed over time 
[19, 24]. As synthetic meshes are permanent, they are associated with numerous 
postoperative complications, such as discomfort, inflammation and tissue ingrowth; whereas 
biologic meshes are expensive to obtain, present poor mechanics, can be difficult to regulate 
in terms of degradation, are more prominent to infections and may induce adverse immune 
responses [25, 26]. 
A number of challenges need to be taken into consideration when developing a mesh 
biomaterial, including minimising the sensation of a foreign body, preventing rapid cell 
ingrowth (deep tissue adhesion), shrinkage, chronic scarring, and reduce immunogenic 
responses [23, 27]. The mesh also must remain adequately flexible, mechanically durable, 
chemically inert and be resistant to bacterial contamination and subsequent biofilm formation 
[23, 27]. Currently, there is no mesh available on the market that preserves an ECM-like 
architecture while preventing bacterial colonisation, either for synthetic or biologically-derived 
mesh materials. Bacterial contamination of a mesh during insertion, due to the primary 
incision, occurs in 1/3 to 2/3 of all hernia operations, from which 1%–8% will develop a deep 
incisional mesh surgical site infection, with the rates varying between open and laparoscopic 
surgery [27–29]. When considering that the implementation of medical devices increases the 
susceptibility of infection by a factor of 10,000 to 100,000, someone can recognise the 
magnitude of the need to advance the antimicrobial properties of implants [29]. 
Other forms of mesh implants such as transvaginal meshes; used to treat stress urinary 
incontinence and pelvic organ prolapse, have been recently suspended by the Independent 
Medicines and Medical Devices Safety Review in the UK due to an increased number of 
reported complications subsequent to mesh surgery, including debilitating pain, infection, 
inflammation, mobility problems and depression [30, 31]. In the UK alone in the past six years, 
the National Health Service (NHS) trust estimated that somewhere between 68,000 and 
170,000 patients had been adversely affected due to hernia mesh-related complications, 
leading to many surgeons estimating that the complication rate can be anywhere between 
12% and 30% [32]. The need to develop better engineered, more reliable mesh prosthesis 
that can address these pressing issues, the medical community is facing, and resolve such 
significant complications remains of utmost importance. 
4                Introduction | Chapter 1 
 
The potential of using biomaterials in wound treatment requires further advancement, 
while the prevention of mesh-specific surgical infection needs to be addressed. Synthetic 
polymers have intrinsic limitations in their biocompatibility, whereas natural polymers suffer 
from variations in their chemistry and show relatively poor mechanical performance [2]. 
In this thesis, the concept of integrating naturally-derived polymers with synthetic polymers 
is explored to assess whether improved biocompatibility, good mechanics and appropriate 
antimicrobial properties can be obtained to provide suitable biomaterials for wound healing 
and hernia repair.  
To address these issues, the work in this thesis focuses on scaffold development by 
electrospinning. Electrospinning is a technique that uses electrohydrodynamic principles to 
fabricate micro-/nanofibres from a polymer solution or melt [33]. The physicochemical and 
morphological properties of the fibres can be manipulated by modifying the process, solution 
and ambient parameters; in this way, the induction and regulation of cell-specific responses 
can be achieved [34]. The spatiotemporal configuration of electrospun membranes makes it 
feasible for them to sequester active agents, such as antimicrobial substances, in various 
compartments of the fibres [35]. This means that it is possible to modulate the release kinetics 
by manipulating the morphological properties, localisation, and drug-polymer interactions of 
the fibres [36]. 
Electrospun fibres present remarkable advantages as dermal substitutes compared to 
conventional dressings such as woven and nonwoven gauzes and non-fibrous structures (e.g., 
hydrogels) [15]. This is because electrospun fibres permit the development of structures that 
closely resemble the native ECM of the skin and abdominal wall fascia where cells can adhere, 
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1.2 Thesis aims and objectives 
This thesis aims to investigate the potential use of fibre-based biomaterials in the form of 
advanced skin substitutes and antimicrobial hernia meshes to address some of the challenges 
associated with aiding chronic wound healing and preventing mesh-specific surgical site 
infections. This will be accomplished by utilising different electrospinning approaches using a 
combination of natural and synthetic polymers.  
The cutting-edge technologies used in the biomedical sector for managing and treating 
wounds present many limitations, and they are often either insufficient or overly complicated 
to obtain. Further, surgical meshes used by surgeons for hernia repair lack an antimicrobial 
profile, making the establishment of an infection on a mesh an ongoing imminent problem. 
With regard to these concerns, this thesis will expand on the progress made in the fields of 
skin tissue engineering and advanced antimicrobial surfaces by investigating material-oriented 
engineering solutions. This proof-of-concept study will facilitate a discussion within the field of 
biomedical engineering and provide alternative routes to tackle these issues from a material 
science perspective. 
The research objectives, as presented in this thesis, are as follows: 
1. Manufacture electrospun fibre-based biomaterials with tuneable properties. 
i. Produce biocompatible, fibrous skin-like substitutes with adjustable mechanical 
properties, tuneable hydrophilicity, and an ECM-like morphology. 
ii. Produce core/shell (bicomponent) antimicrobial nanofibres that facilitate a 
spatiotemporal configuration that allows the controlled release of antimicrobial 
agents while fulfilling the mechanical requirements of a prosthetic mesh. 
2. Assess the impact of the electrospun scaffolds architecture regarding the following: 
i. Physiochemical and mechanical stability. 
ii. Biocompatibility in the case of skin-like substitutes. 
iii. Drug release profile and antimicrobial efficiency in the case of hernia meshes. 
3. Assess the effect of different forms of poly(glycerol sebacate) towards the mechanics 
and wetting properties of the skin-like fibrous mats. 
4. Describe the photocrosslinking process of the PVP/PGS fibres. 
5. Design and build a nozzle-free electrospinning device intended to augment the meagre 
fibre production associated with lab-based electrospinning equipment. 
6. Develop a straightforward, efficient and rapid protocol of extracting silk fibroin from 
Bombyx mori silkworm cocoons. 
7. Compare the antimicrobial efficacy of the developed bicomponent electrospun 
nanofibres to those of the currently available synthetic and biologic meshes. 
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1.3 Thesis outline 
This thesis spans two distinctive and well-explored domains of biomedical engineering; tissue 
engineering and biomaterials science. As a multidisciplinary work, the research conducted 
touches the fields of chemical, mechanical, and bioengineering, nanotechnology, material 
science, and microbiology. 
Chapter 2: This chapter presents a literature review that introduces the anatomy and 
physiology of the skin, the concept of wound healing and discusses the current challenges 
and advancements in the development of advanced wound healing dressings and skin-like 
platforms. An introduction to hernia repair is then provided from a surgical perspective, and 
the material science behind surgical meshes is described. The major implications and an 
overview of the current advancements in research are discussed. Finally, the theory and 
significant parameters of the electrospinning technique are provided, followed by descriptions 
of free-surface and co-axial electrospinning. 
Chapter 3: This chapter describes in detail the materials, methods and methodology followed 
in this thesis. Where appropriate, the background justifying the choice of specific materials 
and substances and the logic behind the characterisation techniques employed are discussed. 
The methodology is divided according to characterisation techniques. Included are 
morphological, physiochemical and mechanical assessment, drug release profiling, and an in 
vitro evaluation of the biocompatibility using fibroblasts and antimicrobial assessment based 
on class S2 pathogenic bacteria. 
Chapter 4: This chapter presents the design and construction of the nozzle-free 
electrospinning apparatus. This device is used to fabricate poly(glycerol sebacate) 
(PGS)/polyvinylpyrrolidone (PVP) microfibrous mats. The chemistry behind the riboflavin-
induced ultraviolet (UV) crosslinking of the fibrous dressings is discussed. Additionally, the 
effect of the proportion and the molecular weight of PVP on the physicochemical properties 
and the tensile properties of the biomaterial are assessed, and an in vitro evaluation of its 
biocompatibility is provided. 
Chapter 5: The nozzle-free electrospinning device described in the previous chapter is used 
for high-throughput fabrication of trinary electrospun scaffolds consisting of silk fibroin, PGS 
and PCL, capable of adjusting the wetting properties of the biomaterial. A novel protocol for 
the extraction of larger quantities of silk fibroin protein from Bombyx mori cocoons in a reduced 
timeframe is also described. Finally, the developed biomaterial is assessed for its ability to act 
as a skin substitute in vitro. 
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Chapter 6: Here, the issues described in Chapter 2 relating to the development of a 
mechanically stable, lightweight, antimicrobial nanostructured hernia mesh are considered. A 
dual antimicrobial system consisting of poly(hexamethylene biguanide) (PHMB) and 5-chloro-
8-hydroxyquinoline (5CLO8Q) in a core/shell structure comprised of nylon-6 in the core and 
chitosan in the shell is developed. The nanofibrous mesh core/shell structure, chemistry, 
mechanical properties, drug release profile and antimicrobial properties are evaluated against 
pathogenic bacteria and further compared to those of the counterpart nanofibres, synthetic 
and natural microfibres, as well as, biologically derived and synthetic meshes that are currently 
available on the market and used by surgeons for hernia repair. 
Chapter 7: This chapter provides conclusions, the limitations of the research conducted, the 
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2.1 Skin physiology and function 
The skin is the largest organ of the human body, with a surface area of approximately 16,000 
to 18,000 cm2, and it accounts for approximately 16% (5 kg) of a person's total body mass [1]. 
Most importantly, as a mucous ectodermal tissue, the skin works as a first line of defence and 
is responsible for the majority of the muscle, bone, tendon, fasciae, and ligament tissue 
compartmentalisation [2]. It is necessary to understand the function and mechanisms of the 
skin, as it can provide valuable insights into the requirements that have to be considered when 
engineering a synthetic skin-tissue-like platform. The subsections below describe the major 
components of the skin, its structure, functions, anatomical characteristics, and the role of the 
ECM. 
Part of the literature presented in this chapter draws from the author’s previously published 
review entitled “2D and 3D electrospinning technologies for the fabrication of nanofibrous 
scaffolds for skin tissue engineering: A review” (Keirouz et al., 2020a) and is used with the 
permission of the publisher (Appendix B). 
2.1.1 Components of the skin 
The skin carries out numerous tasks to maintain the physiological and biochemical conditions 
of the human body at an optimum level [3]. The integrated appendages into the skin's structure 
allow it to serve as a cushion for deeper structures [3, 4]. Amongst other functions, the skin 
also can regulate the body's temperature via eccrine and apocrine sweat glands, act as an 
external barrier against toxins and pathogens, and secrete and excrete substances with 
antimicrobial and bactericidal properties [2, 5]. Moreover, through the cutaneous production 
of small cationic antimicrobial peptides (AMPs) such as defensins, cathelicidins, and histatins, 
the skin can provide the first line of defence against pathogens through direct antimicrobial 
activity or by modulating host immunity responses, as Figure 2.1 indicates [6]. Furthermore, 
the skin provides mechanical support to the human body, it is an important sensory organ, 
carrying out primary immunological mediations, and it is responsible for the synthesis of 
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vitamin D upon exposure to sunlight [7]. In addition, as an excretory organ – the skin helps 
remove waste urea, salts, and water from the body [7]. 
 
 
Figure 2.1 Antimicrobial peptides (AMPs) secreted from the skin offer direct and indirect 
pathogen protection pathways.  Firstly, it induces membrane disruption due to electrostatic 
interactions between the bacterial membrane and AMPs. Secondly, through modulated host 
immunity, as it recruits/activates immunocytes or promotes the downstream regulation of Toll-
like receptors (TLR) which in turn promote the recognition of microbial metabolites, membrane 
constituents, or nucleic acids released by the damaged tissue. DC, dendritic cells; LPS, 
lipopolysaccharide; LTA, lipoteichoic acid; MAVS, mitochondrial antiviral signalling protein. 
Modified from Zhang et al. [6]. 
 
2.1.2 Layers and functions of the skin 
The general structure of the skin consists of a stratified tissue that has three layers; the 
epidermis, dermis and hypodermis (subcutaneous fat), from outermost to innermost, as 
illustrated in Figure 2.2. Each layer carries different physiological functions, and thus evolves 
and ages differently [3]. Regardless of its continuity, the morphological and mechanical 
properties of the skin differ significantly among diverse anatomical positions, where its 
thickness varies from 0.5 mm to 4.0 mm [8]. Healthy epidermis regenerates entirely from the 
basement membrane approximately every 28 days [9]. 
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The epidermis is the outer layer of the skin, with a thickness ranging between 50 µm 
(eyelids) up to 1,550 µm (palms and soles of feet), where sex discrepancies exist, with male 
skin being about 25% thicker [10]. The epidermis accounts for approximately 5% of the skin’s 
weight and is composed of five strata or layers: basale, spinosum, granulosum, lucidum, and 
corneum [3]. The stratum corneum is the outer layer of the epidermis and is composed of dead 
corneocytes containing keratin that conceal the ECM, thus acting as a physical protective 
barrier [10]. The epidermis has no blood supply of its own (avascular), and it receives 
nutritional support (oxygen and glucose) via a primary papillary layer of loose connecting 
tissue that is present in the dermis [11]. The epidermis is mostly composed of multiple layers 
of keratinocytes, along with Langerhans (dendritic) cells, melanocytes and produces 
basement collagens and keratin [12].  
 
 
Figure 2.2 Schematic representation of the structure of the skin layers and appendages. 
The architecture of the skin and epidermis, as well as the morphological properties of key 
reconstruction proteins. The letter “S.” stands for stratum. Modified from Benitez and 
Montans[10]. 
The dermis (1 to 2 mm thick) is a rich in blood vessels (vascular) layer of connective tissue 
interconnected (via junctions) beneath the epidermis layer [9]. The dermis provides structural 
and mechanical support, regulates the water content, and conveys neural sensory receptors 
such as Merkel cells (nerve endings) that act upon external stimuli [13]. Furthermore, it 
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facilitates adrenal (eccrine, apocrine, and sebaceous) glands, hair follicles, and permits blood 
and lymphatic circulation based on the confined metabolic requirements of the specific skin 
area [9, 12]. It predominately presents fibroblasts that synthesise type I, and IV/VII collagens 
[12, 13]. 
Lastly, beneath the dermis, the hypodermis facilitates the conjunction of skin with bones, 
muscles, and tendons [14]. The dermis further presents blood vessels, hair follicles, nerves, 
type I collagen fibres and elastin [12, 14]. The main cell types present are adipocytes and 
endothelial cells [13]. Moreover, the hypodermis acts as a storage site for adipose tissue 
(producing and storing triglycerides), and it is responsible for the photolysis of pre-vitamin D3 
and the excretion of vitamin D3 [9, 13]. 
 
2.1.3 The role of the extracellular matrix (ECM) 
The ECM is nature's template, responsible for maintaining the structural integrity of tissues 
and organs. Stem cells place ECM components in their surroundings from the starting point 
of embryogenesis [15]. The ECM regulates a range of intrinsic biochemical and mechanical 
signals that facilitate cell survival, phenotyping, cell-to-cell contact, and is responsible for the 
multicellular compartmentalisation of tissues and organs [13]. Dynamic reciprocity, defined as 
the constant bidirectional communication between the ECM and cells that allows for tissues 
to communicate with the external environment, is of great importance in identifying the 
required microenvironment responses of a wound [16].  
The skin's ECM is of fundamental importance when investigating the wound healing 
cascade for the development of efficient synthetic skin substitutes that can aid in wound 
healing as it directly – and indirectly – influences the architecture and composition of the newly 
forming tissue. During wound healing, the surviving cells in the wound bed will modify their 
secreted ECM products in response to fluctuations in oxygen level and nutrient depletion, the 
mechanical instability of the injured matrix, and numerous other factors from the surrounding 
niche [16]. These signals, then, travel through the ECM and are detected by cell-surface 
receptors that, in turn, activate the downstream regulation of genes that facilitate the skin's 
response to the injured area [17, 18]. 
Cells modify their secreted ECM products in response to various stimuli, including 
mechanical cues, oxygen, nutrient concentration, and many other factors taken up from the 
tissue's microenvironmental niche [19]. The ECM is composed of an array of approximately 
300 multidomain macromolecules [15]. The processes of the multifaceted wound healing 
cascade are mediated by ECM components such as collagen, fibronectin, vitronectin, elastin, 
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proteoglycans, a range of biochemical mediators, cytokines, and growth factors, among others 
[20]. That dynamic process also involves the coordination of blood cells, several growth factors 
(epidermal, platelet-derived, transforming, basic, and tumour necrosis), and ECM elements. 
Those factors regulate the haemostasis, inflammation, proliferation and differentiation of cells, 
ECM biosynthesis, epithelialisation and tissue remodelling, ultimately reinstating the continuity 
and physiochemical functionalities of the newly formed tissue [17, 18]. The ECM's 
microenvironment is critical for cell growth, survival, and differentiation; cells cannot survive 
without the ECM as it provides the basic template required for growth and maintenance [21].  
Among the skin's proteins, collagens are of pivotal and comprise more than 70% of the 
total dry weight of the dermis [22]. Type I collagen is a triple helix of repeated sequences of 
glycine with proline and hydroxyproline (MW 290,000 Da) that constitute approximately 80% 
of the entire dermis, whereas type II, III and IV (fetal) constitute for the remaining 20% of its 
total mass [23]. Type I fibres tend to be thick and elongated, whereas type III fibres are reticular 
and work as a framework for the synthesis of type I collagen. Collagen is almost solely 
responsible for the tensile strength and most of the mechanical properties of the skin [22]. 
Another protein present in the dermis, elastin, is a water-insoluble protein that makes skin 
pliable, via the secretion of the precursor tropoelastin [24]. Tropoelastin gives the epidermis 
its elasticity; it is approximately one thousand times as flexible as collagen and is the reason 
skin can distort [24]. 
On the other hand, vitronectin (MW 75,000 Da) is a proteolytic glycoprotein of the 
hemopexin family, present in the blood plasma that interacts with the ECM to assist clot 
formation during wounding [22]. Lamins (Type-A 400,000 Da and Type-B 210,000 Da) are 
present between the dermal and epidermal layers of the skin, where they crosslink cell surface 
receptors that ultimately assist cellular organisation and tissue generation [25]. Lamins are 
one of the first structural proteins that are produced during embryogenesis (from the 16-cells 
stage), followed by collagen IV [15]. 
Hyaluronic acid (HA) is a hydrophilic, anionic, non-sulphated glycosaminoglycan [26]. HA 
is capable of retaining moisture due to its molecular structure, thus keeping the skin layers 
hydrated [27]. Furthermore, HA acts as a short-term membranous frame during the wound 
healing process, transporting biomolecules, nutrients, and laminates keratinocytes to the 
damaged site [27, 28].  
Figure 2.3 shows the interaction of cells within an ECM-like scaffold, as well as how the 
ECM provides conditions that facilitate survival, growth, and expansion of the cells. Moreover, 
engineered ECM biomimetic analogues deriving from decellularised ECM components, 
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synthetic or natural polymers, or a combination of these materials, can act as a template in 
replacing injured ECM substrate. ECM-like scaffolds promote healing and growth of the tissue 
and are especially helpful in cases where the extent of an injury makes the response of the 
body insufficient to heal the wound properly [15]. 
 
 
Figure 2.3 Schematic representation of the cell-ECM interactions on different substrates 
and ECM remodelling. (a) Cells growing on a culture substrate dish. In this scenario, cells are 
grown in a planar direction, following an apical-basal polarity within a culture medium. (b) Cells 
growing on an ECM-like biomimetic scaffold. The biocompatible scaffold allows for planar and 
perpendicular growth without limiting the polarity of the cells. The matrix provides a biomimetic 
environment where cells can secrete growth factors and ECM-related components along the 
scaffold's fibrils. (c) A summary of the physiochemical and mechanical stimuli that, in turn, 
activate downstream intracellular signalling cascades and, ultimately, the transcription of ECM-
related factors. Afterwards, the secreted factors interact with cells that promote functions such 
Chapter 2 | Literature Review   17 
 
as proliferation, migration, differentiation, and tissue remodelling. MBV, matrix-bound 
nanovesicles; MMP, matrix metalloproteinase; FGF2, fibroblast growth factor 2; TGF-β, 
Transforming growth factor-β; VEGF, vascular endothelial growth factor. Modified from Springer-
Nature, Hussey et al. [15]. 
 
2.1.4 Anatomical characteristics and mechanics of the skin  
The skin will differ in structure and function based on different regions of the body [29]. Soft 
tissues are made of complex material and, structurally, can greatly differ among different 
anatomical sites [30]. The skin is a mechanically complicated tissue due to the heterogenic, 
anisotropic, highly nonlinear, and viscoelastic multidimensional behaviour [10].  
Dermal cells are regularly subjected to mechanical stimuli deriving from the ECM's 
surroundings and other neighbouring cells [31]. The way dermal cells adapt and reconstruct 
the ECM at an injured site depends on the dermis mechanics, where the viscoelasticity of the 
skin can influence the activity and phenotype of the resident fibroblasts [32]. Accordingly, the 
fibroblasts in the area will adapt the cytoskeletal actin remodelling according to the rigidity of 
the ECM, which in turn will directly impact the cell's phenotype, lineage and state [31]. 
Research has focused on determining the correlation between the axial and transverse 
mechanics of the skin and its microstructural characteristics, based on location and collagen 
fibre orientation [33]. In a rat model, this was found to be influenced by variations in the quantity 
of collagen and the micro-organisation of collagen fibres present in different anatomical areas 
of the skin [33]. When determining the tensile properties of different regions of the skin, the 
Langer lines of skin tension are taken into account that define the natural orientation of 
collagen fibres within the dermis [34]. The fibrils present in the ECM of the skin range between 
10–500 nm depending on the collagen ageing and maturation, where mechanically different 
anatomical sites can differ significantly in tensile strength, based on quasistatic and dynamic 
measurements, as indicated in Table 2.1 [19, 35, 36].  
From a mechanical perspective, electrospun fibres are broadly researched as graft 
implants or dressings in order to improve both wound healing time and outcome [37]. 
Electrospun fibres can present tuneable tensile mechanical anisotropy that can facilitate 
cellular contact guidance similar to that of the native ECM [37]. The biomechanical behaviour 
of the different skin sites can be used as a standard for the development of skin-like 
electrospun mats. By adjusting the mechanical properties of the electrospun fibrous 
biomaterial to match those of the specific skin area that endured the injury, the physiochemical 
responses deriving by the mechanical stimuli can be positively influenced, reducing the 
inflammation rate and subsequent fibrotic scarring. 
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Human skin 15 – 135 2 – 30 20 – 150 [35] 
(Arm) 87 – 101 13 – 15 59 – 102 [38] 
(Abdomen) 19 – 25 2 – 15 60 – 80 [8] 
(Back) 48 – 118 13 – 30 37 – 71 [34] 
(Forehead) 20 – 24 5 – 6 27 – 34 [38] 
Electrospun fibres 
Collagen 25 ± 5.2 1.5 ± 0.2 33 ± 9 [39] 
Collagen/Chitosan 380 ± 150 8.0 ± 2.2 30 ± 12 [40] 
Collagen/PCL 82.1 ± 17.9 8.6 ± 1.4 24 ± 7.2 [41] 
PCL 21.4 ± 0.1 6.9 ± 0.3 116 ± 6.5 [41] 
PCL/Gelatin 12.5 ± 2.8 4.9 ± 0.6 75.7 ± 9.1 [42] 
PLCL 47.7 ± 2.2 7.2 ± 0.2 158 ± 6.7 [43] 
PLGA 355 ± 58 5.6 ± 1.1 107 ± 20 [44] 
PLGA/Chitosan 75 ± 11 4.3 ± 0.7 32 ± 11 [44] 
PLGA/Chitosan/PVA 296 ± 32 5.4 ± 0.6 14.7 ± 6.6 [44]
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2.2 Skin burns and wounds 
The skin is an interface that establishes a barrier between the body and the environment [45]. 
When the structural integrity of the skin is compromised, a wound occurs. A wound is formed 
due to loss of continuity of the skin tissue layers, inclusive or exclusive of loss of function [46]. 
This can be due to the rupture of the tissue by trauma, burn, congenital anomalies, disease 
imposing physical distress, or other chronic defects [47]. Upon a skin injury, it is imperative to 
reinstate the skin's structural integrity to assure haemostasis, inflammation, cell migration, 
proliferation, and tissue maturation. 
 
 
2.2.1 Classifications of wound types 
Wounds can be classified as acute or chronic, based on anatomical properties and 
characteristics of the wound bed [46]. An acute wound arises when the continuity of the skin 
is fractured superficially [48]. The majority of acute wounds are due to minor trauma, avulsion 
fractures, surgical incisions or burns [49]. For a healthy individual that is not suffering from an 
excessive wound or does not have any underlying health conditions, an acute wound will 
generally self-regenerate and repair within 14 days to a month, following the stages of the 
cutaneous wound healing cascade described in the next section [46]. 
If the impaired skin area is incapable of reinstating the tissue's functions, restoring a 
functional ECM and promoting re-epithelialisation, the wound is defined as chronic or non-
healing [47]. Non-healing wounds can also be present in excessive wounds [47]. Chronic 
wounds do not follow the typical wound healing cascade, usually because of endogenous 
mechanisms related to predisposing pathological conditions or other risk factors that 
compromise the skin's structure [47, 50]. Upon haemostasis, a chronic wound is followed by 
constant inflammation on-site and a lack of healing; this ultimately causes ECM destruction, 
hypoxia, reactive oxygen species production, and an increased likelihood of bacterial 
colonisation and subsequent infection [51]. Factors such as autoimmune diseases, 
chemotherapy, obesity, malnutrition and ageing may worsen the chances of complete 
recovery and facilitate the development of chronic wounds [52]. Leg or foot ulcers and 
pressure sores are the most common chronic wounds, primarily present due to poor 
vasculature [52]. 
By contrast, burns are formed due to trauma of the skin tissue through exposure to extreme 
heat or cold, radiation, chemical agents, or high current electricity [53]. In trauma medicine, 
the 'rule of nines' is used to assess the total body surface area (TBSA) covered by the burn 
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[53]. For adults, each upper limb corresponds to 9% of TBSA, and each lower limb to 18%, 
the trunk (abdomen and chest) accounts for 18%, while the head and neck together make up 
9% [29]. The thermal injury of the skin will depend upon the temperature, thermal propagation 
and the duration of contact or exposure [54]. For instance, exposure of hot water at 65 °C will 
produce a full-thickness burn in 45 s, will create a deep partial-thickness burn in 15 s, and a 
superficial partial-thickness burn in 7 s [29]. 
Burns are commonly classified visually into first, second or third-degree burns based on 
the severity of the injury [55]. Typically, superficial first-degree and second-degree burns 
confine the epidermis and are visually red due to hyperaemia in the area and heal within two 
weeks without residual scarring [55]. However, deep (partial thickness) second-degree burns 
extend from the dermis, pass through the dermal papillae, and reach the reticular layer of the 
dermis [56]. The exposed dermis, along with the hyperaemia, forms vesications (blisters) and 
oedema. Medical intervention in second-degree burns will depend upon the extent of the burn, 
as they may lead to secondary infections and hypertrophic scarring [56]. Third-degree (full 
thickness) burns extend through the dermis to the hypodermis, which is composed of adipose 
and connective tissue [55]. Third-degree burns fully destroy the dermis, and consequently, the 
blood supply in the area. Moreover, due to the lack of blood and thrombosed vessels 
underneath the dermis, the area is visually ischemic with loss of sensation due to nerve 
damage [54]. Such burns require critical medical intervention and almost always requires 
some type of grafting to prevent systemic shock, due to body-fluid loss, and infection [57]. 
 
2.2.2 The wound healing cascade 
Healing is a normal response of a tissue to an injury. Wound healing is a multifaceted pathway 
of well-controlled and defined cellular responses, which facilitate the restoration of the skin's 
continuity along with its physiochemical functionalities [58]. This dynamic process involves the 
coordination of blood cells, biomolecules, growth factors, and ECM elements. The wound 
healing cascade can be separated into three distinct stages: (a) haemostasis and 
inflammation, (b) proliferation, and (c) remodelling and maturation [58]. The key aspects of the 
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a. Haemostasis and inflammation 
Once a penetrating trauma occurs, damaged epithelial cells initiate the antifibrinolytic -
coagulation pathway due to the release of inflammatory mediators [59]. Thrombin and clotting 
factors generate a platelet-rich plasma which coagulates the wound, within minutes [59]. In 
response to anti-inflammatory stimuli, prostaglandin is secreted from inflammatory cells, 
causing vasoconstriction, to limit blood loss in the wounded area [58]. The epithelial and 
endothelial cells on-site then secrete growth factors and chemokines that stimulate the 
recruitment of neutrophils and macrophages that, in turn, stimulate the production of 
interleukins (IL-13) and growth factors (e.g., TGF-β) [60].  
The neutrophils infiltrate the area within the first 24-48 h, clearing necrotic tissue and 
bacteria [60]. The circulating monocytes in the area will then differentiate to macrophages and 
further polarise to types M1 (pro-inflammatory) and M2 (anti-inflammatory) [59, 60]. Type M1 
is necessary as part of early defence responses, where M2 stimulate tissue regeneration. The 
ratio between M1/M2 plays a crucial role in chronic wounds, where M1 is the predominate 
form present, inducing chronic inflammation, via the constant secretion of IL-1β and TNF-α, 
and thus, preventing M2-mediated healing [59 – 61]. The myofibroblasts work towards 
contracting the wound, reducing the margins [59]. Stimulated myofibroblasts and epithelial 
cells also secrete matrix metalloproteinases (MMPs), which break down the basement 
membrane to allow for the recruitment of cells on the site [61]. The neutrophils and 
macrophages mature and cause complement-mediated opsonisation and phagocytosis, 
respectively, which remove tissue debris and dead cells [61]. Connective tissue matrix 
deposition allows for the development of a new ECM [62].  
 
b. Proliferation 
During the proliferative phase, granulation and epithelialisation occur, epithelial and 
endothelial cells move from the basement membrane of the tissue towards the epithelial layer 
[62]. Afterwards, fibroblasts and keratinocytes derived from local mesenchymal cells or bone 
marrow are recruited and activated in the area [62].  
The low oxygen tension and low pH due to an increase in the concentration of lactic acid 
stimulate the revascularisation of the area, to fulfil the energy requirements of the newly 
formed build-up [60]. Additionally, myofibroblasts cause wound contraction, which facilitates 
the closure of the wound from the edges towards its centre [63]. As the wound area starts to 
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recover, lymphocytes stimulate the prolonged release of TGF-β which in turn downregulates 
the gene expression of proteases that are responsible for the breakdown of the ECM and 
upregulate fibroblast release growth factors, interleukins and tumour necrosis factors [64]. As 
fibroblasts are deposited to the newly formed ECM, secreted collagen chains undergo 
processing, ultimately causing matrix reorganisation that can start to reinstate the proper state 
and responsiveness of the newly formed tissue [62].  
 
c. Remodelling and maturation 
In the final phase, the epithelial cells in the area divide and migrate through the basal layer of 
the skin to reinstate the normal structure of the tissue, completing the wound healing process 
[63]. Repeated injury or chronic inflammation can cause the newly formed granulated tissue 
to experience increased tensile strength due to extensive deposition of ECM components, 
eventually forming a fibrotic scar [65]. After, pro-fibrotic mediators (e.g., IL-13 and TGF-β) 
augment collagen deposition from the myofibroblasts in the area [65]. If the actin-myosin 
complex does not induce apoptosis to remove the myofibroblasts in the area (through the 
upregulation of TGF-β), the constant expansion of the ECM, through collagen deposition, can 
form excessive scars, such as keloids [63, 65]. MMPs and tissue inhibitors will control and 
provide a balance between the upregulation and downregulation of collagen-related factors, 
based on the net amount of collagen present in the newly formed tissue [62]. Several growth 
factors and ECM proteins slowly guide tissue maturation, which will ultimately restore 70%–
80% of the previously unwounded skin's mechanical strength within a year [63]. 




Figure 2.4 The wound healing cascade. The major phases of the wound healing process: 
Haemostasis, inflammatory response, proliferation, and remodelling. Whereas various cell 
lineages, cellular and ECM components contribute to coherent wound closure. EGF, epidermal GF; 
FGF, fibroblast GF; IGF, insulin-like GF; IL-1, interleukin-1; MMP, matrix metalloproteinase; PDGF, 
platelet-derived GF; TGF, transforming GF; TNF-𝛼, tumour necrosis factor-𝛼; VEGF, vascular 
endothelial GF. Light yellow colour boxes indicate an estimate timeframe for each phase. 
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2.3 Skin tissue engineering so far; advances and challenges 
Aiding wound healing and managing chronic wounds has been a critical issue since the onset 
of tissue engineering. Skin equivalents Integra® (Integra LifeSciences, Inc., USA) and 
Apligraf® (Organogenesis, Inc., USA) for treating burns and venous leg ulcers, respectively, 
were the first tissue-engineered products to obtain Federal Drug Administration (FDA) 
approval in the mid-late 90s [66]. The prospects for tissue engineering flourished in the next 
two decades, with many technical and regulatory challenges met. Nanotechnology and the 
benefits of nanoscale materials in all disciplines, including medicine, surfaced with the global 
nanomedicine market cap predicted to exceed 350 billion USD, from which over 26 billion USD 
will account from the global wound care market by 2023 [67]. Nonetheless, the current 
treatment options for handling chronic wounds, expounded in the section below, remain limited 
and – in many scenarios – ineffective. With approximately 1 in 5 diabetic patients developing 
a chronic non-healing wound, this is becoming an increasingly important issue worldwide [68]. 
Recent trends in developing such therapeutic approaches focus on achieving synergy 
between the biology that facilitates wound healing and the physicochemical aspects that a 
biomaterial system can provide. 
 
2.3.1 Traditional and impregnated dressings 
The Wound Healing Society has introduced the use of the acronym TIME to evaluate a wound 
and the corresponding healing steps required. "T" stands for tissue, referring to the 
assessment of the wound bed for dead or devitalised tissue. The "I" refers to the incidence of 
infection or inflammation. The "M" refers to the required moisture balance of the wound bed, 
and the "E" stands for the wound edges and extent of re-epithelialisation required [68]. 
Conventionally, this requires debridement of the wound followed by vacuum-assisted closure 
(VAC), which applies localised negative pressure to the surface and margins of the wound 
thus reducing the fluid around the wound while supporting granulation tissue formation [69]. 
This is followed by the use of the appropriate wound dressing, of which there are various 
choices available on the market, with the selection depending upon the stage of the wound 
and its pathophysiology. 
Traditional dressings and gauzes in the form of cotton, wool, and natural or synthetic 
polymers play a passive role in wound care, by preventing bleeding and initial contamination 
deriving from contact with the external environment [70]. The main advantage of such 
dressings is that they are affordable. However, they present poor bacterial protection, are 
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prone to dehydration, and damage of the newly formed epithelium, and can be painful to 
remove [70]. The use of topical antimicrobials such as iodine-releasing agents, chlorine-
releasing solutions, honey or – most popularly – silver nanoparticles are some of the 
approaches taken to improve the comfort of the patient and the antimicrobial effect of such 
dressings [71]. There are no findings that suggest that the use of a traditional dressing 
improves the outcome or timeframe of the wound closure [70]. 
A hydrogel is a three-dimensional (3D) network of crosslinked hydrophilic polymers 
capable of carrying large amounts of water due to the hydrophilic nature of its polymer chains 
[72]. Crosslinking of hydrogels can be based on covalent bonds or non-covalent interactions 
while adjusting the crosslink density will affect the porosity and swelling properties of the 
hydrogel [73]. Although hydrogels have been thoroughly studied, with several hydrogel-based 
dressings available on the market today, the excessive swelling due to the high-water content 
(>80%) limits the absorption of exudates [74]. Further, the prolonged exposure of the wound 
bed to moisture makes the injured site more prone to skin maceration and biofilm development 
[74]. The physical properties of hydrogels allow for tailored drug-delivery of antibiotics and 
other antimicrobial substances, which can be entrapped in the hydrogel's network during 
gelling [75]. Nonetheless, high-water retention formulates mechanically unstable structures 
[73]. Considerable work has been focused on reinforcing the structure of hydrogels, with the 
integration of materials such as graphene oxide and boron nitride. Nevertheless, this forms 
more brittle hydrogels that lack elasticity, a prerequisite for a wound dressing in order to be 
capable of adjusting to different anatomical sites of the body [32, 75].  
Semipermeable film dressings made of polyurethane (PU), such as Tegaderm® (3M 
Company, Inc., USA) and Opsite® (Smith & Nephew, Plc., UK) can adhere to the surroundings 
of the wound, while the transparency of the dressing allows monitoring the progression of 
wound healing [67]. Although such dressings provide a protective environment that does not 
permit the entry of moisture and limits contamination, they have poor breathability, thus 
entrapping CO2 and not allowing the entry of oxygen on the site [70]. Further, PU has a high 
water contact angle, which limits the film's ability to uptake exudates from the wound bed and 
is, therefore, only recommended for superficial wounds [70, 76]. Bilayer structures of 
semipermeable films integrating a hydrogel to increase the uptake of exudates have been 
developed, and films have been produced in literature by a range of materials, including 
chitosan, collagen, hyaluronic acid among others. However, it has been challenging to improve 
the degradability, breathability and mechanical stability of such dressings in vitro and in vivo 
[77]. 
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Foam dressings are absorbent porous structures, typically of PU or poly(vinyl alcohol) 
(PVA), capable of retaining the moisture required by the wound bed while absorbing wound 
exudate [78]. Foam dressings provide a "cushioning", an initial barrier to bacterial 
contamination, are not adhesive and are effective for the treatment of hypergranulation [78]. 
Such dressings are commonly used with secondary dressings to attain the required 
mechanical stability. However, they can easily desiccate the wound bed if there is no exudate 
present, which in turn can drop the wound bed temperature that has a direct negative effect 
on the wound healing process by delaying cell and enzymatic functions [67]. Further, 
decreased local temperature can increase the chances of infection due to vasoconstriction 
[70].  
In general, such dressings are contraindicated from being used in the case of full-thickness 
wounds and third-degree burns, as aside from providing a barrier to contamination they do not 
actively facilitate any part of the wound healing process. Lowering the temperature of the 
wound bed, not permitting gas transport, completely draining or overfilling the site with 
exudate, and thus increasing the chances of infection are some of the drawbacks of the 
conventional wound dressings described above. In any instance, acute and chronic wounds 
may demand the use of dermal substitute and skin-like constructs if the damage is severe. 
 
2.3.2 Current treatment and management options for excessive and 
chronic wounds 
The types of traditional wound care approaches described above aim to underpin the 
prevention of infection, limit ischemia and oedema by maintaining various states of hydration, 
thus allowing for the body to heal the injury naturally. Epidermal wounds can regenerate, but 
consequent breach to the dermis relegates granulation and subsequent scar formation [68]. 
The use of tissue engineering approaches through the advancements of biologic scaffolds can 
transform the scar tissue response to constructive remodelling of the wound bed [68]. Biologic-
derived scaffold materials consist of decellularised tissues, ECM components or hybrids 
composed of biologic and synthetic materials that can mimic the ECM’s architecture. In 
contrast to the wound dressings described earlier, biologic scaffolds ultimately act as an 
inductive microenvironment that through altering biochemical cues can facilitate the prompt 
restoration of the healthy skin's architecture, actively.  
The current standard for the treatment of non-healing wounds, wounds larger than 4 cm2, 
and excessive third-degree burns involve the use of different types of dermal substitutes or 
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skin grafts [79]. During the tissue flap procedure, skin is harvested from a non-affected part of 
the body – usually the thigh area – and transplanted to the wound. The current standard for 
skin harvesting is split-thickness skin grafting (SSG), which comprises the excision of the 
epidermis and a small portion of the dermis, leaving behind the bottom layer (reticular) dermis, 
which eventually heals by secondary intention [79]. In a different emerging approach of 
autologous grafting, epidermal grafting (EG), harvesting of only the epidermal layer, is 
achieved by applying heat to the area to form and raise blisters by negative pressure [80]. 
Nonetheless, autologous skin grafts can be associated with infection, pain, discolouration, and 
hypertrophic scarring; moreover, the total amount of skin that can be harvested from a patient 
is limited [81]. 
Epidermal and dermal substitutes are bio-derived scaffolds 1–2 mm thick composed of 
synthetic polymers or ECM components that incorporate autologous-derived cells that act as 
a dermal layer that assists wound healing [82]. Dermal substitutes can be used as less 
invasive alternatives to skin grafts. Dermal substitutes are not a new concept, with numerous 
products being well-established on the market today. Those can be (1) human-derived: 
Alloderm® (derived from acellularized cadaver skin); Glyaderm® (ETB-Bislife, Inc., 
Netherlands) (Glycerol-preserved acellular dermis), (2) porcine-derived such as Apligraf®, 
Permacol® (Metronic, Inc., USA) and Xenoderm® (MBP, GmbH, Germany) (3) bio-derived 
polymer material such as lyophilised collagen-based Integra®, Matriderm® (MedSkin 
Solutions, AG, Germany), OrCel® (Ortec International, Inc., USA) and hyaluronic acid-based 
Hyalomatrix® (Haemo-Pharma, GmbH, Austria) as well as (4) synthetic-based Dermagraft® 
(Organogenesis, Inc., USA) (polyglactin) and Transcyte® (Advanced Tissue Sciences, Inc., 
USA) (nylon coated with porcine collagen) [83, 84].  
Due to the complexity of the immune system, a successful dermal implant will involve 
complicated interactions between the wounded tissue and the biomaterial. Patients can 
receive immunosuppressive treatment to overcome those immunological challenges that are 
associated with artificial skin grafts derived from autologous cells, allogeneic cells, or 
xerographic tissues [85]. Moreover, immunomodulatory biomaterials (IBMs) can enable 
localised and targeted immunomodulation to the wound site, promoting specific immune 
responses that prevent the need for immunosuppressive medications, while prolonging the 
implant's lifetime [86]. Although considerable success has been associated with the use of 
dermal substitutes, complete bio-integration of the scaffolds requires an infection-free wound 
bed that is well-vascularised to promote tissue adhesion. However, such constructs are prone 
to infection and haematomas due to the poor integration with the injured host-tissue and 
immune rejection and are associated with prolonged periods of immobility [84, 87]. 
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2.3.3 New trends of electrospun biomaterials for wound healing 
Although significant advances in dermal skin substitutes have improved the outcome for many 
patients, there are many issues relating to the repair process of a wound yet to be solved [88]. 
Skin grafts, acellularized and synthetic bio-derived scaffolds are still associated with 
immunorejection, contraction, fibrosis, insufficient blood supply, inadequate bacterial 
protection, sensory loss, defective pigmentation and a high cost of production [4, 21]. These 
issues make the development of effective bioengineered skin models that can completely 
restore skin functions a current need.  
Electrospinning (Described in detail in Section 2.6) has always played a pivotal role in the 
fabrication of skin substitute products that encompass all the desired properties for successful 
wound closure and skin regeneration. Natural polymers have, from an early point, been 
considered suitable candidates for the development of electrospun materials due to their 
intrinsic architecture and elicited biological properties [89]. Furthermore, natural polymers also 
carry various tissue niche requirements, are biocompatible, and may present antimicrobial 
properties. Due to their high resemblance with ECM components, these materials are less 
prone to induce chronic inflammatory responses and immunotoxicity, which is more often 
encountered in the case of synthetic polymers [90].  
Many in vitro and in vivo studies suggest that naturally derived polymers, such as collagen 
and silk fibroin-based fibrous membranes, present better cell adhesion and proliferation 
properties than synthetic polymer-based fibres [91, 92]. Collagen nanofibrous scaffolds with 
sustainable release of silver (Ag) nanoparticles showed increased antimicrobial activity 
against Staphylococcus aureus and Pseudomonas aeruginosa, with no signs of oedema and 
complete re-epithelialisation of a full-thickness wound in a rat model within 14 days [93]. A Silk 
fibroin-PEO composite where sodium chloride crystals were incorporated to increase the 
porosity of the electrospun nanofibrous membrane upregulated the expression of burn-
induced cytokines and growth factors and induced re-epithelialisation of rat models of tissue 
burns in 21 days [94].  
Nonetheless, naturally derived scaffolds present poor mechanical stability; moreover, their 
rapid degradation may affect the subsequent phases of the healing cascade [95]. Furthermore, 
the overlap concentration (Co), the degree of polymer branching, and the chosen solvent 
system may be hard to adjust and thus affect the electrospinnability, reproducibility, and 
homogeneity of natural-derived fibres, as insufficient solubility, stiff molecular conformations, 
and low conductivity can halt a solution from being electrospun [96]. For this reason, many 
studies have focused on the development of scaffolds that integrate the cytocompatibility of 
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natural polymers with the mechanical and physiochemical integrity of synthetic polymers. The 
incorporation of natural-derived polymers such as silk fibroin, chitin, and cellulose with 
synthetic polymers can increase their mechanical complexity while alleviating their 
processability. Combining such materials and forming polymer blends can increase the 
chemical bonding, for instance by forming higher ratios of polyester and polyether linkages, 
thus vastly improving the mechanics, surface wettability, and cell-scaffold interplay [97]. 
Synthetic non-toxic polymers such as poly(vinyl pyrrolidone) (PVP), poly(vinyl alcohol) 
(PVA), poly(ethylene oxide) (PEO), poly(caprolactone) (PCL), poly(lactic-co-caprolactone) 
(PLCL) are some of the most used polymers for skin TE applications. Variations of such 
polymers within the electrospinning polymer mixture can directly impact the characteristics of 
the fibres formed, such as the fibre diameter, pore size, and mechanical properties of the 
fibrous mats.  
The first requisite of a skin substitute is that it maintains a microenvironment that favours 
wound contraction and re-epithelisation, while minimising excessive collagen deposition and 
subsequent scarring. Factors such as fluid uptake and water vapour retention can support the 
required moisture in the wound site and remove any excess drainage appropriately. Due to 
the micro/-nanostructure and increased porosity, electrospun materials are better at taking up 
fluids than conventional dressings and dermal substitute products [94]. A dressing with high 
water vapour transmission rate dehydrates the wound, making it more prone to scarring, 
whereas the low water vapour transmission rate increases the risk of infection and may impair 
the healing process due to the build-up of exudates in the wound bed, consequently finding 
the balance between the two remains challenging. An electrospun wound dressing developed 
out of cellulose acetate/gelatin with variant amounts of hydroxyapatite showed that increasing 
the concentration of hydroxyapatite increased the water vapour transmission rate (WVTR) 
because of the wider pores (15.6 ± 7.1 µm) of the dressing [98].  
Altering the biomechanics of the electrospun mats with an aim to increase the flexibility 
and mechanical stability of the wound dressing is also crucial for wounds in “difficult” 
anatomical sites, such as places where the skin naturally curves or is more rigid. Being able 
to produce a skin-like product tailored to the mechanics of a specific anatomical site can 
directly impact the ECM depositions and subsequently, the cellular response, reducing the 
chances of fibrotic tissue formation [31]. Contrary to the observations relating to guided cell 
infiltration and improved unidirectional mechanical properties, randomly oriented fibres grant 
better outcomes for wound healing due to the higher complexity and better stability. The 
matrices composed of random fibres present polymer chains entangled to formulate distinct 
voids and porosities, which can further promote wound healing of difficult anatomical sites due 
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to bidirectional mechanical stability [99]. A recent study found that PCL cast films are inferior 
to randomly oriented or aligned nanofibres (NFs) due to their semi-crystalline brittle and 
inflexible nature, in contrast with the enhanced plasticity linked to the amorphousness of the 
electrospun mats [99]. It has been shown that scaffolds with aligned NFs promote better cell 
migration, where the orientation of the fibres may play a crucial role in promoting actin growth 
[100]. Nonetheless, aligned fibres present poor bidirectional mechanical properties, do not 
present the advanced interconnectivity provided by the increased porosity in randomly 
oriented matrices, and cannot prevent bacteria entry. 
Common strategies have been developed to implement the immunomodulatory activity in 
electrospun fibres via M1/M2 macrophage polarisation [101], glycosaminoglycans (GAGs) 
[102], and decellularised ECM material [103]. Castellano et al. [100] developed a 
poly(hydroxybutyrate) (PHB) electrospun bilayer dermo-epidermal skin equivalent implant 
consisting of human keratinocyte and fibroblast isolates, which was compared with 
Matriderm® and PCL NFs. The PHB dermo-epidermal graft was implanted as a xenograft onto 
mice and was found to be superior in terms of cell adhesion and proliferation; capable of 
inducing M2 macrophage polarisation (based on CD206+ CD68+ quantifications of the biopsied 
tissue), with a significant reduction in the M1/M2 ratio, increased angiogenesis, and absence 
of hyperplasia during the re-epithelialisation of the wound site (the dorsal region of NOD/SCID 
mice) compared to the other groups examined. Recently, sustained release of a synthetic 
GAG-mimicking polymer structurally-tailored glycopolymers, in the form of core-shell NFs 
consisting of PCL, modulated endothelialisation due to VEGF and bFGF bound endothelial 
receptors triggering downstream events [101]. Moreover, a fibrillar structured Human umbilical 
vein endothelial cells (HUVECs) cultivated biodegradable poly(L-lactide-co-caprolactone) 
(PLCL) human fibroblast-derived ECM (hFDM) electrospun membrane, formulated a 
mechanically stable construct that promoted re-epithelialisation, collagen deposition, 
neovascularisation, and effective wound closure within 28 days [102]. 
Several in vivo studies using a variety of cell types have indicated that seeded scaffolds 
with the corresponding dermal lines, or cells deriving from a recipient donor, are associated 
with better healing properties than acellular scaffolds [104]. Electrospun scaffolds cultivated 
with dermal cells can improve the skin regeneration properties as they can engage in the 
injured site and accelerate the repair and restoration processes. The versatility of 
biocompatible synthetic and natural materials for electrospinning allows the development of 
lightweight constructs with tuneable mechanics and elasticities, reducing the morbidity 
associated with dermal substitutes [105]. The small pores and increased porosity of the 
electrospun mats, which is in general over 80% for TE constructs [105], along with the range 
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of different tactics that can facilitate the integration of antimicrobial substances, can deter an 
infection from occurring through physical or active barriers.  
Various functionalities, such as the wetting behaviour of the matrices, antimicrobial 
properties, drug release, and stimulant-responsiveness can be adjusted to attain the best 
available requirements for wound protection and healing [106]. Table 2.2 summarises the key 
properties of interest of electrospun fibres for skin tissue engineering applications. 
 
Table 2.2 List of the key properties of interest of electrospun fibres for skin tissue engineering 
applications. 
Property Purpose Ref. 
Vast choice of natural and 
synthetic polymers 
Capable of attaining biocompatible constructs with variant 
morphologies and properties. Possible to adjust the 
degradability of the biomaterial. 
[90] 
Fibre diameter ranging from 
nano to micrometres 
Mimics the physical geometry of the natural ECM. [90] 
High surface area-to-mass (or 
volume)-ratio 
Haemostasis promotion. Surface functionalisation. 
Increased space available for cells to expand and transport 
substances. 
[90] 
High porosity (60%–90%) Cell respiration; cellular ingrowth; gas permeability; 
prevention of wound dehydration. 
[94] 
Interconnected porosity Prevention from microbial infiltration and cell ingrowth. [94] 
Mechanical properties Can be adjusted to those of the human skin. [99] 
Lightweight Ease pain and reduce foreign body sensation. [105] 
Thermal insulation Preserve the wound bed temperature. [94] 
Design the drug release profile 
of interest 
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2.4 Hernia 
A hernia is the abnormal protrusion or prolapse of a tissue or organ through the wall of the 
cavity that usually contains it [107]. Weakening of the abdominal muscle, deserted connective 
tissue and increased abdominal pressure incite the organ to bulge out [108]. The protrusion 
through the peritoneum (the lining of the abdominal cavity) forms the hernial sac that consists 
of fatty tissue, bowel, other organs or fluid [107]. Typically, the hernia bulging can be seen and 
felt externally. 
A substantial body of evidence supports a genetic predisposition to hernia formation and 
reherniation, with a genetic profile displaying a decreased expression of collagen I and 
increased expression of collagen III [109]. In general, hernia formation occurs in anatomical 
sites where there is an absence of fascia and muscle [108, 109]. Such areas include the 
inguinal canal (groin), umbilicus, pelvis, and the femoral canal [108]. Early or late 
postoperative wound-related issues, such as wound infections, seromas or wound 
dehiscence, can also predispose to the creation of incisional hernias [110]. Other contributing 
factors linked with hernia occurrence include ageing, obesity, smoking and pregnancy, among 
others [110]. 
Inguinal and paraumbilical/umbilical hernias are the most common, accounting for over 
75%, followed by epigastric and incisional 15% and other forms 10% [111]. The majority of 
inguinal hernias occur in men (98%), with 30% of the patients developing a second hernia at 
the opposite side of the groin [112]. Approximately 5% of the population aged over 45 years 
will develop a hernia; where it is 10–fold more likely to occur in men than in women [113]. 
Hernias are classified according to location, size and their ability to reduce [114]. Reducible 
hernias can be dealt with by applying manual pressure using a supportive undergarment, such 
as a hernia truss or belt [115]. Irreducible hernias, on the other hand, can constitute a medical 
emergency and over time, require surgical intervention [115]. Hernia repair is one of the most 
commonly performed elective operations [116]. Surgically, hernia repair involves reduction of 
the hernia, closure of the hernia defect, and reinforcement of the abdominal wall by either 
sutures or a net-like prosthesis [107]. The two common approaches of surgical intervention 
involve hernioplasty (open or laparoscopically) or herniorrhaphy (open hernia repair) [114]. 
• During herniorrhaphy, also known as the Bassini technique, an incision is made in the 
abdominal wall followed by excision of the contents of the hernial sac, sewing the 
weakened tissue, and suturing the opening [117]. As the sewing and the placement of 
the sutures induce tension in the region, herniorrhaphy presents higher risks of hernia 
reoccurrence, post-operative chronic pain and prolonged recovery and is thus 
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generally not the avenue of choice today [118]. However, herniorrhaphy remains the 
most prevalent form of hernia repair in most of the developing world due to its low cost 
[114].  
• During hernioplasty, the hernia is reduced into the abdomen and reinforced with a 
mesh that is fixed on the site with fibrin glue, staples or sutures [107, 119]. There are 
different mesh placement techniques (onlay, inlay, sublay, and underlay) that take into 
account the area of the hernial sac and the corresponding fascia [117]. The post-
operative probability of surgical complications will be influenced by the type of mesh 
and the surgical technique chosen, as well as the surgeon's “learning curve” [120]. 
o Among the hernioplasties, the two most common laparoscopic techniques for 
hernia mesh placement are transabdominal preperitoneal (TAPP) repair and 
total extraperitoneal (TEP) repair [119]. These two laparoscopic techniques are 
less invasive procedures. The TAPP technique involves entering the peritoneal 
cavity and placing the mesh over the probable hernia site, whereas the TEP 
technique, does not enter the peritoneal cavity, but rather, places the mesh at 
the transversalis fascia region, the area between the parietal peritoneum (the 
peritoneum of the abdominal wall) and the visceral peritoneum (the peritoneum 
of the internal organs) [117, 119].  
Suture closure for hernia repair is acknowledged for having high recurrence rates, while 
the use of synthetic and biologic meshes can reduce the chances of hernia reoccurrence by 
over 50% [121–123]. Nonetheless, surgical prosthesis has been associated with foreign body 
sensation, rapid cell ingrowth (deep tissue adhesion), shrinkage, chronic scarring, 
immunogenic responses, and mesh-specific surgical site infections (SSI) [107].  
Although the chances of mesh-related SSI are typically low, ranging from 0.7%–2.0% for 
laparoscopic and as high as 9%–18% for open hernia repair, due to the high number of hernia 
operations performed annually, this corresponds to tens of thousands of cases [124]. In the 
United States, the Clinical Congress of the American College of Surgeons has determined 
that the total excess of mesh infection treatment surpasses $100,000 USD, taking into account 
hospitalisation expenses and follow-up costs for the span of a year [125]. Unfortunately, once 
an infection settles on a surgical mesh, a limited number of options are available, where re-
operating to surgically remove the implant will be required for more than 40% of the incidents, 
which significantly increases the chances of hernia reoccurrence and predisposes the patient 
to surgery-related complications [126]. There have been significant efforts in the literature to 
functionalise meshes to provide some form of antimicrobial protection, with some being 
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clinically available today. Nevertheless, further understanding the risk factors, pathogenicity, 
and limiting aspects of the prosthetic meshes available today, can further advance the 
properties of such implants and their post-implantation responses over time. 
 
2.4.1 Hernia mesh architecture: morphological, physiochemical and 
mechanical properties 
Since the first reported hernia mesh developed in the mid-1950s by Dr Francis Usher 
consisting of a woven type of polyolefin plastic, research, and development of surgical meshes 
has focused on textile-based constructs that provide good mechanics and porosity for efficient 
transport of intracellular metabolites, nutrients, and gases [107]. At this point, the aim of a 
prosthetic mesh was to replace and reinforce the defected area, stabilising the abdominal wall, 
providing long-term relief of symptoms and preventing hernia recurrence [127]. Subsequently, 
the development of mesh implants has shifted towards nonwoven, knitted and warp-knitted 
structures due to their macroporous morphology and high anisotropic elastic strength, rather 
than woven meshes that offer tightly packed structures of low filament density that have been 
linked to poor cell ingrowth [128].  
After that, as more synthetic polymers obtained FDA-approvals based on their 
biodegradability, biocompatibility and non-toxic properties, mesh implants started being 
classified based on the material’s biological response as absorbable, non-absorbable, or 
partially-absorbable [128]. Absorbable meshes degrade within the body over time, gradually 
reducing the mechanical strength of the implant, while non-absorbable meshes do not fully 
degrade and can provide long-term reinforcement of the repaired hernia [128, 129]. Partially 
absorbable mesh implants are based on bicomponent fibres, consisting of a biodegradable 
and a non-biodegradable polymer drawn together to a single filament in the format of side-by-
side, core-sheath, segmented or matrix-fibril [129].  
The majority of synthetic polymers used for prosthesis are characterised as nonpolar, 
highly hydrophobic, electrostatically neutral, and resistant to enzymatic degradation [130]. 
Polypropylene (PP), polyester (PE) and expanded polytetrafluoroethylene (ePTFE) are the 
most commonly used polymers employed for the development of mesh materials [131]. 
Numerous factors need to be considered when examining a material towards its ability to be 
used as an implant for hernia repair, including the material’s mechanics, morphological 
properties, and biological responses. From a design perspective, the biomechanical and 
compositional properties of a mesh are distinguished based on filament construction (mono-
/multifilament), pore size (macro/micro) and weight [132]. 
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The porosity and pore size of the mesh refers to the ratio of nonsolid (voids) to solid space 
of a defined area and the diameter of the pores, respectively [131]. The porosity is a significant 
indicator of an implant, as it incites the proportion of host tissue incorporation that may, to an 
extent, also reduce the chances of bacterial colonisation [133]. Currently, the pore size of 
prosthetics is defined as; very large (> 2000 µm), large (1000–2000 µm), medium                                   
(600–1000 µm), small (100–600 µm), and microporous, also referred to as solid (< 100 µm) 
[134]. Studies suggest that meshes with widre pores (> 1.5 mm), referred to as macroporous, 
can promote collagen deposition and vascularisation while minimising granuloma bridging, a 
process where individual granulomas become confluent encapsulating the entire mesh [135]. 
This event is commonly associated with microporous structures where the pores are in close 
proximity [135].  
Nevertheless, macroporous meshes may induce enterocutaneous fistulas; the connection 
of the bowel lumen to the skin wound formed due to the surgical incision when the mesh is 
placed intraabdominally in direct contact with the viscera, a severe condition with a high 
mortality rate (≤ 15%) [136, 137]. To minimise bowel adhesion, second-generation (composite) 
meshes, capable of being placed in the intraperitoneal space preventing adhesion between 
viscera and parietal regions have been developed [138]. Parietex® (Medtronic, Plc., Ireland) 
and Proceed® (Ethicon, Inc., USA) offering a resorbable collagen coating on one side, 
4DryField® PH (PlantTec Medical, GmbH, Germany) offering a barrier gel basing deriving 
from potato starch, as well as DualMesh® (W.L. Gore & Associates, Inc., USA), Dulex® and 
Composix® (Bard Davol, Inc., USA), which offer micro and macroporous sides, are 
commercially available products that have been used to limit visceral attachment [107, 138].  
Over the years, “heavyweight” meshes (≥ 80 gm-2), have been associated with chronic 
pain, foreign body response, fibrosis, as well as enterocutaneous fistula [127]. Ever since 
prostheses design has focused on reducing the density of the material while attaining the 
appropriate mechanics [127]. Today, a prosthetic mesh can be defined as medium-weight 
(50–80 gm-2); lightweight (35–50 gm-2); and ultralight-weight (≤ 35 gm-2) [139]. Reducing the 
thickness of the filaments during extrusion is the main approach used to decrease the overall 
weight of the material and the corresponding weight to foreign material density ratio [140]. 
Several studies have indicated that the use of lightweight meshes is substantially more 
advantageous in reducing long-term complications, such as scar formation and are less prone 
to severe inflammatory reactions and foreign body responses, compared to heavyweight 
meshes [141]. 
The filaments of synthetic meshes are produced via extrusion in the form of multi-/or 
monofilaments [107]. Monofilament yarns are larger in diameter, whereas multifilament yarns 
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consist of a series of braided, smaller diameter fibres [142]. The monofilament diameter 
ranges from 0.065 to 0.165 mm [107], where the multifilament diameter is at a similar range 
but consists of fine monofilaments ranging between 10–50 μm each [143]. Nevertheless, the 
risk of infection is a prominent issue of multifilament meshes, as small approximately 10 μm 
interstices created in-between braided fibres, can allow for the infiltration and sufficient 
colonisation of bacteria, thus causing infection [132]. In general, monofilament meshes are 
less prompt to bacteria adherence, due to low pore interconnectivity, and have been found to 
present an enhanced bacterial clearance compared to multifilament meshes, by readily 
allowing access of the immune cells onto the mesh [142, 143]. In such instance, mesh 
explantation due to an infection is also more commonly associated with multifilament 
compared to monofilament meshes, mostly due to the better bacterial adherence and the poor 
infiltration of macrophages and neutrophils at the area [139]; a macrophage is about 20–30 
μm in diameter, although it can deform to fit through gaps as small as 5 μm [144], as oppose 
to Staphylococci species that range between 0.5–1.0 μm [145]. Electrospinning can resolve 
this issue while attaining a multifilament morphology through the loading of antimicrobial or 
antibiotic substances within the fibres; by fibre surface modification (e.g., polycationic surface) 
that can induce contact killing; or by creating wider pores (e.g., cryogenic electrospinning, salt 
leaching), which can produce pores ranging from 10–500 µm [146]. 
The abdominal wall has a laminar organisation that underlies several broad, sheet-like 
muscles attached on the deep fascia that form tendon fibres and fibre bundles oriented in 
various directions [147]. Due to the anatomy of the abdominal muscles, the transverse and 
oblique muscle groups produce lateral forces significantly greater than the stress produced by 
the longitudinal rectus abdominis muscles, making the abdomen naturally more rigid 
horizontally and elastic vertically [148]. A prosthesis should be able to mimic the abdominal 
wall biomechanically and withstand the intraabdominal pressure, which will depend upon the 
material chosen and the architecture of the drawn filaments [132]. Cobb et al. [149] measured 
the intraabdominal pressure (IAP) of a group of individuals under different scenarios; such as, 
sitting and standing, coughing, jumping while lifting weights, and found the highest IAP to be 
171 mmHg, which did not differ based on sex. Klinge and co-workers [150] used the Laplace 
equation and the thin-walled cylinder theory; that states that the overall tensile strength 
required will not dependent upon the thickness of the mesh, to define the maximum 
physiological tensile strength per unit of width at 32 Ncm-1 in the lateral direction. Pott et al. 
[148], examined the longitudinal and transverse mechanical properties of six commercially 
available hernia meshes using a uniaxial tensile tester and discovered that the maximum force 
(11.1 ± 6.4 to 100.9 ± 9.4 Ncm-1) and stiffness (0.3 ± 0.4 to 4.6 ± 0.5 Nmm-1) differ significantly 
considering the direction of tension. 
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At a force of 16 N, Junge and co-workers [151] have defined the elasticity of the abdomen 
to be 15%–69% vertically and 7%–25% horizontally. In general, knitted structures present 
higher elasticity in comparison to woven structures, due to unidirectional stretching of the 
fibres [132]. Depending on the weight of the mesh, the elasticity of most commercially 
available meshes ranges between 4%–16% for heavyweight meshes and 20%–35% for a 
lightweight prosthesis [152]. Further, the rate of degradation of the mesh has a direct impact 
on its tensile strength over time and if the required mechanical stability is lost early on (five 
months post-implementation), it may contribute to hernia reoccurrence [153].  
 
 
Figure 2.5 Morphological characteristics of synthetic versus biologic mesh reinforcement. 
Macroscopic images of (a) synthetic polypropylene mesh; Ultrapro® (Ethicon, Inc., USA) and (b) 
Biologic collagen-derived mesh; Strattice™ Reconstructive Tissue Matrix (Allergan, Plc., Ireland). 
SEM micrographs of synthetic polypropylene meshes (c) BARD™ (C. R. Bard, Inc., USA), (d) ECM-
coated BARD™ and (e) Ultrapro®. SEM micrographs of biologic meshes (f) Strattice™, (g) 
Veritas™ collagen matrix (Veritas Technologies, LLC., USA) and (h) Alloderm® acellular human 
tissue matrix (Biohorizons Implant Systems, Inc., USA). The images were obtained as follow, (a, 
c-e) derived from [160], (b, f and g) from [161], and (h) from [162]. 
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To achieve permanent repair of the fascia defect and prevent reherniation, the 
implemented mesh needs to finely regulate the integration of material within the host tissue, 
in a process that involves inflammation, proceeded by cellular and vascular infiltration and 
ECM remodelling [133]. As with skin grafts and dermal substitute products discussed in the 
previous section, biologic prostheses are referred to as third-generation meshes; deriving from 
decellularised animal (xenografic) or human (allograft) sources [154]. In general, biologic 
meshes are in the form of collagen matrices and have been introduced as a promising 
alternative to first-generation (non-absorbable) and second-generation (absorbable) synthetic 
prostheses [154]. Due to the morphological and intrinsic similarities with the native ECM 
fascia, biologic meshes can better promote tissue reconstruction at a cellular level [155]. 
Synthetic meshes are commonly associated with chronic pain, bowel adhesion 
(enterocutaneous fistula), shrinkage, discomfort and infection [128, 156]. Unlike synthetic 
meshes, biologic meshes can grow into a highly vascularised mesh-tissue complex, that over 
time and through the constant deposition of collagen can provide the appropriate strength and 
integrity to the affected region [132]. This occurs similarly with the closure of a wound. The 
long-term success of a biologic graft will depend upon the fine-tuning of its properties to avoid 
strong inflammatory responses that may lead to excessive scarring and allow for the efficient 
collagen deposition and tissue remodelling to replace the fibrotic tissue, followed by the latent 
resorption of the implant [133]. Figure 2.5 compares the macro- and micromorphology of 
various commercially available synthetic and biologic, surgical meshes. 
Adjusting the degradation properties of biologic-derived materials can be hard to obtain 
and mostly inconsistent, predominately done by adjusting the number of collagenase binding 
sites, ultimately retarding the degradation of the donor collagen [133, 155]. Crosslinking the 
biologic tissue can also be used to adjust the degradation rate but at the expense of not 
preserving the ECM structure of the mesh that may increase the chances of chronic foreign 
body type reactions [157]. Even so, when comparing absorbable with biologic prostheses, 
absorbable meshes are associated with an 8%–10% rate of enterocuteneuous fistula and 
higher chances of rehernation (≥ 50%), as they do not offer an appropriate substrate for 
effective wall reconstruction, but rather just the resorbability of the mesh material over a poorly 
defined period [128, 158, 159]. Nevertheless, the cost of producing and preserving biologic 
meshes is high due to tissue donor limitations, manufacturing, decellularisation methods and 
the requirement of biologic tissue-derived materials being kept under constant rehydration 
[158]. 
The probability of hernia reoccurrence after implantation of a biologic mesh over a 
permanent synthetic prosthesis, is higher, as demonstrated in large groups (660 participants) 
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of patients undergoing hernia repair using collagen-based Surgisis Gold® (Cook Biotech, Inc., 
USA) or conventional polypropylene prosthesis (19% over 5% recurrence, 95% CI, p≤ 0.05) 
based on the LAPSIS trial (ISRCTN: 34532248). Nevertheless, it is hard to equate the 
reoccurrence rate in a “one-fits-all” approach, with many groups arguing that the type of 
biologic prosthesis and the period that the construct maintains its tensile strength for, will affect 
the rate of collagen deposition and the “quality” of the reconstructed tissue [130, 133, 163]. 
Overall, biologic meshes are expensive to obtain, carry ethical concerns (animal treatment, 
religious concerns, etc.), can be limited to the size of the graft, can be challenging to determine 
the degradation rate of the material, may present high recurrence rate, and can present poor 
mechanical stability [139]. Nevertheless, the high resemblance with the native fascia and the 
high vascularisation and scar remodelling, makes them a useful candidate in the market.  
 
2.4.2 Mesh-specific surgical infections 
Along with mesh erosion, mesh migration and enterocutaneous fistula, hernia mesh-related 
infection is a prevalent and potentially serious condition for which the patient will require further 
interventions, incurring significant health costs. Approximately 60,000 mesh-related surgical 
site infections occur in the US alone every year, with similar numbers being reported in Europe 
[139]. In contrast with superficial surgical site infections (SSI), where the infection only 
interferes with the skin and subcutaneous tissue and can be dealt with by draining the wound 
bed, deep incisional SSI occur on the surface of the mesh and are extremely complicated to 
manage [164]. Further, monitoring and treatment of a deep incisional SSI will account for a 
year, rather than two months in the case of superficial SSI [164]. 
 In general, the most frequent route of mesh contamination is during the initial incision, 
where endospores and other bacteria forms on the skin flora or the intestine due to missed 
bowel injuries may relocate to the surface of the mesh upon contact with the skin during 
emplacement [165]. Gram-positive Staphylococci species, primarily S. aureus, are the most 
common pathogen, accounting for 90% of mesh-related infections [166]. Other Gram-negative 
bacteria that have been isolated from infected meshes, such as Pseudomonas aeruginosa 
and Enterobacteriaceae species are also commonly found [166]. Polymicrobial mesh 
infections may also occur [167]. 
 It has been shown that the implantation of a medical device increases the chances of 
infection by a factor of 10,000 – 100,000; in the case of surgical meshes, even though about 
a third up to a half of the implanted meshes will be contaminated with bacteria, only  a small 
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number of them will develop an infection under clean surgical practices [139]. The chances of 
mesh-specific infection will depend upon the type of hernia and the surgical method; the 
chances of incurring deep tissue mesh infection during open surgery is between 2%–4% for 
most hernia operations, but as high as 6%–10% for incisional hernia repair [168]. 
Nevertheless, laparoscopy decreases the chances of infection to below 2% [164]. Other 
factors negatively affecting the chances of infection include the “learning curve” of the surgeon, 
the size of the hernia, the type, density and form of the mesh filaments, the patient’s long-term 
health conditions, such as diabetes, obesity, or autoimmune disorders among others [126]. 
Pre-administering antibiotics is a common practice, although there are no studies that have 
indicated that doing so reduces the chances of establishing a mesh infection [169]. Mesh 
infection diagnosis is based on clinical, microbiological and radiological findings, and can be 
categorised as early or late. Diagnosing a deep mesh infection is conducted by imaging via 
ultrasound or computerised tomography (CT) and serologically by fluid aspiration [170]. In 
many instances, the low number of bacteria obtained during collection may result in false-
negative cultures [165]. 
Late diagnosis of a mesh infection constitutes to a mortality rate of 1% [139]. Treatment 
consists of wound irrigation, prolonged antibiotics, partial or complete mesh removal or a 
combination of these [171]. Despite all the efforts, the blood-mesh barrier and poor 
incorporation of the surrounding tissue limit the innate cells from reaching the formed biofilm, 
ultimately necessitating for the surgical removal of the mesh in over 40% of the cases [164]. 
Re-operation to surgically remove the mesh, predominately in the form of open surgery, may 
require as many as five surgical interventions, thus significantly increasing the risk of 
subsequent reherniation by over 20% [172]. 
As previously noted, with over 200 hernia meshes being commercially available today, 
there is a direct correlation between the variant types of surgical prostheses available and the 
chances of infection [173]. Adherence of bacteria is highly variable, where the microscopic 
structure of the filaments directly influence the adherence and subsequent colonisation, where 
multifilament meshes have been found to be twice as likely to lead to infection than 
monofilaments meshes [173]. Biologic meshes are generally less prone to infections due to 
better revascularisation and cellular infiltration through their inherent ECM morphology [174]. 
Figure 2.6 indicates the ineffectiveness of the different types of surgical prostheses to 
circumvent bacteria colonization and subsequent infection. Darehzereshki et al. (2014) and 
Kanitra et al. (2019), in two independent studies, through the meta-analysis of clinical 
outcomes have demonstrated that the incidence of infection using biologic mesh is only               
10%–11% compared to 33%–40% with the use of synthetic prosthesis in a contaminated 
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setting [174, 175]. Nevertheless, the extremely high costs of biologic prostheses that in most 
instances exceed 30,000 USD compared to a monofilament polypropylene meshes that cost 
between 80-150 USD [158] makes the use of biologic-derived prostheses improbable for the 
majority health care providers and most economies around the world.  
Over the years, several approaches have been proposed in an attempt to reduce the 
incidence of mesh contamination. Initially, several groups have attempted presoaking the 
mesh within an antibiotic solution, such as gentamicin or vancomycin, a method that was found 
to reduce the occurrence of methicillin-resistant S. aureus (MRSA) but did not prevent biofilm 
formation in the long-run as it only provided protection over a 6 h period [169, 176]. Some 
spore-forming bacteria can stay dormant in the form of endospores for extended periods 
before they enter germination [177]. Furthermore, many antibiotics, such as aminoglycosides 
and amoxicillin, have shown increased resistance (≥ 25%) against Staphylococci species, with 
predominately only vancomycin left to handle MRSA infections [139]. Due to this, the 
European Medicines Agency (MDA) and FDA have positioned themselves strongly against 
the direct use of antibiotics as a prophylactic measure for surgical implants, due to the 
prolonged antibiotic resistance implications that may carry. 
Delivering antiseptics is a great approach to circumvent antibiotic resistance as they are 
effective over a broad spectrum of bacteria and are rarely associated with resistance [178]. 
Bioabsorbable sutures that elicit triclosan are commercially available by Ethicon under the 
brand name Vicryl®Plus and are recommended for all types of surgeries, but are not routinely 
used due to high costs [179]. Today, the manufacturing methods used to develop prostheses 
that provide certain antimicrobial properties are based on (1) dipping or soaking the material 
[176], (2) physical coating of the mesh [180]  or (3) chemically functionalizing the surface, such 
as grafting [178]. Submerging a surgical mesh with an antimicrobial agent or antibiotics has 
only been found to offer protection for a 6-h window post-operation [181], where no superiority 
over systematic administration of antibiotics has been observed [164]. 
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Figure 2.6 Comparisons between the bacterial colonisation on synthetic mono-
/multifilament, absorbable and biologic surgical meshes. Contaminated biofilm-forming S. 
aureus on (a) multifilament (braided) polypropylene mesh, SEM image (Credit: The Institute of 
Photonic Sciences, ICFO, Spain); (b) Bard® monofilament knitted polypropylene mesh [167]; (c) 
biologic mesh from human dermal collagen (Bard® Davol Inc., USA) [182], and; (d) Vicryl® 
(Johnson & Johnson Innovation, LLC., USA) polyglactin 910 absorbable mesh [182]. For b, c, and 
d the specimens were stained with live/dead Baclight® bacterial viability stain and image using 
a confocal scanning microscope. Note: This figure presents different types of bacteria-
contaminated hernia meshes in vitro, in an attempt to demonstrate the inability of commercially 
available mesh implants to provide active protection against bacterial infection. The responses 
would have differed significantly in vivo, post-implementation, where the body’s immune system 
would have mitigated bacterial growth and prompt clearance. 
 
 The FDA approved antimicrobial prostheses and ongoing clinical and preclinical trials 
presented in Table 2.3, refer to mesh material being impregnated via physical coating or 
chemical surface modifications with antimicrobial substances. Such approaches are 
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predominately based on solvent casting by drop-by-drop or immersion and grafting and 
generally allow for 7 days up to one month of some form of antimicrobial activity [183, 184]. 
Nevertheless, it is difficult to control the deposition and thickness of the coatings, as well as 
the overall efficiency of most grafted meshes. As the architecture of the meshes listed on the 
table below does not offer any advantages over the commercially available conventional 
meshes, with the majority of them incorporating antibiotic substances, at present, those 
products have not been widely popular among the surgical community.  
 
Table 2.3 Prosthetic meshes with different forms of antimicrobial properties available on the 
market, and in clinical trials or preclinical studies. 
Mesh Mesh architecture and highlights Ref. 
Mycromesh® Plus 
(W. L. Gore and 
Associates, 
Inc., USA) 
Expanded-polytetrafluoroethylene (ePTFE) patches impregnated 
with chlorhexidine diacetate and silver carbonate. 
Note: Poor fibroblast penetration and tissue adhesion [184]. 
Succeeded by Dualmesh® Plus. (FDA approved; K946106). 
[185] 
Dualmesh® Plus 
(W. L. Gore and 
Associates, Inc., USA) 
 
Similar to Dualmesh® Plus but with an improved architecture; 
consisting of a “smooth” side and a Corduroy® (ribbed pattern) 
surface side, in an attempt to induce bacteria contact-killing. 
Note: Not allowed for intraperitoneal use due to increase toxicity 
levels correlating with the presence of silver [184]. A recent study 
has indicated several a log decrease of bacteria present per implant 
compared to Mycromesh® Plus; 2.85 x 102 colony forming units 
(cfu)/implant, but was concluded not sufficient to render an 
infection from occurring [186]. The use of Corduroy® surface to 
encourage and enhance cell ingrowth did not appear to 
significantly differ compared with conventional ePTFE prostheses  





(C. R. Bard, Inc., USA) 
 
A non-crosslinked porcine dermal graft coated with rifampin and 
minocycline. 
Note: First bio-prostheses to provide a form of bacterial protection.  
Nonetheless, the use of antibiotics is a widely unpopular approach 




patch with TRM 
antimicrobial 
coating. 
A double-side mesh consisting of macroporous polypropylene from 
one side and an anti-adhesive submicron ePTFE coating from the 
other, integrating 115 mgcm-2 rifampin/minocycline within a 
biodegradable matrix of tyrosine-based polyacrylate (TRM). 
[139] 
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(C. R. Bard, Inc., USA) Note: The adhesion area, tenacity, and tissue ingrowth were found 
to be similar to other commercially available meshes. Complete 
absorption of the coating by hydrolysis was noted within 24-32 
weeks [189]. Nonetheless, the use of antibiotics is a widely 
unpopular approach due to risks associated with antibiotic  









A porcine-derived submucosa biologic graft incorporating 
gentamicin sulfate. 
Note: A unique architecture where the antibiotic is kept within 
raised wall craters. Gentamicin is one of the last remaining effective 
antibiotics against MRSA, where studies have shown that long-term 
exposure in low concentration increases the chances of antibiotic-
resistance [190]. Further, ethical concerns may be an issue due to 
the use of porcine for some groups. A study concluded earlier this 
year that no adverse toxicity is directly attributable to the presence 
of gentamicin within the mesh. Nevertheless, the clinical study 
recorded graft infection at 8% of the patients undergoing single-





(Ariste Medical, Inc., 
USA) 
A macroporous mesh consisting of polypropylene knitted filaments  
incorporating rifampin and minocycline. 
Note: No information available or published, only the granted 
patent. Since then, the company has filed for Chapter 11 
bankruptcy. 
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2.4.3 Current advancements and future perspectives in hernia mesh 
development  
The progression of material science can divert the trajectory of the current "passive" approach; 
where the key focuses are the structural integrity and mechanical stability of the hernia mesh, 
and move it towards a more "active" approach that can further influence mesh-tissue 
integration and attain antimicrobial protection. The key research areas in the development of 
advanced hernia meshes involve limiting acute and chronic forms of inflammation, obtaining 
physiologically relevant tensile properties, formulating a microscopic niche that can induce cell 
ingrowth and vascularisation, and preventing mesh-related SSI.  
 Despite the research focus and progression to date, and since the early 2000s, there have 
been minimal, predominately inconsequential, advancements in the engineering of hernia 
meshes. Non-absorbable synthetic meshes, predominately made of polypropylene, remain 
the most widely used prosthesis, possibly due to its low cost and the surgeon’s familiarity with 
the material. As aforementioned, absorbable mesh materials were initially linked with higher 
chances of hernia reoccurrence, mostly due to the lack of controlling the degradation of such 
implants. On the other hand, biologic meshes are too expensive to be used in every-day 
practice and are usually reserved for specific circumstances, such as contaminated fields. The 
future requires an economically viable surgical mesh that can further advance the implant's 
properties to fulfil today's critical clinical challenges. 
 Different methodologies can be used to compose an environment that can prevent or limit 
infection. Research on antimicrobial surgical prostheses has focused on antimicrobial 
coatings, drug-eluting implants, antifouling surfaces, or electrospun NFs [132, 139, 192]. 
 The development of antimicrobial surfaces by covalently grafting polycationic polymers 
and macromolecules, such as poly(quaternary) ammoniums, chitosan, and antimicrobial 
peptides, at the surface of the implant, ultimately inducing contact killing by lysing the 
bacteria's negatively charged membranes, has been considered as an interesting approach 
[193]. Nevertheless, although such a tactic can reduce the need for antibiotic use and limit the 
chances of multidrug resistance, upon the integration of the mesh by the host tissue, the 
surface of the implant gets rapidly coated by tissue-related proteins, thus substantially limiting 
its bactericidal activity [194].  
 Coating the mesh filaments with a drug-impregnated hydrophilic hydrogel by embedding 
or immersing; such as dip-coating, the implant to form an antimicrobial layer has also been 
found to be ineffective, mostly due to the ease of enzymatically breaking down hydrogel 
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coatings in vivo [192]. This is ultimately associated with high cytotoxicity and antiproliferative 
activity due to the rapid release of the entrapped drug in the surroundings, which can further 
encourage bacterial resistance [192]. For instance, a nitric oxide (NO)-releasing 
poly(ethylene-vinyl acetate) coating on a polypropylene mesh initially presented effective anti-
biofilm activity against a range of Gram-positive and Gram-negative pathogenic bacterial 
strains but was found to be ineffective in a subsequent murine model, in vivo study [195]. 
Further, antifouling layers on mesh material based on superhydrophobic and superhydrophilic 
surfaces have been found to be effective in preventing bacterial colonisation, but at the same 
time, vastly reported in the literature to inhibit the proliferation of adherent cells, preventing 
subsequent tissue ingrowth [139, 196]. 
 Another approach widely studied has been the use of metal ions, which are effective 
against a wide range of bacteria, and not generally associated with microbial resistance [197]. 
Among the metal ions, silver and gold have been readily coated on the surface of surgical 
materials by sputter coating, physical vapour deposition, and plasma polymerisation to form 
nanoparticle agglomerates [197]. Recently a nano-crystalline silver-coated polypropylene 
mesh produced via the electrospraying technique, with an average particle size of 200 nm, 
was found to induce a significant (p< 0.05) bactericidal effect in comparison to an uncoated 
commercially available polypropylene mesh, in a rat model [198]. Nevertheless, the particle 
distribution was inhomogenous, making the toxicity findings of the in vivo study inconclusive 
[198]. However, the induced mechanical alterations on a mesh due to the addition of a metal 
layer, along with ion leaching-induced cytotoxicity due to erosion have limited the willingness 
of the FDA to approve such constructs as implantable devices [192]. 
 The favourable morphological and surface properties of electrospun fibres toward 
mimicking the tissue's native fascia that can, thus, promote mesh-tissue integration in a similar 
manner with biologic meshes, has led to different tactics of employing NFs as prosthesis [199]. 
Such approaches involve either direct deposition of electrospun fibres, as functional coatings, 
at the surface of commercially available meshes, or through the fabrication of nanofibrous 
mesh constructs. The most commonly employed polymers for the construction of such mesh 
material have been PCL, PP, and PLLA [200–202].  
 The majority of the studies have focused on the compliance of electrospun mesh material 
towards improving mesh-tissue ingrowth and subsequent abdominal wall reconstruction, with 
no published work to date focusing on drug-loaded antimicrobial systems for the prevention of 
mesh-associated SSI while circumventing the incorporation of antibiotics [203, 204]. Although 
electrospun NFs have illustrated their ability to act as hernia meshes for hernia reconstruction 
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due to their good biocompatibility, several studies have demonstrated insufficient mechanical 
stability [200, 203].  
 A recent study developed a large pore PP mesh integrating a coating consisting of PCL 
nanofibres integrating antimicrobial peptides (PEP-1) [205]. The findings suggested no toxicity 
on dermal fibroblasts and similar mechanics with commercially available surgical meshes. 
However, antimicrobial efficiency was only apparent over a span of 48 h against E. coli, but 
not for the most commonly associated SSI pathogen, S. aureus [205]. In recent work Liu and 
colleagues [204], assessed the effectiveness of PCL-only, PCL-irgasan, and PCL-levofloxacin 
loaded nanofibres produced via conventional blend electrospinning to act as hernia mesh 
material. The loaded fibres presented a first-order release of half of the loaded drug within a 
week, where the antimicrobial properties were only assessed in the form of inhibition zones 
by disc diffusion (approximately 2.6 cm clearance zone in E.coli and S. aureus) and did not 
evaluate the constructs mechanics [204]. Further, as aforementioned, it should be noted that 
the incorporation of antibiotics within implants is widely disregarded as an effective long-term 
approach.  
 A nanofibrous mesh is yet to reach a clinical study with a substantial amount of work still 
required in assessing the in vitro antimicrobial efficiency, mechanical stability, and, in later 
stages, the in vivo evaluation of mesh integration and tissue in-growth capabilities, allowing 
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2.5 Electrospinning 
Among the several processing techniques, including thermal-induced phase separation, 
drawing, template synthesis, and self-assembly, electrospinning is of considerable 
significance as a rapidly evolving fibre preparation method [206]. It is a highly versatile method 
used to process solutions, suspensions or melts into continuous fibres of nano/microscale 
diameters [207], and is the only method for mass-producing continuous fibres at this range 
[208]. A detailed description of this process is provided in the following section. 
 
2.5.1 Principles of electrospinning 
Electrospinning is one of the most conventional methods used in TE, and it is based on the 
principle that electrostatic forces can be used to form and expand fibres out of a polymer 
solution [209]. The principle of this process was first described in a patent entitled “Process 
and Apparatus for Preparing Artificial Threads” in the 1930s by Anton Formhals, who was 
considered by many to be the father of electrospinning [210]. However, considerable emphasis 
was not given to the process until the 1990s, with works led by Reneker and Rutledge, who 
described the process [211]. 
The electrospinning process uses high voltage to charge a liquid solution or a melt by 
placing it between two conductors that endure the electromagnetic charge of opposite 
polarities to form fibres [212]. A standard laboratory-scale setup consists of four main 
components: a high-voltage DC (or AC) power supply, a syringe pump, a nozzle (usually 
metallic capillary), and a collector that can simply be a metallic foil/plate/disc [213]. The 
electrostatic force produced by the high-voltage supply is applied to a polymer solution or melt, 
which is dispensed through the fine needle orifice at a controlled rate. When electrospinning, 
the precursor solution extruded from the spinneret orifice forms a small droplet that is subject 
to an accumulated charge in the presence of an electric field [97]. The electrified discharged 
polymer induces a conically-shaped geometry referred to as the ‘Taylor cone’ [213, 214]. 
Increasing the strength of the electric field causes an increased accumulation of charges at 
the surface of the polymer bud. After this, the repulsive electric forces overcome the surface 
tension of the polymer solution/melt, and that leads to vigorous whipping and splitting motions 
due to the bending instabilities generated, which causes the fibre to elongate through the 
application of mechanical force [215]. At this point, the geometry of the formed asymmetrically 
electrospun (as-spun) fibres is directed by the electrostatic repulsion, colloid stability, the 
incoming surface ratio, and gravity [209, 212]. Solidification of the liquid solution occurs by 
Chapter 2 | Literature Review   49 
 
establishing a zone that thrusts the charged molecules, allowing for solvent evaporation to 
occur continuously, stretching the drawn polymer threads as they advance towards the 
grounded or oppositely charged collector [209]. This transition between the liquid and solid 
phase is due to the Ohmic current that presents a low acceleration being transited primarily to 
convective flow, thus increasing its acceleration [216]. Figure 2.7 (a-b) illustrates the basic 
concept behind the electrospinning process.  
 
 
Figure 2.7 Fundamentals of electrospinning. (a) Conventional electrospinning concept; (b) 
high-speed photograph outlining the Taylor cone formation where it shows the linear segment of 
the polymer jet, followed by the whipping jet region, modified from [217] and [218]; (c) the 
prototypical instantaneous position of the jet path succeeding through the three sequential 
bending instabilities, modified from Xue et al. [97]. 
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Figure 2.8 Structural diversity of individual electrospun fibre morphologies.  (a) Aligned; 
(b) randomly-oriented; (c) core/shell [221]; (d) hollow [222]; (e) multichannel microtubes 
[223]; (f) colloidal nanoparticle-decorated [224]; (g) shish-kebab [225]; (h) helical [226]; (i) 
porous, electrospun fibres. 
 
The unique properties carried out by engineered nanofibres include a high specific surface 
area, a large surface-to-volume ratio, and a large fibre length-to-diameter aspect ratio [97]. 
Moreover, those properties allow the construction of highly-porous ECM-like constructs that 
mimic membranes with adjustable pore size and wide surfaces that allow chemical 
functionalization [219]. 
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The formed electrospun mats exhibit a web-like fibrous structure, due to the considerable 
extent of plastic deformation caused by the high charge density of the jet and the unstable 
whipping motion [220]. This phenomenon is known as bending instability, and it leads to a 
randomly-oriented and non-aligned fibrous mats [220]. Nonetheless, through the continuous 
research and evolvement of these basic principles, as well as the manipulation of the 
conventional electrospinning apparatus, unique morphologies and structures have been 
successfully produced over the past two decades, as indicated in Figure 2.8. 
Recently, several nano/microfibre structures were generated using a variety of 
electrospinnable organic and inorganic materials, and the size-dependent structural behaviour 
of the generated nanofibres has made them of interest in many fields, including tissue 
engineering, drug delivery [227], sensing [228], energy [229], fibre reinforcement [230], and 
more.  
 
2.5.1.1 Jetting mechanism, fibre growth and deposition 
The electrospinning process represents an electro-fluid-dynamics (EFD) problem, which 
stimulates electrified liquid jets to whip and elongate to form fine fibres [231]. In the interest of 
controlling the morphology, structure, and output of the fibres, the underlying processes that 
cause a polymer droplet to undergo this transition can be described into three principal stages: 
(a) the formation of the Taylor cone, which is also known as the post-liquid droplet charging; 
(b) jet stretching (whipping instabilities), accompanied by jet elongation and branching; and 
(c) the expansion, solidification, and deposition of the formed fibres. The three stages are 
described in detail below. 
 
a. Formation of the Taylor cone (post-liquid droplet charging) 
As the name suggests, electrical forces are the driving force of the electrospinning process. 
As the droplet gets electrified, it gradually reduces in size at the orifice of the needle in an 
attempt to keep an equilibrium force. As the voltage amply increases, the spherical droplet 
electrifies and deforms to a hemisphere-shaped cone denoted “Taylor cone”, with the electric 
force being directed towards the tip of the Taylor cone [232]. When the surface tension of the 
solution overcomes the applied electric field, jets get ejected from the Taylor cone’s surface 
[232]. Taylor [233] calculated the critical tension (Vc in kV) at which the eruption occurs based 
on the following equation: 








) − 1.5)(1.3𝜋𝑅𝛾)(0.09) (2.1) 
where, H is the distance between the needle-tip and the collector (in cm), h is the length of the 
needle’s capillary (in cm), R is the radius of the needle (in cm), γ is the surface tension of the 
polymer solution (in dyncm-1), and 0.09 is the conversion factor to express the voltage (in kV). 
Several groups have calculated the velocity of the electrospinning jet at the point of collection 
using high-speed cameras [234, 235]. As expected, increasing the voltage increases the 
repulsive forces between the needle-tip and the collector and thus the jet’s velocity, which has 
been calculated to be between 0.6 and 15 m.s-1 [234, 235]. Cauchy–Schwarz inequality has 
been applied to predict the critical length of a jet before it enters the instability regions and 
branching (Figure 2.7(c)), which has been evaluated and verified experimentally on cellulose 
and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) polymer solutions [236], based on 






−2) 𝑓𝑜𝑟  𝑅0 = (2𝜎𝑄 𝜋𝜅𝜚𝐸⁄ )
1/3 (2.2) 
where, L is the critical length (in cm), σ is the surface charge (in Cm−2), Q is the flow rate                     
(in mLh-1), r is the radius of the jet (in cm), k is the dimensionless conductivity of the fluid, ρ is 
the density of the polymer solution (in gcm-3), E is the applied voltage (in kV), and I is the 
current passing through the jet (in nA). 
 
b. Jet stretching and elongation 
As the straight segment of the jet begins to decrease monotonically (in relation to the travelling 
distance of the jet to the collector), the time required for the excess charges to be redistributed 
along the jet prolongates [237]. Those excess charges redistribute within the surface and the 
centre of the jet, causing electrically-driven bending instabilities that deform the straight 
segment to produce coils through the remainder of the jet path [237]. These system 
instabilities can be explained based on the Earnshaw theorem [220] that states: 
“Collection of point charges cannot be maintained in a static equilibrium solely by the 
electrostatic interactions of the point charges.” 
Research conducted at the University of Akron and the Israeli Institute of Technology, led by 
Reneker and Yarin [238], first described the complex series of sequential events causing 
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bending, coil formation, and stretching onto thin fibres. Afterwards, studies carried out by 
different groups [232, 238, 239] mathematically described the three types of instabilities that 
occur during the elongation of each travelling segment of a jet, as can be seen in Figure 2.7(c). 
 
i. Rayleigh (capillary driven) instabilities due to high ion currents  
The Rayleigh instability is symmetrical to the straight segment axis  [240], where surface 
tension is suppressed due to the applied electric field E0, and the surface charge density 









where, ε and ε’ are the dielectric constants within the jet and at the surface of the jet 
respectively, (with 𝜀 𝜀 ′ ≫ 1⁄ , σ being the surface charge), γ is the surface tension (in 
mN·m−1), and h is the distance from the pendant drop to the grounded or oppositely 
charged collector (in cm). 
 
ii. Axisymmetric instabilities 
Axisymmetric instabilities are presented at higher electric fields when the Rayleigh 
instability of the jet is suppressed by the accumulation of viscoelastic stresses caused by 
the excessive stretching of the polymer [241]. 
 
iii. Non-axisymmetric (whipping or bending) instabilities 
The non-axisymmetric instabilities are rapid bending instabilities that the jet experiences 
at the final stages and when the travel path of the jet has expanded significantly [242]. 
They are presented as a fluid column with long disordered waves that are directed by the 
lateral direction of the electric force (due to the dipolar nature of the distributed energy) 
and unsteady aerodynamic interactions [242]. 
The three instabilities evolve as the electric field increases, with Rayleigh instability 
presenting the lowest and the non-axisymmetric instability presenting the highest electric field 
strength. As the path through the bending instabilities is electrically driven, it is not influenced 
by the surface tension of the polymer solution. 
These instabilities ultimately cause the cylindrically-shaped jet to collapse and grow to 
unstable segments [238]. Bending and branching may co-occur or progress in independent 
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segments [238]. Moreover, it is common that the established coils form beads and branches 
during the segmentation of the jet. Also, when the charge per unit area is too low (characteristic 
of less viscous solutions), beads form due to droplet division, whereas branches build up as 
the electric field exceeds the requirements for generating a single jet in highly viscous 
solutions [243]. 
 
c. Expansion, solidification, and deposition 
During the elongation process, the solvent evaporates, allowing for charged polymer fibres to 
get deposited at the collector’s surface. As the fibre forms, expands and dries from the 
spinneret to the collector, a portion of the initial polymer fluid will be collected in the final stage. 
The solid fibre has been calculated, by Yarin and co-workers, to be on average, 0.0013 times 
that of the fluid jet, although it will differ among variant polymers and by altering the 
concentration of the polymer solution [244]. Through the prolongation of the solidification 
process, the jets can further expand and generate thinner fibres. Furthermore, manipulating 
the diameter and morphology of the fibres can be achieved by different approaches that are 
explained in detail in the following section (2.5.1.2 Parameters Affecting the Electrospinning 
Process). 
Finally, the morphological properties of the fibres will be predominately determined by the 
configuration of the collector where the fibres are deposited. After deposition, the electrical 
charges are still captured at the surface of the dry fibres but will be quickly dissipated, with no 
further apparent instabilities [245]. Nonetheless, the low conductivity of most dried polymeric 
fibres leads to the accumulation of residual charges that will repel jets that carry a similar 
charge from being deposited due to a pendulum-like motion. This ultimately limits the 
thickness of nonwoven mats to less than 1 mm [97]. 
 
2.5.1.2 Parameters affecting the electrospinning process 
Whilst electrospinning can be overall considered a straightforward fabrication method; many 
parameters affect the formation of fine fibres from a polymer solution. In the interest of 
producing electrospun fibres for tissue engineering, their structural properties need to be 
tweaked to generate the appropriate fibre morphology, diameter and porosity, fibre orientation 
(aligned or randomly oriented), and cell-scaffold interactions that provide a biocompatible 
environment that can facilitate improved cellular expansion and proliferation [213, 214].  
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A list of the most critical parameters that affect the production of electrospun fibres is 
presented in Table 2.4. These can be classified based on solution, electrospinning, and 
ambient parameters. Solution parameters refer to polymer concentration and polymer 
molecular weight, solvent volatility, solution viscosity, surface tension and solution 
conductivity, among others. With regard to the electrospinning parameters, the electric field 
strength, electrostatic potential, flow rate, and distance between the spinneret and the collector 
need to be adjusted. Finally, ambient parameters refer to the chamber and solution 
temperature, humidity and type of atmosphere, among others. 
In general, by prolonging the fibre elongation or flight time during the electrospinning 
process, finer fibres can be produced, which can be achieved by increasing the distance 
between the collector and the spinneret. Moreover, using low volatility solvents and raising the 
temperature to increase the evaporation rate of the solvent is also possible. However, it must 
be noted that increasing the working distance beyond the critical threshold (the point at which 
the stability of the Taylor cone is impaired) results in a significantly longer flight time, which 
can lead to inhomogeneous fibre formation [29]. Insufficient solvent volatility and low 
temperatures may lead to wet fibre fusion during deposition [29]. Therefore, it is crucial to 
observe and monitor the different parameters that affect the electrospinning process to 
determine the ideal operating conditions that yield optimised fibre characteristics tailored to 
the specific requirements of each study.  
One of the most important parameters for obtaining an electrospinnable solution is 
determining the chain entanglement of the polymer solution from the molecular weight and its 
concentration. Within a solution, the root-mean-square distance of the segment of a molecular 
chain towards the centre of its mass provides the average radius of gyration (Rg) [246]. If the 
concentration is too low (diluted solutions), the polymer chains do not overlap, with the 
viscoelasticity of the solution being governed by shorter polymer chains. By increasing the 
concentration of the polymer, entanglement occurs as the polymeric chain begins to overlap.  
The critical concentration (Cc*) is generally accepted to be proportional between the 







where, NA is the Avogadro’s constant [247]. When the polymer concentration is below the 
critical point (C<Cc*), inadequate chain entanglement renders the formation of a stable jet due 
to Rayleigh instabilities (Figure 2.9(a-b)). For stable electrospinning, the polymer 
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concentration needs to be higher than the critical point (C<Cc*) (Figure 2.9(c)) [248]. The 
rheological behaviour of the polymer solution from which the Cc* of the polymer solution can 
be evaluated is presented in Figure 2.9(d). Evidently, there is a clear correlation between the 
Mw of a polymer solution and the corresponding Rg value, and thus, in many cases, attempting 
to electrospin variant molecular weights of the same polymer can ultimately contribute to the 
procurement of the required concentration (beyond Cc*) for effective and stable 
electrospinning. 
The ideal operating range of electrospinning conditions differ significantly due to the vast 
selection of polymers and the corresponding solvent systems. Moreover, most of the 
parameters listed, in Table 2.4, are interdependent, leading to non-linear causalities that are 
one of the many great challenges in the electrospinning field.  
At the moment, the majority of the research conducted for skin TE surrounds the use of 
the conventional needle-based setup described earlier (with either a drum or a flat collector). 
Understanding the parameters that influence the electrospinnability of a polymer solution and 
the subsequent properties of the formulated fibres, have made it possible to advance the 
polymer chemistry further and evolve the capabilities of the produced electrospun scaffolds. 
However, a significant amount of research has focused on further manipulating the design of 
electrospinning devices, based on these fundamental principles that were described in this 
section, to further advance on the producibility and morphological architecture of the fibres. 
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Figure 2.9 The effect of solution viscosity towards the electrospinnability of a polymer 
solution. (a) The concentration is too low; (b) chain entanglement on critical concentration; (c) 
chain entanglement above critical concentration; (d) log phase of solution viscosity over polymer 
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Table 2.4 List of parameters affecting the fibre formation during electrospinning [29, 227].  







- Low viscosity → electrospraying, bead defects, may require 
higher voltage or higher solution viscosity for electrospinning. 
- High viscosity → fibre diameter generally increases while the 
chances of bead forming decreases. 
   
Molecular mass 
- High molecular chain entanglement → viscosity increases,  
which in turn decreases the electrospinnability of the solution → 
increases fibre thickness. 
- Influences viscosity (vide supra) → a higher molecular mass 
results in a more uniform fibre scaffold morphology. 
   
 
Concentration 
- A sufficient polymer concentration allows for the required 
molecular chain entanglement → overcoming surface tension 
without fragmentation of the jet → resulting in uniform 
continuous fibres.  
   
 
Conductivity 
- A correct conductivity will promote charge accumulation → 
requiring less voltage for the jet eruption. 
- High conductivity has been reported to cause unstable multi-
jetting because of electrical discharges to the surrounding air.  
- The fibre diameter decreases with increasing conductivity; 
where ionic materials can reduce atomisation of polymer jet. 
  
Dielectric constant 
- A solvent’s higher capability to retain an electric charge within 
a solution helps to distribute the surface charge of the jet 







- Sufficiently volatile solutions → prevent the collection of wet 
fused fibres. 
- Highly volatile solutions → induce premature solidification 
without sufficient elongation of the fibres and subsequent 
morphological defects, hinder thin fibre production, while 
increasing the risk of spinneret blockage (clogged needle). 
  
Surface tension 
- Beads may form if surface tension is considerably higher than 
the critical Wenzel level; this can be appropriately adjusted by 
adding a compatible surfactant within the polymer solution. 
   
Vapour pressure 
(vapour diffusivity) 
- Influences the solvent evaporation rate during electrospinning.  
- Rapid solvent evaporation may influence the formation of non-








- Must exceed critical voltage, VK, to overcome the surface tension 
of the polymer solution and maintain a jet.  
- By increasing voltage → the jet’s flight time can be significantly 
reduced, that can increase the diameter of the fibres. Commonly 
this is dealt with by adjusting the working distance, or by 
lowering the voltage potential difference between the spinneret 
and the collector. 
- Above VK, it may induce an erratic jet and form secondary  





Solution flow rate 
- An increased flow rate → generally constitutes in a shorter jet 
stretching path, larger pore size, and thicker fibres, and vice versa. 
Secondary morphologies, as well as completely rending the 
electrospinnability of a solution, will occur beyond a critical 
distance, which will be specific to the polymer and solvent 
system. 




- By decreasing the distance beyond a critical point → thicker 
fibres and morphological defects may arise. 
- By increasing the distance → thinner fibres can be obtained, but 
an increase in the corona discharge and Rayleigh instabilities, can 
result in beaded or fused fibre defects beyond a critical distance. 
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Collector geometry 
- Different fibre arrangements are possible with different 
collector configurations. Aligned and randomly oriented, crossed 
array, braided, nanoweb, or coil fibres can be obtained through 
collector geometries, such as drum, plate, disc, honeycomb,  
parallel wires, rings, centrifuge walls, and others. 
   
 
Spinneret orifice 
- A smaller spinneret orifice diameter (smaller gauge size, for 
instance, a 24G needle instead of 21G) → may produce narrower 
fibres and reduce morphological defects, but at the same time can 
increase the probability of nozzle clogging.  
- Hollow, core/shell and multicomponent fibre configurations  







Temperature affects most of the parameters listed above; it is 
solution specific and can influence the fibre production yield. 
When: 
- Temperature increases → it decreases the solution’s viscosity, 
increases the electrical conductivity → producing thinner 
uniform fibres with a greater polymer chain alignment.  
- Temperature decreases → it decreases the evaporation and 
elongation time of the jet before solidification → that counteracts  
the formation of finer fibres.  






- Increased humidity → can delay the solidification of the fibres  
prior to deposition → increasing the elongation time → 
producing thinner fibres. 
- High humidity (generally > 60%) has been known to produce 
non-uniform fused fibres or circular pore formations, such as 
beads, especially in the case of hygroscopic polymers such as 
nylon, cellulose and polyvinylpyrrolidone. Furthermore, high 
humidity can affect the total charge distribution on the Taylor 
cone, reducing the surface charge density, and thus affecting the 
polymer solution’s electrospinnability. 
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2.6 Co-axial electrospinning 
Co-axial electrospinning is a modification of the conventional electrospinning technique that 
enables independent reservoirs of two or more different solutions fed onto a co-axial needle, to 
formulate single composite fibres that present a core/shell morphology [45]. The co-axial spinneret 
consists of a double capillary compartment arranged concentrically, with the inner needle fitted 
within the outer needle. Independent solutions travel to the orifice of the co-axial needle from 
separate pumps, where the flow rates are adjusted accordingly. The inner capillary contains the 
core solution, while the outer capillary produces the shell polymer [249]. At the orifice, a 
compound Taylor cone forms as the shell polymer solution entraps the core fluid and is then 
subjected to an applied electric field, conceptually similar to conventional electrospinning 
[213]. After the solvents evaporate, a heterogeneous but continuous fibre composed of the core 
and shell constituents will be collected [250]. The basic concept of co-axial electrospinning is 
illustrated in Figure 2.10. 
The interactions that govern the resultant core/shell fibre properties derive from the degree 
of rheological, physical, and chemical dissimilarities of the two solutions [251]. However, a 
uniformly assembled core/shell fibre forms if a stable Taylor cone is maintained [252]. 
Processing parameters relating to co-axial electrospinning have been reviewed in the literature 
[253, 254], all of which agree that the complexity of co-axial electrospinning originates from 
the difficulty in maintaining a stable Taylor cone.  
To induce a stable Taylor cone, process parameters should be such that: (1) an 
electrospinnable shell solution is utilised; (2) the shell solution viscosity is higher than the core 
solution viscosity, so the stress relating to the viscosity between the core and shell solutions 
overcome the interfacial tension between them [255]; (3) a low vapour pressure solvent should 
be used (as fast evaporation may destabilise the Taylor cone); and (4) the conductivity of the 
shell solution has to be greater than that of the core solution to inhibit core/shell structural 
discontinuities induced by the rapid elongation of the core polymer [251]. 
Co-axial electrospinning can produce fibres from highly diverse polymer pairs; core-
sheath, hollow, nanoparticle decorated, while each one can maintain its separate material 
identity [253]. Through this process, it is feasible to electrospin materials that are not 
electrospinnable per se due to their chemistry (such as oligomers), by accommodating them 
within the core of the fibre [253]. By exploiting this feature, sophisticated pairs of materials can 
combine desired properties into a single fibre. Highly unstable materials, such as enzymes, 
growth factors, and rapidly degradable compounds that would otherwise be rapidly broken 
down within an intricate niche, can be preserved by the sheath material [256]. For this reason, 
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the properties of the material can be manipulated while employing the co-axial electrospinning 
technique, which is of interest in the biomedical sector because it can be used to develop 
biocompatible and mechanically stable materials [256].  
Co-axially electrospun fibres are also widely employed for the development of drug 
delivery systems that can attain a tailored substance release [257]. For example, co-axially 
electrospun fibres consisting of a silk fibroin/hyaluronic acid in the shell and PEO/polyphenols 
from olive leaf extracts (OLE) in the core, presented the sustained release of OLE for 30 days 
with no apparent cytotoxicity [258]. 
In another study, Gao et al., 2018 [260], co-axially electrospun dimethyloxalylglycine 
(DMOG)/PCL-collagen type I core-shell fibres. DMOG is a competitive inhibitor of procollagen-
proline dioxygenase, an enzyme that plays key roles in prolonging ischemia and upregulating 
inflammatory responses. Moreover, they found that in both the in vitro and in vivo 
assessments, the DMOG sustained release from the fibres stabilized the hypoxia-inducible 
factor-1A (HIF-1) that, in turn, accelerated the expression of genes that induce re-
epithelialization and angiogenesis prompting to successful wound closure within 14 days in 
diabetic mice. On the other hand, there is a need to research and develop bicomponent 
antimicrobial surfaces that can present the appropriate physicochemical properties and 
mechanical stability for advancing the properties of hernia meshes, and the co-axial 
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Figure 2.10 Generation of co-axial electrospun fibres. (a) Schematic of a standard co-axial 
electrospinning setup; (b) configuration of the co-axial Taylor cone, following the evolvement of 
the electrified jet as the voltage amply increases, where polyvinylpyrrolidone (PVP) is the shell 
and mineral oil is the core solution [259]; (c) schematic representation of the charges forming 
the co-axial Taylor cone, (i) surface charges develop around the surface of the shell solution, (ii) 
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2.7 Nozzle-free electrospinning 
Considering that the production output of needle-based electrospinning devices is commonly 
meagre; ranging at 0.01–0.3 gh-1 [261], scaling up the process has been progressively studied 
as a suitable approach of industrialising this fabrication process. This can be generally 
achieved by scaling up the spinneret’s structure while retaining an energetically stable and 
well-distributed configuration [262]. As opposed to multi-needle electrospinning, where the 
electric field around a given needle is affected by the nearby jets, which can produce 
inhomogeneous fibres, free-surface electrospinning is an alternative method capable of 
producing fibres at high-throughput with no constraints of clogged needles.  
In 2004, Yarin and Zussman initially described the production of free-surface nanofibres 
by placing a layer of polymer solution underneath a magnetic liquid (that was overlapping a 
permanent magnet) against a vertically placed oppositely charged magnet by applying high 
DC voltage [263]. A year later, Jiri and co-workers patented a process where a rotating 
charged electrode, immersed within a polymer solution, placed at a close distance to a counter 
electrode, at a bottom-up manner, could be used to fabricate nanofibres at an increased 
production rate with the assistance of an airstream to increase the auxiliary drying efficiency 
of the system [264]. 
Lukas et al. developed an electrohydrodynamic theory that describes the self-organization 
of electrified liquid jets from an open flat surface, founded on the fact that fibres can arise 
during electrospinning from linear clefts even without the support of a magnetic fluid 
underneath [265]. The critical electric field intensity (Ec) to produce fibres deriving from free-
surface electrospinning was described as: 




Where, γ is the surface tension of the solution (Ncm-1), ρ is the density of the liquid mass                  
(gcm-2), g is the gravitational acceleration (cm.s-2), and ε0 is the absolute permittivity (Fcm-1). 
During the onset of free-surface electrospinning, the electric force is essential for Taylor cone 
formation and subsequent jet initiation. Prior to jet growth and the corresponding bending 
instabilities, the initial straight segment of the jets is amplified as the Coulomb forces 
concentrate towards the leading segments that are trying to reach the collector [237]. The 
ultra-slow-motion images presented in Figure 2.11(b) indicate the stages from Taylor cone 
formation to jet depletion, which occur within a tenth of a second. 
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During nozzle-free electrospinning, the polymer solution is submerged in a bath containing 
a rotating cylinder electrode against a biased rotating collector electrode under constant 
airflow. By controlling the motor, the rotating speed of the roller can be fixed. High-voltage 
power with a potential greater than 50 kV needs to be applied between the two rotating 
electrodes, which induces the formation of multiple Taylor cones emerging from the rotating 
electrode surface that is immersed in the solution bath. When voltage is applied on the roller, 
the liquid changes to a conical shape and forms a great number of Taylor cones (Figure 
2.11(c)) on the surface of the rotating spinneret. When the voltage reaches a critical value, 
multiple jets stretch from numerous locations to form fibres in an upward motion at a large 
scale. Under a strong electrical field, the jets will move and get deposited on the collector’s 
surface, which is placed at a fixed distance over the roller. Because of this, the roller 
electrospinning method is a continuous and efficient process to fabricate nanofibres [266]. 
Besides fluctuations in the conductivity of the polymer solution [267], variations in the shape 
of the spinneret play a vital role in the morphology and diameter of the formed fibres [268–
271]. 
Although free-surface electrospinning presents a high-volume output and is easy to operate 
once the appropriate solution and electrospinning parameters have been met, it can be 
challenging to maintain a consistent solution concentration and viscosity. Furthermore, due to 
the high electric force, incomplete solidification of the fibres may allow residual solvents to get 
incorporated into the scaffolds, affecting the biocompatibility of the developed constructs; 
nevertheless, post-fabrication treatments may resolve this issue in most cases. Additionally, 
and of major concern is that as the polymer solution is being openly exposed to the ambient 
conditions, highly volatile solvents may rapidly evaporate, where fluctuations in the 
conductivity and viscosity of the solution can negatively affect the uniformity of the fibres, as 
well as the consistency of process between experiments. This can be partially regulated by 
restraining the exposure of the polymer solution in the open, the solvent system selection, 
regulating the ambient conditions, and the configuration of the spinneret. Thus, all solution, 
electrospinning and ambient parameters need to be accurately tuned to obtain a consistent 
fibres production output.  
In a recent study by Agrawal and Pramanik [272], chitosan-PVA blended nanofibrous 
scaffolds (with an average fibre diameter of 269 nm), formed using a needleless setup, were 
successfully fabricated and found to present good attachment, growth, and expansion in 
human mesenchymal stem cells (HMSCs). Free-surface electrospinning is at an early stage, 
and it is yet to be explored extensively for tissue engineering applications. To date, 
NanospiderTM (Elmarco, Ltd., Czech Republic) has developed a commercially available 
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industrial-scale electrospinner based upon this concept, where a high-voltage potential (up to 
80 kV) facilitates the formation of fibres out of a polymer-layered thread at a defined rate [273].  
 
 
Figure 2.11 Free-surface electrospinning. (a) Diagram of a roller electrospinning setup. 
Modified from [266]. (b) Jet formation. (i) Conical droplet on an open surface in the presence of 
an electric field (time = 0 s), (ii) extended conical droplet (time = 33 ms), (iii) Taylor cone and 
jetting of the droplet (time = 66 ms), (iv) depletion of the droplet (time = 99 ms) [274].                                
(c) Schematic diagram of the roller electrospinning method [275]. (c) Taylor cone formation,                    
(i) schematic diagram where h is the thickness of the layer, D is the diameter covered by the 
Taylor cone, and f is the electrostatic force, (ii) a photograph depicting the initiation of the 
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2.8 Selection of polymers and antimicrobial agents 
For each research work presented in the following chapters, polymers and solvents were 
chosen based on extended parametric studies, which examined the effect of a specific 
polymer/solvent system to the reproducibility, Taylor cone stability (optically inspected using a 
magnifying monocular), and fibre properties. Factors such as the polymer's concentration, its 
solubility and compatibility to a specific solvent system, viscosity, and conductivity 
measurements, had to be predetermined. 
 
2.8.1 Natural and synthetic polymers 
Natural polymers have been considered as suitable candidates for TE applications due to their 
superior intrinsic architecture and biological properties in comparison to synthetic derivatives 
[276]. Due to their high resemblance with ECM components, these materials are less prone 
to induce chronic inflammatory responses that are more often encountered in the case of 
synthetic polymers [277]. Furthermore, natural polymers also carry various tissue niche 
requirements, are biocompatible, and may present antimicrobial properties [278]. 
Naturally occurring polymers are produced by an organism, where the desired polymer 
material can then be extracted [279]. Natural polymers can be components of the ECM, 
polysaccharides (chitosan, cellulose, aloe vera, hyaluronic acid, etc.), proteins (collagen, 
elastin, fibroin, sericin, gelatin, etc.) or polynucleotides (DNA, RNA, etc.) [278]. Such polymers 
can increase the efficacy of cellular communication and enhance the biological interactions 
between the developed construct and the host tissue due to sharing similar intramolecular 
domains [278].  
Nonetheless, the rapid degradation of scaffolds produced using naturally derived polymers 
may affect the subsequent phases of the wound healing cascade, as well as present 
inadequate mechanical stability; a prerequisite of hernia meshes [279]. Furthermore, the 
overlap concentration (Co), the degree of polymer branching, and the chosen solvent system 
may be hard to adjust and thus affect the spinnability, reproducibility, and homogeneity of 
natural-derived fibres, as insufficient solubility, stiff molecular conformations, and low 
conductivity can halt a solution from being electrospun [280]. For this reason, synthetic 
polymers were further incorporated within the electrospinning solutions. Blend electrospinning 
can develop scaffolds that integrate the improved cytocompatibility of natural polymers with 
the mechanical stability and physicochemical integrity of synthetic polymers. The incorporation 
of naturally derived polymers such as silk fibroin with synthetic polymers can increase their 
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mechanical complexity while alleviating their difficult processability. Combining such materials 
and forming polymer blends can increase the chemical bonding, such as higher ratios of 
polyester and polyether linkages, thus vastly improving the mechanics, surface wettability, and 
the subsequent ability of such matrices to support cell growth. 
 
2.8.2 Polymers 
Throughout this thesis, several polymers were examined, chosen based on their application-
specific properties of interest and their corresponding electrospinnabilities. This section 
summarises the polymers that were ultimately selected to develop the biomaterial systems 
presented in the upcoming research chapters. 
 
• Poly(glycerol sebacate) (PGS) 
Poly(glycerol sebacate) (PGS) is an FDA approved semicrystalline thermoset, mostly studied 
for soft tissue engineering applications [276, 278]. As shown in Figure 2.12, PGS is 
synthesised via the polycondensation of glycerol and sebacic acid to form a pre-polymer, 
which can then be further covalently esterified [281]. Poly(polyol sebacate)-derived polymers, 
such as PGS, refer to a family of ester-bonded elastomers formed via the polycondensation 
of polyol alcohols, containing multiple hydroxyl groups (e.g., glycerol, isomalt, xylitol), and the 
dicarboxylic acid present in sebacic acid [282]. One of the main advantages of PGS is that it 
can gradually degrade (hydrolytically and enzymatically) to non-toxic by-products (e.g., glycol 
acid that can further promote antibacterial activity at neutral pH levels) [283]. Most importantly, 
PGS is an attractive polymer as it exhibits tailored mechanical properties and bioresorbability 
pertinent to varying the polycondensation parameters and stoichiometry, which correlate to 
the surface degradability of its ester linkages [284].  
• Poly(caprolactone) (PCL) 
Polycaprolactone (PCL) is a non-aromatic polymer synthesised mainly through ring-opening 
polymerisation (ROP) of ε-caprolactone (Figure 2.13c) [285]. It is semi-crystalline, 
biocompatible, slow-degrading, and relatively inexpensive to synthesise. Its prevalent use lies 
on its superior mechanical strength over most other biopolymers and its ability to act as a 
mechanically stable backbone for the development of tissue scaffolds. However, PCL is known 
to be hydrophobic, and pure PCL constructs have been found to lead to suboptimal cell 
adhesion and proliferation, as indicated by several studies [286, 287]. Hence, in the work 
68   Literature Review | Chapter 2 
 
described in this thesis, PCL was incorporated as a copolymer with the bioactive natural 
polymer, silk fibroin in an attempt to promote enhanced cell attachment and proliferation. 
 
 
Figure 2.12  The condensation polymerisation reaction of glycerol and sebacic acid that yields 
the poly(glycerol sebacate) polyester. The hydroxyl groups of the glycerol act as the initiator of 
the reaction by forming a monoester with the carboxylic acid of the sebacic acid. In the first stage, 
the pre-polymer (pPGS) is synthesised. In the second stage, the pre-polymer is cured under heat 
and vacuum to form a 3D network between the polyester chains, giving rise to the PGS thermoset. 
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• Polyvinylpyrrolidone (PVP) 
Polyvinylpyrrolidone (PVP) is a well-established hydrophilic polymer that is soluble in a range 
of solvents, making it an attractive material for several applications (Figure 2.13(b)). PVP can 
be easily processed in various forms such as films, hydrogels, and porous sheets. Moreover, 
it has been proven to be biocompatible and chemically inert as a biomaterial; therefore, it is 
widely used in biomedical applications [288]. The utilisation of PVP as a carrier polymer during 
free-surface electrospinning can efficiently increase the fibre production output of the process. 
As part of this thesis, PVP 360,000 and 1,300,000 gmol-1 were blended with highly esterified 
PGS, electrospun and crosslinked in an attempt to tune the mechanical properties of the 
electrospun membranes to mimic the skin while creating an environment that presents 
adequate swelling to absorb exudate [288]. The developed protocol and chemistry behind the 
photocrosslinking of the PVP/PGS electrospun fibrous mats submerged in a riboflavin solution 
is described in detail in Chapter 4. 
 
 
Figure 2.13 Chemical structures of the synthetic polymers. (a) Nylon-6 (PA6);                                                       
(b) polyvinylpyrrolidone (PVP); (c) poly(caprolactone) (PCL). 
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• Nylon-6 (PA6) 
Polyamides are condensation polymers produced via amide bonding between amines and 
acids, in a similar manner with protein synthesis in the body (Figure 2.13(a)). Nylon-6 
(polyamide-6, PA6) is synthesised by the formation of free-radicals via thermal decomposition 
of the ε-caprolactam ring, followed by chain growth through ring-opening polymerisation [289]. 
PA6 is a commonly used polymer as surgical material for non-absorbable synthetic sutures, 
while PA6 and polyurethane are conjointly used as balloon material in angioplasty, due to the 
superior tensile strength of PA6 [290]. PA6 has several advantageous characteristics, such 
as flexible functionalisation possibilities and superior mechanical performance compared to 
many other polymer materials [291]. PA6 has been shown to carry good responses and 
increased stability in bodily fluids [291]. As part of Chapter 6, PA6 was chosen as the core 
material of the bicomponent core/shell NFs, due to its mechanical stability. 
 
• Silk fibroin (SF) 
The silk fibroin protein extracted from Bombyx mori cocoons is composed of fibroin (70%–
80%) and sericin (20%–30%) [292]. B. mori silkworms have been domestically bred and part 
of the textile industry for centuries [293]. Silk fibres are protein-based fibrous biopolymers, 
formed of repetitive hydrophobic motifs of hexapeptides that consist of [Gly-Ser-Gly-Ala-Gly-
Ala]x, which form a stable anti-parallel beta-sheet structure with [Gly–Ala/Ser] dipeptides 
(Figure 2.14) [294, 295]. The strong hydrogen bonding between the beta-sheets contributes 
to the semi-crystalline structure of the macromolecule; making SF mechanically superior to 
most of the other bio-derived polymers [294, 296]. It has been shown that SF is a valuable 
material for the development of wound management products because of its excellent 
biocompatibility, good oxygen and vapour permeability while inducing minimum inflammatory 
responses [297]. The conventional extraction protocol of silk fibroin from B. mori cocoons, via 
molecular cassette cut-off methods, is a time consuming and expensive process that delivers 
low yields of the protein. Chapter 5 describes a variation of the conventional protocol, based 
on ethanol precipitation, which was developed and employed in this thesis to reduce the time 
required and obtain substantially increased quantities of silk fibroin. 
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Figure 2.14 Chemical structure of the silk fibroin (SF) protein. 
 
• Chitosan (CS) 
Chitosan (CS, a partially deacetylated chitin) is an abundant in nature, polycationic polymer, 
composed through an extended number of β(1–4) linked glucosamine and N-acetyl 
glucosamine units, and it is considered as a valuable biopolymer with strong bactericidal 
properties (Figure 2.15(a)) [298, 299]. It carries three reactive functional sites, an amine and 
a secondary hydroxyl group at C–6, and a primary hydroxyl group at C–3 [298]. Solid chitosan 
fibres can act through a wide range of mechanisms against both Gram (+) and (–) bacteria, 
where chitosan is considered as both a bactericidal and a bacteriostatic agent [300]. Due to 
its polycationic structure, CS can permeabilise the cell wall of prokaryotes by forming ionic 
complexes with the negative charges found: (1) on the phospholipids and lipopolysaccharides 
present in the outer and inner membrane on Gram (–) bacteria, and (2) the teichoic acids 
linked to the peptidoglycan present in the cell wall of Gram (+) bacteria [301]. Such interactions 
provoke internal osmotic imbalances, leakage of intracellular electrolytes, and other low 
molecular weight proteinaceous constituents, consequently inhibiting growth. Hydrolysed 
products of microbial DNA and RNA, also negatively charged, can ultimately inhibit 
downstream transcription and translation [302]. Further, the chelating capacity of the chitosan 
matrix can uptake nutrients and essential metals needed for microbial growth (Figure 2.15(b)) 
[303]. 
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Figure 2.15 Chitosan (a) chemical structure of chitosan deriving from the deacetylation of chitin; 
(b) model of the metal-chitosan chelation complex, based on Wang et al. [304]. 
 
2.8.3 Antimicrobial agents 
As part of the co-axially electrospun nanofibrous hernia mesh construct developed for the 
prevention of mesh-associated surgical site infections in Chapter 6, the antimicrobial agents 
used were selected by carefully evaluating their chemistry, encapsulation properties, and drug 
release profile limitations. The selection of antibiotics was excluded due to numerous studies 
indicating a correlation between long-term exposure and the establishment of resistant 
bacterial strains [305, 306]. The incorporation of nanoparticles and active particles to improve 
the efficiency of the antimicrobial agents were excluded due to the low reproducibility of 
formulating nanoparticle-containing fibres via co-axial electrospinning [307, 308]. Essential 
oils and other natural compounds were found to be less susceptible to the pathogenic bacteria 
of interest [309]. Then, taking into consideration that the selected antimicrobial agents 
presented the appropriate chemical profile to be incorporated within a nanofibre-platform, and 
while possessing the required bactericidal mechanisms against the most commonly 
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associated surgical site infection pathogenic bacteria, it was narrowed down to the binary 
antimicrobial system, consisting of 5-chloro-8-hydroxyquinoline (5CLO8Q) and polyhexanide 
(PHMB). 
 
• Polyhexanide (PHMB) mechanism of action 
Poly(hexamethylene biguanide) (polyhexanide, PHMB) is a well-known antiseptic of mucous 
membranes and wounds, increasingly appearing in a variety of products, such as a skin 
disinfectant in wound dressings (Figure 2.16(a)) [310]. PHMB is a small molecule, with a 
characteristic carbon tail adjacent to a biguanide complex. PHMB's chemical structure closely 
resembles that of chlorhexidine, the most commonly used disinfectant/antiseptic employed by 
surgeons to disinfect surgical instruments and the skin prior to surgical incisions [311]. From 
a chemical perspective, chlorhexidine’s solubility in water is 0.8 mgmL-1 as opposed to                              
426 mgmL-1 for PHMB [312], thus limiting its ability to be homogeneously distributed within 
the NFs. From a medical perspective, as opposed to PHMB, which is FDA-approved for 
internal use at concentrations below 0.4% (w/v), chlorhexidine has been proven by the FDA 
to be highly toxic in both in vitro and in vivo studies (FDA hazardous substance 7196). For this 
reason, PHMB was chosen over chlorhexidine. 
At physiological pH, PHMB is polycationic due to the monoprotonation of each biguanide 
residue [313]. PHMB can widely permeabilise bacterial membranes, due to its small size                         
(180-500 Da), and is able to infiltrate the bacterial wall and intercept cell division by condensing 
the negatively charged chromosomes – a property that previously has not been considered 
and has been since shown to be selective to prokaryotes with no adverse responses to 
mammalian cells [312]. This has been observed in the Gram (+) Bacillus megaterium, where 
growth inhibitory concentrations of PHMB (0.25%–0.4% (w/v)), were able to arrest cellular 
division, as observed by DAPI-stained bacterial foci [312]. PHMB is an effective antimicrobial 
agent against Gram (+) and Gram (-) bacterial species with 100% bactericidal activity, at 
concentrations as low as 4 mgL-1 [312]. In this thesis, a PHMB concentration of 0.3% (w/v) 
was loaded within the core of the core/shell nanofibrous membranes – selected based on the 
regulations of the Scientific Committee on Consumer Safety (SCCS) of the European Union 
[314] and the FDA [315]. 
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Figure 2.16 Chemical structures of the antimicrobial substances. (a) Poly(hexamethylene 
biguanide) (PHMB) and (b) 5-chloro-8-hydroxyquinoline (5CLO8Q). 
 
• 5-Chloro-8-hydroxyquinoline (5CLO8Q) mechanism of action 
5-Chloro-8-hydroxyquinoline (Cloxyquin, 5CLO8Q) is a derivative of quinoline and belongs to 
the bihalogenated 8-hydroxyquinolines family. 5CLO8Q is slightly soluble in water and has 
been previously shown to be active against various bacteria, as well as fungal and amoebic 
organisms [316, 317]. Quinolines are aromatic nitrogen compounds that present a bicyclic 
structure consisting of a saturated benzene ring being joint at two carbons with a pyridine ring 
(Figure 2.16(b)). Hongmanee et al. tested the bactericidal activity of 5CLO8Q against 150 
strains of Mycobacterium tuberculosis – a species of pathogenic bacteria whose cell wall has 
features of both Gram (+) and Gram (-) bacteria – and demonstrated good bactericidal 
responses [318, 319]. The mechanisms through which 5CLO8Q acts against bacteria are 
poorly understood, but they are thought to relate to its chelating abilities. Iron chelation 
deprives microorganisms of essential nutrients [47]. It has been proposed, in a recent study, 
that 5CLO8Q can inhibit the RNA-dependent DNA polymerase of respiratory syncytial viruses 
by chelation of copper [320] and inhibit the synthesis of RNA by chelation of Mg2+, Zn2+, and 
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2.9 Conclusions 
This chapter provided an overall description of the skin and hernia physiology and went 
through the current issues faced by clinicians in the management of wounds and the 
prevention of deep surgical infections, respectively. The advancement of these constructs over 
the years up to the current state-of-the-art skin substitute products and hernia mesh materials 
are elaborated while underlying the challenges that are yet to be met. The reasons why 
electrospinning was chosen for the work conducted in this thesis is substantiated, and the 
theory and advancements in the field of electrospinning are discussed. 
 
In this thesis, the electrospinning device designed, based on the free-surface 
electrospinning theory described above, was employed for the research conducted in 
Chapters 4 and 5 aiming to facilitate the high-throughput production of electrospun 
biocompatible materials that through the chemistry and morphology of the fibres can facilitate 
an “active” and protective environment for improved wound healing responses. Co-axial 
electrospinning, as aforementioned, was chosen to facilitate the development of bicomponent 
fibres that integrate antimicrobial substances in a spatiotemporal configuration, while attaining 
mechanical stability from the core and shell material, respectively.                      
 
The work presented in this thesis will aim to: 
1. Manufacture electrospun fibre-based biomaterials with tuneable properties. 
2. Assess the impact of the electrospun scaffolds architecture regarding physicochemical 
and mechanical stability, biocompatibility (in the case of skin-like substitutes), and drug 
release profile and antimicrobial efficiency (in the case of hernia meshes). 
3. Design and build a nozzle-free electrospinning device intended to augment the meagre 
fibre production associated with lab-based electrospinning equipment. 
4. Assess the effect of different forms of poly(glycerol sebacate) towards the mechanics 
and wetting properties of the skin-like substitutes. 
5. Describe the photocrosslinking process of the PVP/PGS fibres. 
6. Develop a straightforward, efficient and rapid protocol for the extraction of silk fibroin 
from Bombyx mori silkworm cocoons. 
7. Compare the antimicrobial efficacy of the developed bicomponent electrospun 
nanofibres to those of the currently available synthetic and biologic meshes. 
The following chapter describes the general methodology, synthesis, materials, in vitro cell 
and bacteria evaluation, drug release study and characterisation techniques employed in this 
thesis. It further provides some in-depth rationale behind the materials and techniques that 
were chosen to facilitate the development and assessment of the constructs. 
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This chapter provides a general description of the materials, chemicals, reagents, 
experimental protocols, and characterisation techniques implemented in this thesis. 
Thereafter, project-specific methodologies will be provided in detail in the subsequent 
research chapters. 
 
3.2 Scaffold fabrication by electrospinning 
Electrospinning is the principal fabrication method used, in this thesis, for the development of 
the skin substitute constructs and antimicrobial hernia meshes, in the form of nonwoven 
fibrous biomaterials. For the high-throughput production of the skin-like substitute electrospun 
mats, a nozzle-free electrospinning device, consisting of two rotating mandrels positioned 
parallel and at a defined distance from each other – where the fibres were collected in an 
upward motion – was designed and built as described in Section 4.2.1. For the development 
of the drug-eluting antimicrobial nanofibrous membranes; considered for the prevention of 
mesh-associated surgical site infections, the co-axial electrospinning technique was employed 
as described in Section 6.2.2. Randomly oriented fibres were collected on a mandrel rotating 
at 500 rpm. A collector drum can be used at a low rotation speed to improve the efficiency at 
which fibres are collected. It has been shown that for a particular electrospinning solution, 
potential difference, and flying path, low rpm can be used to collect randomly oriented rather 
than aligned fibres [1]. 
Although the National Science Foundation deems fibrils of less than 100 nm as nanofibres 
(NFs), polymeric fibres in the submicron scale are considered as NFs in the literature [2], and 
thus throughout this thesis fibres are described based on their diameter as nano-scale                       
(≤1 µm) or micro-scale (>1 µm). Details on specific electrospinning, solution preparation, and 
post-processing procedures are provided at the corresponding methodology sections of the 
research Chapters 4, 5, and 6. 
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3.3 Materials 
For each research work presented in the following chapters, polymers and solvents were 
chosen based on extended parametric studies, which examined the effect of a specific 
polymer/solvent system to the reproducibility, Taylor cone stability (optically inspected using a 
magnifying monocular), and fibre properties. Factors such as the polymer's concentration, its 
solubility and compatibility to a specific solvent system, viscosity, and conductivity 
measurements, had to be predetermined. 
 
 
3.3.1 Poly(glycerol sebacate) (PGS) 
Poly(polyol sebacate) is a family of ester-bonded crosslinked elastomers. A polyol is an 
alcohol containing multiple hydroxyl groups; in the case of PGS, glycerol. Sebacic acid is a 
ten carbon-long dicarboxylic acid [3].  
Pre-polymerisation and esterification are the two steps involved in the synthesis process. 
The pre-polymer is a result of the pre-polymerisation stage when the linear chain of the 
polymer is formed through an esterification reaction between glycerol and sebacic acid. The 
initiator of the reaction is the hydroxyl groups of the polyol [3]. The primary hydroxyl group of 
the glycerol grasps a carboxyl group to form a monoester with a free carboxyl group and water 
as a by-product. Subsequently, the monoester reacts with another primary group of glycerol 
to form another monoester, and it continues until all the available functional groups have been 
used. In the next stage, curing is required to evaporate glycerol and water residues, enabling 
the synthesised PGS to form a stiffer, crosslinked network. The fully cured form of the 
thermoset presents a three-dimensional (3D) network of the polyester chains via intra-
hydrogen bonding [4]. 
The product of the first stage of this reaction – due to the esterification between the two 
monomers, results in the formation of linear chains of pre-polymer which are referred to as 
pre-PGS (pPGS) throughout this thesis. The hydroxyl groups (–OH) of glycerol act as the 
initiator of the reaction by binding to the carboxyl group (R–COOH) of the sebacic acid to form 
a monoester that presents a free carboxyl domain and water as a by-product. At the second 
step, the formed monoester reacts further with the remainder of the –OH groups of glycerol 
until all its functional groups have been replaced. At the end, water evaporation produces a 
stiff network of PGS chains. 
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Distinct physicochemical properties of the synthesised PGS polymer can be obtained by 
fluctuating the temperature, reaction time, and atmospheric pressure at the second stage of 
the synthesis scheme. Pre-polymerisation of PGS can produce pPGS of varying degree of 
esterification (DE) ranging from 0% to 100%. The DE can be used as a measure of the 
polymerisation degree and, more importantly, for predicting the unreacted alcohol groups after 
the pre-polymerisation process, which will depend upon the temperature and curing time [4]. 
 
DE(%) = 
Amount of water collected (mL)
Theoretical amount of water (mL)
 ×  100 (3.1) 
 
The synthesis protocol followed to obtain the two different esterification degrees of the 
polymer referred to as PGS and pPGS are described in Table 3.1. Electrospinning neat PGS 
into homogenous fibres is an arduous process because its low molecular weight does not 
allow sufficient chain entanglement of the pre-polymer and the high viscosity of the cured 
polymer makes it insoluble in most organic solvents [3]. For this reason, in this work PGS and 
pPGS were electrospun in the presence of carrier polymers as explained in detail in                       
Chapter 5 (where PGS was incorporated with different molecular weights of PVP) and Chapter 
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Table 3.1 The synthesis protocol and some key aspects of the two PGS forms (pPGS and PGS) 
used for the development of the novel biomaterial systems in this thesis. PGS was synthesised 
based on the initially published polycondensation method [5] with modifications to obtain the 
pre-polymerised (pPGS) form. 
pPGS PGS 
Low esterification degree. High esterification degree. 
No exogenous catalysts or solvents are required 
for the synthesis. 
No exogenous catalysts or solvents are required 
for the synthesis. 
The pre-polymer PGS (pPGS) was produced by 
thoroughly mixing equimolar (1:1 M) glycerol and 
sebacic acid at 120 °C under N2 gas purged at a flow 
rate of approximately 120 cm3min−1, using a round 
bottom three-necked reactor at reduced pressure          
(1 Torr) for 24 h. 
The cured form of the polyester, PGS, was then 
obtained by steadily reducing the pressure to 40 
mTorr, at 120 °C for an additional 48 h, under a 
reduced atmosphere. 
pPGS is a white elastomer with a wax-like texture. Pure PGS is a viscous, yellowish, “sticky” elastomer. 
PGS and pPGS 15% (w/v) were prepared by separately dissolving them in HFIP, while still in the viscous 
liquid phase of the polymer, by pouring each polymer directly from the three-neck flask before cooling 
off. 
The (p)PGS polymer solutions were then thoroughly stirred at 500 rpm overnight prior to incorporating 
predetermined amounts of the polymer to each blend developed and electrospun as described in 
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3.3.2 Stock chemicals, reagents, cells and equipment  
To ensure the reproducibility of the performed experiments, the tables below list the specific 
polymers, solvents, reagents, chemicals, and cell-lines (Table 3.2) and the equipment used 
(Table 3.3) to conduct the research presented in this thesis. 
 
Table 3.2 List of the materials, CAS registry number, and the corresponding suppliers used in the 
experiments. 
Materials CAS Number Supplier 
Polymers 
Bombyx mori silkworm cocoons - Local sericulture  
Chitosan powder (CS, degree of de-acetylation 85/100,  
MW 100,000 – 300,000 gmol-1) 
9012-76-4 Heppe Medical 
Chitosan GmbH 
Nylon-6 pellets (polyamide-6; PA6)  25038-54-4 Sigma-Aldrich 
O-carboxymethyl chitosan (O-CMC, degree of de-acetylation  
90/100, MW 100,000 – 300,000 gmol-1) 
83512-85-0 Santa Cruz 
Biotechnology 
Poly(caprolactone) (PCL, MW 80,000 gmol-1) 24980-41-4 Sigma-Aldrich 
Poly(ethylene oxide) (PEO, MW 900,000 gmol-1) 25322-68-3 Sigma-Aldrich 
Polyvinylpyrrolidone (PVP) 
(MW 360,000 and 1,300,000 gmol-1) 
9003-39-8 Sigma-Aldrich 
Poly(glycerol sebacate) synthesis   
Glycerol (≥ 99.5%, MW 92.09 gmol-1) 56-81-5 Alfa-Aesar 
Sebacic acid (≥ 98%, MW 202.20 gmol-1) 111-20-6 Alfa-Aesar 
Antimicrobial agents   
5-Chloro-8-hydroxyquinoline (5CLO8Q, ≥ 95%, C9H6ClNO,  
MW 179.60 gmol-1) 
130-16-5 Sigma-Aldrich 
Poly(hexamethylene biguanide) hydrochloride (PHMB, ≥98%,  





1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP, ≥ 99%) 920-66-1 Fluorochem 
Acetic acid (AcOH, ≥ 99.8%) 64-19-7 Sigma-Aldrich 
Chloroform (CF, ≥ 99.8%) 67-66-3 Acros Organics 
Dimethylformamide (DMF, ≥ 99%) 68-12-2 Acros Organics 
Ethanol (EtOH, anhydrous, ≥ 99.8%) 64-17-5 Acros Organics 
Formic acid (FA, ≥ 99%) 
                        (Chapter 5) 
64-18-6 Acros Organics 
(Chapter 5) 
                        (FA, ≥ 95%) 
                        (Chapter 6) 
-/- Sigma-Aldrich 
(Chapter 6) 
Ultrapure water - Distilled  
in-house 
Chemicals   
Calcium chloride (CaCl2, ≥ 96%, MW 110.98 gmol-1) 10043-52-4 Thermo-Fisher 
Scientific 
Hydrochloric acid (HCl, 34%–37% in H2O, pH< 1) 7647-01-0 Sigma-Aldrich 
Lithium bromide (LiBr, ≥ 99%, MW 86.84 gmol-1) 7550-35-8 Thermo-Fisher 
Scientific 
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PVP:PGS UV photoinitiator   
Riboflavin (≥ 98%, MW 376.36 gmol-1) 83-88-5 Alfa-Aesar 
O-carboxymethyl chitosan grafting   
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC, ≥ 98%, MW 115.09 gmol-1) 
25952-53-8 Sigma-Aldrich 




TEM ruthenium tetroxide staining   
Ruthenium(III) chloride hydrate (RuCl3, 45%–55% in H2O,  
MW 207.43 gmol-1) 
14898-67-0 Sigma-Aldrich 
Sodium hypochlorite (NaClO, 14% in H2O, MW 74.44 gmol-1) 7681-52-9 Sigma-Aldrich 
Mounting media for microscopy   
1,4-Diazabicyclo[2.2.2]octane (DABCO, ≥ 97%) 280-57-9 Acros Organics 
Glycerol (≥ 99%, MW 92.09 gmol-1) 56-81-5 Sigma-Aldrich 




Mowiol® 4-88 (PVP, MW 31,000 gmol-1) 9002-89-5 Sigma-Aldrich 
Cell-lines   
Fibroblasts immortalised with hTERT 
(Isolated from human foreskin) 
(pGRN145 hTERT-expressing plasmid) 







Escherichia coli (Migula); Castellani and Chalmers 
(Isolated from urine) 







(Isolated from human skin burn) 







Staphylococcus aureus (subsp. aureus Rosenbach) 
(Isolated from human lesion) 






Mammalian cell culture   
Dulbecco's Modified Eagle Medium (DMEM), high glucose, sodium 





























Triton X-100 (10% (v/v) detergent in ultrapure water) 9002-93-1 Thermo-Fisher 
Scientific 
Tween-20 (PEG sorbitan monolaurate) 9005-64-5 Sigma-Aldrich 
Trypan blue solution (0.4%), sterile filtered 72-57-1 Sigma-Aldrich 
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SEM cell-seeded scaffolds fixation   
Ethanol (anhydrous, ≥ 99.5%) 64-17-5 Sigma-Aldrich 
Glutaraldehyde (C5H8O2, Grade II, 25% (v/v) in H2O) 111-30-8 Sigma-Aldrich 




Hexamethyldisilasane (HDMS, ≥ 98%) 999-97-3 Alfa-Aesar 
Sucrose (D-Saccharose, ≥98%, MW 342.30 gmol-1) 57-50-1 Alfa-Aesar 
Bacteriological culture   
Agar powder ((C12H18O9)n) Merck 05040 Sigma-Aldrich 
Brain–heart infusion broth (BHI, 5 g/L calf brains infusion from 
200g, 12.5 g/L disodium hydrogen phosphate, 2.5 g/L D(+)-










Mueller–Hinton broth (MH, 2.0 g/L beef infusion, 17.5 g/L casein 





Phosphate-buffered saline (PBS, pH 7.4) Merck P3813 Sigma-Aldrich 
SEM bacteria seeded scaffolds fixation   
Ethanol (anhydrous, ≥ 99.8%) 64-17-5 Sigma-Aldrich 
Formaldehyde solution 4% (v/v) in PBS (pH 6.7–7.1) 50-00-0 Sigma-Aldrich 
Hexamethyldisilasane (HDMS, ≥ 99%) 999-97-3 Sigma-Aldrich 
Bacteria fluorescence imaging   
BaclightTM live/dead bacterial viability kit (consisting of SYTO™ 9  
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Table 3.3 Equipment used to characterise the pristine material, synthesised polymers and 
composite electrospun mats. The specific chapters that each equipment was used are indicated 
in brackets ( ).  
Equipment Model Manufacturer 
Fibre morphology   
Scanning electron microscopy (SEM) JSM 6010 PLUS 
(Chapter 4) 
JEOL, Ltd, Japan 
 JSM IT100 
(Chapter 5) 
JEOL, Ltd, Japan 
 Zeiss Crossbeam 550 focused ion 






















Sputter coater Balzers BAS450 (target Au) 
(Chapter 4) 
Oerlikon Balzers 
Coating, Ltd, UK 
 Agar AGB7341 (target Au) 
(Chapter 5) 
Agar Scientific, Ltd, 
UK 
 Leica ACE 600 – ICN2 (Pt/Au) 
(Chapter 6) 
Leica, AG, Germany 
Polymer solution evaluation   
Conductivity meter HI99301 (Res. 0.01 mScm-1) 
(Chapters 4 and 5) 
Hanna Instruments, 
SRL, USA 
pH meter HI98129 
(Chapters 4 and 5) 
Hanna Instruments, 
SRL, USA 




Rheometer MCR 301 Viscometer 
(Chapter 6) 
Anton Paar, GmbH, 
Austria 
Physicochemical characterisation   
Fourier-transform infrared spectroscopy,  





 Varian 640-IR 
(Chapter 5 and 6) 
Varian Medical 
Systems, Corp., USA 





Water contact angle (WCA) Drop Shape Analyser, DSA100 
(Chapters 4 and 5) 
Krüss, GmbH, 
Germany 
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3.4 Characterisation 
Engineering a biomaterial is designing it to tackle a particular medical problem. It is essential 
to comprehensively characterise the biomaterial's physicochemical properties and biological 
responses, to better understand whether the requirements to tackle that specific medical 
problem have been met. Multidisciplinary characterisation allows the development of 
biomaterial that carry the required features while being adequately reproducible. 
The physicochemical properties of a biomaterial play key roles toward its ability to provide 
a biomimetic niche that integrates the appropriate architecture and material-tissue interface 
capacities to facilitate better cellular interactions. The physical properties of electrospun 
biomaterials are heavily dependent on the intrinsic properties of the incorporated materials, 
as well as the micro/-nanoarchitecture of the fibres; such as fibre structure (e.g., core/shell) 
and diameter, surface area, density, fibre orientation, pore size, and porosity. The electrospun 
biomaterials were characterised towards their micro/-nanostructural features by scanning 
electron microscopy (SEM) and transmission electron microscopy (TEM). The chemical 
characterisation of the fibres was based on qualitatively identifying the polymers’ composition 
and chemical interactions, as well as quantitatively by determining the surface chemistry of 
the fibres. Fourier transform infrared spectroscopy (FTIR), and X-ray photoelectron 
spectroscopy (XPS) were employed to determine the chemical structures of the synthesised 
polymers, the composition of the developed composite electrospun fibres, and the surface 
chemistry of the fibres. 
The wettability and degradation of a biomedical implant are also of great importance, as 
variations in the hydrophilicity/hydrophobicity and the rate at which the material breaks down 
can directly or indirectly affect the biocompatibility, cell attachment behaviour, elicited immune 
responses and antimicrobial activity of the biomaterial. For this reason, the water contact 
angles, and degradation behaviour of the fibre-based biomaterials were also investigated, with 
drop shape analysing equipment and prolonged degradation studies.  
In addition, the mechanical properties of the electrospun membranes were evaluated 
under standardised conditions based on the stress-strain relationships, using universal tensile 
testing equipment. This was conducted as part of Chapter 4; while attempting to mimic the 
mechanics of variant anatomical sites of the skin, and as part of Chapter 6; while attempting 
to meet the mechanical requirements of hernia mesh materials. 
In connection with the core/shell antimicrobial nanofibrous meshes, developed in Chapter 
6, understanding and evaluating the drug release profile of each substance and the conditions 
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under which it is released can provide further insights towards the capabilities of the 
biomaterial to act as a drug-loading matrix and provide the required bactericidal activity. 
Carefully designed drug release experiments examined the drug release of the antimicrobial 
agents at defined pH conditions and temperature, over an extended period of time using UV 
spectroscopy. The various characterisation techniques employed in this thesis are described 
in detail in the subsequent sections. 
 
3.4.1 Scanning electron microscopy (SEM) 
During scanning electron microscopy (SEM), electrons are emitted from a filament through 
thermionic emission, which accelerates to the surface of the sample by means of a bias 
voltage between the electron source and the target. The scanning beam irradiates the 
specimen causing it to interact with the electrons at the surface to produce the detecting 
signals: secondary electrons (SE) and backscattered electrons (BSE), which are subsequently 
taken up by an X-ray detector. The detector accelerates the secondary electrons into a 
scintillator that converts the electron-based signal into a light signal, followed by a 
photomultiplier, which converts the photons into an electronic pulse that is then amplified to 
modulate the intensity of the image projected on a computer screen. 
SEM imaging is vastly used in this thesis to determine the quality, reproducibility, and 
morphological properties of the electrospun fibres. All specimens were mounted on aluminium 
stubs using double-sided carbon adhesive tape and sputter-coated with a thin layer of Au 
(ranging from 8 to 10 nm thickness) to form an electrically conductive surface. As several SEM 
devices were used, the voltage of the electron beam (ranging from 2 to 20 kV) and current 
(ranging from 5 to 20 mA) were adjusted accordingly every time. Images were obtained at 
consistent magnifications of 200x, 500x, 1000x, 2000x, 5000x, 10000x and 20000x, 
depending on the thickness of the fibres for each specimen examined. 
 
3.4.1.1 Determining the fibre diameter, pore size and porosity 
The mean fibre diameter and pore size were measured using the Fiji-ImageJ software (v.1.52, 
National Institutes of Health, USA); where at least three different SEM micrographs were 
chosen, and randomly a total of 90–120 fibre width values were measured manually per 
sample. This was done by determining the known distance of the SEM micrograph's scale bar 
(in pixels) and converting them to units of length. Fibre diameter distribution graphs and normal 
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distribution histograms were also produced in SPSS (v.24, Statistical Package for Social 
Sciences, IBM, USA). 
The surface porosity and density of the nanofibrous scaffolds were then evaluated using 
the ImageJ add-on 'DiameterJ' from n ≥ 1000 fibre-points. The margin of error between the 
manually calculated and automatically measured computations was, for all specimens  ≤ 5%. 
Porosities were determined via threshold image analysis of the SEM micrographs using 
ImageJ. The density of the fibrous scaffolds was determined as "intersections per μm2", using 
DiameterJ, where; the average length of the fibres was divided by its radius determined based 
on four points for each fibre per image that was analysed. Then, the total number of 
intersections were calculated as the specific area (in pixels) × 104, which corresponds to 
1/1000th points per pixel of the image. 
 
3.4.2 Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) differs from SEM, as the electron beam is 
transmitted rather than scattered, and thus it can be used to obtain details on a thin specimen 
over its internal composition. 
The TEM was one of the methods employed to confirm the core/shell structure of the 
antimicrobial hernia mesh nanofibrous mats. The double contrast method was utilised to 
distinguish between the shell consisting of chitosan, and the core of the fibre made of                       
nylon-6. Ethanol was used to mount the TEM copper grids to the surface of the collector, on 
which fibres were directly electrospun and deposited for a few seconds. After drying, the fibre-
containing grids were stained by placing them on a desiccator containing a ruthenium tetroxide 
(RuO4) solution at the gaseous phase, prepared by dissolving RuCl3 in 10 wt.% NaClO 
solution, for 2 h, in order to attain an increased contrast between the two polymers when 
exposed to the transmission electron beam. Ruthenium tetroxide closely relates to osmium 
tetroxide but is less toxic and volatile. As a strong oxidising agent, it can react with many 
organic compounds, including primary and secondary alcohols like the ones present in the 
chitosan's structure. Further, RuO4 staining can carry a stabilising effect against fibre damage 
that can be caused by exposure to the electron beam [6].  
2 RuCl3 ·  3 H2O +  8 NaClO →  2 RuO4  +  8 NaCl +  3 Cl2  +  6 H2O      (3.2) 
The stained grids were then analysed at an acceleration voltage of 80 kV, and the obtained 
images were evaluated using ImageJ. 
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3.4.3 Fourier transform infrared (FTIR) spectroscopy 
The Fourier transform infrared (FTIR) spectroscopy technique was used to determine the 
chemical structure and interactions between the polymers and drugs in their pristine, fibrous 
and crosslinked forms. The FTIR technique identifies the presence of the chemical bonds in a 
molecular structure (in the form of bending, symmetric and asymmetric stretching) by 
interacting the specimens with infrared light and producing an infrared absorption spectrum. 
IR radiation is absorbed by chemical bonds; as the stretching and bending of every bond result 
in a change in the molecule's dipole moment. As electromagnetic radiation interacts with the 
bond's altered dipole moment, radiation from the IR-emitter is absorbed and can be computed 
by measuring the change in the intensity of the beam, prior and post, passing through the 
specimen. When all measurements have been taken, a Fourier transform decomposes the 
raw absorbance data as the amount of energy absorbed per wavelength over time, through a 
mathematical transform. 
In this thesis, the measurements of each specimen were directly analysed using the 
attenuated total reflectance (ATR) crystal mode of the FTIR equipment. All samples were dried 
to obtain sharper spectra and avoid broadening of the polar group absorptions. The mid-
infrared scanning range was 650 and 4000 cm-1 with a spectral resolution of 2 cm-1 (32 scans) 
for Chapter 4, 600–4200 cm-1 with a spectral resolution of 2 cm-1 (72 scans) for Chapter 5, and 
600-4500 cm−1 with a spectral resolution of 2 cm−1 (126 scans) for Chapter 6. Silk fibroin and 
chitosan region-specific scans ranging from 800–2000 cm-1 and 1200–2000 cm-1, respectively, 
were also obtained. The spectra were examined in Origin (v.10, OriginLab, Corp., USA), and 
the graphs were produced in Matlab (v.R2019a, MathWorks, Inc., USA). 
 
3.4.4 X-ray photoelectron spectroscopy (XPS) 
X-ray photoelectron spectroscopy (XPS) is a surface-sensitive analytical technique that 
quantifies the photoelectron energy (50–2000 eV) released when the surface of a material is 
bombarded with X-rays under high vacuum (≥ 10−7 Pa) at a depth that extends from the surface 
of the specimen to approximately 50–70 Å [7]. If the incoming energy of an X-ray photon is hv, 
the maximum kinetic energy (Ekin) of the electron leaving the surface of the material is defined 
as: 
Ekin = hv − Ebin  − φ (3.3) 
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where, Ebin is the binding energy of the electron and φ the analyser work function (specific to 
the device, typically between 2–5 eV for the equipment used). XPS is an excellent technique 
for determining a surface's elemental composition and the binding states of the elements 
present. 
An XPS with an Al Kα X-ray source was used in this thesis to determine the surface 
chemistry of the electrospun skin substitute fibres and further validate the core/shell structure 
of the antimicrobial hernia meshes, by quantifying the elements present at the surface and the 
corresponding binding energies. The energy resolution of the spectrometer was set to 0.8 
eV/step at a pass-energy of 187.85 eV for the survey scans. Carbon at 284.5 eV binding 
energy was used as a reference to correct for charge effects. The elemental compositions 
were determined using instrument-dependent atom sensitivity factors based on the C1s peak 
area. The photoelectron-transitions of C1s, O1s, N1s, Ca2p, Cl2p, and Si2p were chosen to 
determine the surface elemental concentration of the fibres. Spectra analysis and peak fitting 
were carried out using CasaXPS (v2.1, Casa Software Ltd, UK) to determine the atomic ratios 
(at. %), as well as carbon and nitrogen bonding contents. The theoretical atomic ratios of the 
composite electrospun mats, based on the molecular structures of each polymer and drug, 
were also calculated to determine and further validate the core/shell structure, as the C, N and 
O content is distinctively different between chitosan (shell) and nylon-6 (core). 
 
3.4.5 Mechanical testing 
Determining the tensile properties of the developed fibrous biomaterials is essential to obtain 
an initial appraisal of their ability to withstand mechanical forces upon incorporation onto the 
defected site. The mechanics were of special relevance to Chapter 4, where variant blends of 
crosslinked PVP/PGS fibres were examined towards their ability to mimic the mechanics of 
different anatomical regions of the skin, as well as for the antimicrobial NFs produced in 
Chapter 6, where nylon-6 was incorporated within the core of the core/shell chitosan-
5CLO8Q/nylon-6-PHMB NFs to improve the composite's mechanics and bring it closer to the 
mechanical requirements of a hernia mesh.  
 The scaffolds were cut using a customised mould into dog bone-shaped specimens with 
an outer area (115 mm (length) × 25 mm (width)) and an inner area (84 mm (length) × 6 mm 
(width)), based on ISO 527–3 Type 5 for determining tensile properties of thin films and sheets 
(Chapter 4) or into rectangular 10 × 40 mm strips based on ISO 527–3 Type 2 (Chapter 6) 
(Figure 3.1) [8]. The thickness of each electrospun mat was measured with a high-precision 
digital micrometre (Chapter 4) or a profilometer (Chapter 6). The weight of each specimen was 
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also determined. The thickness was between 0.1–0.8 mm (Chapter 4) and 0.05–0.15 mm 
(Chapter 6). The specimens were then placed into an acclimatised room under standard 
atmospheric conditions (22 ± 2 °C and 65% ± 5% RH) for two days prior to the measurements. 
 
 
Figure 3.1 Standards for determining tensile properties of thin films and sheets. (a)  
Schematic representation and a photograph of the mould designed based on ISO 527–3 Type 5 to 
determine the mechanical properties in Chapter 4; (b) schematic representation of ISO 527–3 
Type 2 used to determine the mechanical properties in Chapter 6. 
 
 The specimens were tested in axial tensile load 100 N, at a constant crosshead speed of 
50 mmmin-1 (5% of non-load value) (Chapter 4) or using a 10 N load cell at a crosshead speed 
of 10 mmmin-1 (Chapter 6). Each specimen was stretched apart gradually from the gripping 
units moving in opposite directions until failure.  
 In this thesis, the tensile properties of each biomaterial assessed were obtained to 
determine the Young's modulus and ultimate tensile strength (UTS). The Young's modulus 
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describes how easily a material can stretch or deform as a ratio between the force applied to 
a material and the subsequent strain. Stress is defined as the force (F) per unit of area, while 
the strain is calculated from the absolute deflection divided by the original deflection. The 








Area (𝑚𝑚2) = Specimen thickness (mm) ×  Specimen width (mm) 
and, 
Elongation at break (%) =
Specimen elongation (mm)
Original length (mm)
 × 100 (3.5) 
 
and,  





The UTS determines the maximum stress that the specimen can endure before failure. 
The Young's modulus was based on the tangential modulus determined from the tangent line 
placed to the envelope, prior to the elastic limit (before permanent deformation occurs), of the 
tensile stress-strain curve plotted for each specimen (Figure 3.2). At least six specimens were 
prepared for every type of electrospun mat, and the average values are represented as the 
mean ± SD. The stress-strain graphs were produced in Matlab, and statistical significance 
between the different groups for the Young's modulus and UTS measurements were 
determined by one-way analysis of variance (ANOVA) using SPSS.  
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Figure 3.2 Stress-strain curve of "model" fibre specimen. Redrawn, based on [8]. 
 
3.4.6 Thermogravimetric analysis (TGA) 
Thermogravimetric analysis (TGA) was conducted to provide indications, where appropriate, 
towards the composition of the composite electrospun mats in comparison to the pristine 
material and neat (non-composite or non-drug containing) fibres. TGA is a quantitative method 
that records mass change in solid material, due to phase transitions and thermal degradation, 
as the temperature amply increases over time. Heat is used to trigger chemical reactions and 
physical alterations in materials [9]. As the sample heats up, weight is lost due to dehydration 
and decomposition or weight is gained due to oxidation. The device is placed on an anti-
vibration table, where a thermocouple is used to monitor the temperature, and a high precision 
microbalance is used to determine the weight of the specimen over time. 
Thermograms were obtained to determine the thermal stability and the onset of 
decomposition temperature (Tonset) of the composite fibres using thermogravimetry. Each dried 
specimen weighing between 2.5–3.0 mg was placed on an open ceramic crucible and heated 
from room temperature up to 800 °C at a rate of 10 °Cmin-1 under nitrogen atmosphere at an 
outlet pressure of 10 mLmin-1.  
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3.4.7 Differential scanning calorimetry (DSC) 
Differential scanning calorimetry (DSC) was used to observe thermodynamic properties, such 
as fusion and crystallisation events, as well as the glass transition temperatures (Tg) of the 
composite electrospun mats in comparison to the pristine material and neat fibres. DSC is a 
destructive thermoanalytical technique that measures the difference in the amount of heat 
required to raise the temperature of a specimen set side by side to a well-defined reference 
sample (empty aluminium crucible), as a function of temperature [10].  
The specific heat capacity (Cp) in a given system is the total amount of heat required to 
raise the temperature of 1 kg of a substance by 1 K, while the heat flow refers to the amount 
of heat supplied per unit of time (in Js-1). The following formulas were applied to determine 
the heat capacity: 




60 ×  Heat flow (mW/mg)
10 K/min
(3.7) 
The enthalpy was determined as: 
Enthalpy (H) =  Heatflow ×  Time (min) ×  60 (3.8) 
and the temperature was given by: 
Temperature (T) =  
H
m ∙ Cp ∙ dT
(3.9) 
The Tg refers to the temperature at which a phase change is observed that transforms a 
polymer from a ductile material into a hard and brittle material. Different materials will differ 
significantly and will present unique glass transition temperatures, which makes a given 
polymer better suited or worse for a particular application. For the composite polymer fibres 
described in the following chapters, the glass transition temperature is dependent on the 
proportion of the individual components of polymers present in the blend, as well as the 
individual Tg of these components. Crystallisation (Tc) is an exothermic process apparent just 
above Tg, where most polymers will experience molecular chain mobility. This results in a 
decrease in the recorded heat flow since less heat is required to keep the heating rate of the 
specimen than that of the reference crucible in the DSC. Tc is observed as a sharp decreasing 
peak by plotting the heat flow against temperature. At the melting temperature (Tm), the 
molecular chains of the polymers are mobile and do not follow an ordered arrangement. 
Chapter 3 | General Materials & Methods  115 
 
Melting is considered an endothermic process that is accompanied by absorption of heat, with 
the temperature remaining constant during melting beside the continuous heating of the 
specimen. 
Since nylon-6 (PA6) is a thermoplastic, it presents a very distinct Tm value, in comparison 
to chitosan that is an amorphous polymer. Based on this observation, the amount of PA6 
present within the core of the core/shell NFs could be estimated. The amount was determined 
based on the enthalpy change (ΔHm) values of the PA6-only and the core/shell PA6-
PHMB/CS-5CLO8Q NFs corresponding to the polyamide melting enthalpies, based on: 
 
Amount of PA6 within the core (%) =
ΔHm (core/shell)
ΔHm (PA6)
× 100 (3.10) 
where, ΔHm(core/shell) and ΔHm(PA6) are the heat of fusion values of the core/shell and PA6-only 
electrospun mats, respectively. 
DSC measurements of the specimens were taken at a heat rate of 10 °Cmin-1 under 
nitrogen flow. Dried samples (weighing between 5–20 mg) were sealed into aluminium 
crucibles and placed into controlled heating and cooling cycles at a temperature range of              
-20 °C (-70°C for the PEO powder) to 320 °C (Chapter 6). 
 
3.4.8 Water contact angle (WCA) measurements 
Wettability refers to the preference of a liquid to form contact with a solid and is determined 
by cohesive and adhesive forces between the liquid and the solid. In the case of cohesive 
forces, molecules of the same kind (similar polarities, reactive groups, among others) are 
pulled towards each other, while adhesive forces refer to interactions between unlike 
molecules. The ability of a material to balance these two forces determines its wettability. A 
contact angle is used to measure wettability. The contact angle of 90° is considered as the 
threshold number. When the angle exceeds 90°, the material is deemed hydrophobic, while a 
contact angle below 90° is defined as a hydrophilic surface. 
In tissue engineering, scaffolds are required to implement various requirements, among 
which are surface properties. These properties include wettability, morphology, and surface 
energy, which affect cell adhesion and migration at the interface of tissue-scaffolds. Polymer 
surface engineering is a tool used to improve the behaviour of scaffolds by tuning surface 
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characteristics. Altering the wetting capabilities of a scaffold can determine how a mammalian 
cell adapts to it, since cells tend to be more responsive to energy free surfaces. The 
composite's interfacial energy will determine the tissue's regeneration capabilities, as well as 
its antimicrobial behaviour. Biomaterial with lower interfacial energy can offer a higher cell-
surface affinity [11]. These surfaces usually have hydrophilic energy that is slightly larger than 
the energy of the water surface tension, therefore leading to better cell attachment by ligand-
receptor interactions, and may, further, prevent bacterial colonization [12]. 
The water contact angle (WCA) measurements of the electrospun membranes were 
determined by the sessile drop method. For each scaffold, at least 8 measurements were 
obtained by dispensing a 5 μL droplet of deionised water (Chapters 4 and 5) or ultrapure 
HPLC-grade water (Chapter 6) and letting it settle at the surface of orderly unswerving fibre 
mats at room temperature. The values were computed from recorded videos on Advance 
(v1.9, Krüss GmbH, Germany) (Chapters 4 and 5) or with the contact angle add-on of the 
ImageJ. The means ± SD were determined, and statistical analysis using repeated-measures 
ANOVA with confidence interval adjustment Bonferroni was conducted in SPSS. 
 
3.4.9 Degradation studies 
The degradation rate of a biomaterial over time can provide key information of its ability to co-
exist within a tissue, long-term biocompatibility, tissue adhesion properties and ultimately act 
as an indicator of whether the construct can be considered bioabsorbable, prior to an in vivo 
study [13]. For each electrospun mat (Chapters 4 and 5), five specimens were punched into                                                       
5 × 5 mm2 pieces obtained from three independently electrospun mats, adapted from a 
previously published protocol [14]. Subsequently, the specimens were weighed (initial mass, 
Wo) and placed in Petri dishes containing PBS (1x, pH 7.2) at room temperature under ambient 
conditions, where the solution was refreshed daily. After being immersed for predetermined 
time points, ranging from 15 min to 30 days, the specimens were dried at 50 °C and weighed 
(dry mass post submersion, Wi). The residual mass (weight loss, μ) of each specimen was 
calculated as: 
 
Weight loss (μ)(%) =
(Wo − Wi)
Wo
× 100 (3.11) 
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3.4.10 In vitro drug release studies 
For the core/shell antimicrobial nanofibrous mats, consisting of nylon-6-PHMB in the core and 
chitosan-5CLO8Q in the shell, the drug release profiles were determined at pH 7.2 and 6.2, at 
37 °C. The pH values were based on the fact that infections surrounding the peritoneal fluid 
of the abdomen range between pH 7.0 and 7.8 (for healthy tissue) and between pH 6.0 and 
7.2 for diseased tissue; where pH 6.0 is found only in anorectal abscesses caused by non-
encapsulated bacterial species. The applicable temperature was chosen at 37 °C to 
approximate the human body temperature.  
By utilising the high surface area of co-axially electrospun NFs, a high drug loading 
efficiency can be obtained by pairing the hydrophilic PHMB with the hydrophobic nylon-6 in 
the core and the hydrophobic 5CLO8Q with the hydrophilic chitosan present at the surface of 
the electrospun mats. 
The dried electrospun mats were cut into pieces weighing ~ 6 mg and placed in 20 mL 
centrifuge tubes containing 10 mL of PBS pH 7.2 or PBS-HCl pH 6.2. All the vials were 
incubated at 37 °C at 30 rpm. At specified time intervals, 1 mL of release medium was pipetted 
and replaced with an equal volume of fresh solution. The drug release profiles of the single 
CS-5CLO8Q and PA6-PHMB, as well as the core/shell PA6-PHMB/CS-5CLO8Q NFs, were 
determined using UV spectroscopy, based on the specific absorption spectra of each drug. 
For 5CLO8Q a designated absorption peak was ascertained as the average of 247/257 nm, 
where PHMB was measured at wavelength maximum of 236 nm (Appendix A: Figure A-1). 
Fortunately, no secondary absorbance peaks, at the corresponding wavenumbers of each 
drug, were present between the two antimicrobial substances, making it feasible to assess the 
drug release of both substances in the core/shell structure. 
The cumulative release of the antimicrobial compounds from the electrospun NFs was 
expressed based on the standard calibration curve of each substance for each medium 
(Appendix A: Figure A-2). The standard curves were produced based on serial dilutions 2, 5, 
10, 15, 20, 25, 50 µgmL-1 of each drug, where readings were obtained at the corresponding 
wavelengths using UV transmittable acrylic 96-well plates. The drug concentration (Ci) at each 
time point was determined as: 
Ci (μg/mL)  = (a ×  Y) ±  b (3.12) 
where a is the intercept, b the slope and Y the absorbance obtained from each reading at time 
(t). Then, the cumulative drug release (CDR) was calculated as: 
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CDR (%) =  




× 100 (3.13) 
where, Ve the volume of release medium removed at each time point (1 mL), V0 the total 
volume of the release medium (10 mL), and m0 the total amount of the drug-loaded on the 
electrospun mats. All measurements were taken in quadruplicates, and the results are 
expressed as the cumulative drug release (in %) over time (in h) as average values ± SD as 
computed in Matlab, based on two independent drug release experiments obtained using 
electrospun mats from different batches. 
Characterising the drug pharmacokinetics of nanofibrous materials is difficult due to the 
complex morphologies of these polymer matrices and the structural variations they may 
undergo due to swelling. Various mathematical models have been proposed to describe drug 
release kinetics, including first-order models, the Higuchi model, the Hixson-Crowell model, 
and the Korsmeyer-Peppas (KP) model [15]. To further investigate the drug release 
mechanisms, the well-established KP model was used. Korsmeyer-Peppas classifies the drug 





n  ↔ log (
Mt
M∞
) = log(Kkp) + n log(t) (3.14) 
where Mt is the amount of drug released in time (t), M∞ is the amount of drug released after 
time (∞), n is the drug release exponent, and Kkp is the Korsmeyer release constant of the 
apparent release. To determine whether the mechanism occurs by diffusion, leaching, or a 
combination of the two, the exponent variable n is used to describe drug release of cylindrical 
shaped matrices. Table 3.4 provides boundaries of the mechanism. 
 
 
Table 3.4 Different drug release mechanisms. 
Release exponent (n) Drug transport mechanism Rate as a function of time 
≤ 0.45 Fickian diffusion t-0.5 
0.45 < n < 0.89 Non-Fickian (kinetic) transport t(n-1) 
0.89 Case II transport* Zero order release 
> 0.89 Super Case II transport** t(n-1) 
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*drug release is constant and controlled by polymer relaxation. **drug release is polymer 
erosion-controlled 
 
3.5 In vitro biocompatibility evaluation 
Evaluating the in vitro cellular responses and the way the material interacts using a relevant 
cell-line can provide an initial appraisal over the ability of the electrospun membranes to act 
as a biomaterial. In this thesis, the biocompatibility of the electrospun fibres was assessed on 
fibroblasts-seeded scaffolds using a proliferation assay, where the fibroblasts’ morphology, 
expansion and adhesion properties were evaluated on fixed scaffolds using SEM. The 
following sections describe the methods used to culture and seed fibroblasts on the 
electrospun mats and subsequently assess their biocompatibility. 
 
3.5.1 Scaffold sterilisation 
There are several sterilisation methods that can be used to produce aseptic scaffolds that are 
considered effective for non-clinical proof of concept studies [16]. When selecting from the 
available techniques including UV radiation, ethanol treatment, argon plasma, autoclaving, 
gamma radiation and ethylene oxide, the scaffold’s chemistry needs to be taken under 
account, as it can influence several of its physiochemical and mechanical aspects [17]. 
Considering that the sterilisation method can directly influence the surface topography and 
subsequent in vitro cell behaviour, distinct protocols were selected for the sterilisation of the 
different biomaterial system developed, based on the material’s profile [18, 19]. In Chapter 4, 
70% (v/v) ethanol was used to disinfect the crosslinked PVP/PGS scaffolds. In Chapter 5, the 
binary (SF:(p)PGS) and trinary (SF:PCL:(p)PGS) fibre mats were initially immersed for 2 h in 
100% (v/v) ethanol to induce crystallisation of β-sheets in the fibroin structure, resulting in 
water-insoluble membranes, followed by 70% (v/v) ethanol treatment for disinfection. For the 
bacteria work carried out in Chapter 6, the core/shell nanofibrous mats containing chitosan, 
were disinfected by shining UV light, as ethanol or ethylene oxide, dry heat, saturated steam 
during autoclaving and γ-irradiation treatment have been shown to alter the chemical structure, 
mechanical properties and solubility of chitosan [20].  
In Chapters 4 and 5, dry scaffolds were punched in 4- or 8-mm round discs, placed in 
sterile 48-well plates and treated overnight in 70% (v/v) ethanol, washed thoroughly with PBS, 
and pre-soaked in DMEM medium for 48 h. The extended period of washing also allowed for 
the removal of any residual solvents that may have been entrapped during electrospinning 
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and were not able to evaporate during drying. In Chapter 6, the electrospun core/shell 
nanofibrous mats were punched into 8 mm circular discs weighing approximately 1 mg and 
placed in sterile Petri dishes that were subjected to UV radiation for 1 h under the fume hood. 
 
3.5.2 Cell culture technique 
As the application of interest in Chapters 4 and 5, is the development of ECM-like skin 
substitutes, fibroblasts were used to assess the biocompatibility, spreading, and 
morphological properties of the electrospun membranes. Immortalised human dermal 
fibroblasts (HDF) were donated from the MRC Centre for Cardiovascular Science, Edinburgh, 
UK, and used for the cell culture experiments. 
The HDFs cryogenic vials (1 mL, 1 x 106 cells) were gently thawed from liquid nitrogen 
using warm media to prevent osmosis, centrifuged at 180 g for 10 min, and carefully aspirated 
the media to remove the cryoprotectant (DMSO). The cell palette was then resuspended in a 
warm fresh culture medium, thoroughly mixed by gentle pipetting and transferred to 75 cm2 
culture (T75) flasks, and the total volume was raised to 15–20 mL. The complete-DMEM 
medium consisted of a basal medium of high glucose-pyruvate DMEM supplemented with 
10% (v/v) FBS, 1% (v/v) Penicillin-Streptomycin, and 1% (v/v) L-Glutamine. The cultures were 
maintained in a humidified atmosphere (37 °C and 5% CO2), with the media being replaced 
every two days. The cell growth on the surface of the flask was continuously monitored using 
an inverted microscope and examined for confluence and morphological changes, up until 
subculturing.  
Cells stop growing when they reach confluence. The HDFs were passage prior to 
becoming fully confluent (70%–80% confluence) so that the proliferation phenotype is 
maintained. Based on the number of cells obtained, cells were either subcultured in a 1:4 
passage ratio or seeded on electrospun mats. The cells were subcultured by discarding the 
old medium and washing the flasks with PBS. Then, 2000 μL of trypsin-EDTA were applied to 
the cell-containing side of the flask’s surface and incubated for 5 min, in order to dissociate 
the cells. A 1:2 (v/v) ratio of DMEM was added to stop the trypsinisation of the cells. The 
DMEM-trypsin solution containing the cells was thoroughly mixed, centrifuged and 
resuspended. Then, 10 µL of cell solution was added to an Eppendorf tube containing 190 µL 
trypan blue and mixed. From this suspension, 10 μL were transferred on a haemocytometer, 
where the cells present in the four corner chambers were counted. The number of cells per ml 
of suspension was then determined as: 
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 Cells per 1 mL of suspension = n 4⁄ × 20 × 10,000 (3.15) 
where n the number of cells counted. Trypan blue is a 960 Da diazo dye, which can only bind 
positively charged intracellular domains of compromised cell membranes, and does not bind 
intact cells as their membrane are also negatively charged [65]. This method is used to 
enumerate and distinguish live (white) from dead cells that have taken up the dye (blue). The 
cells were then, based on the number of cells calculated, if low, subcultured to new T75 flasks 
or, if adequate, used to seed the electrospun mats. 
When the required experiments were concluded, aliquots of 1 mL cryogenic vials 
containing 1 x 106 cells were refrozen. The freezing medium consisted of complete-DMEM 
with 20% (v/v) FBS and 7% (v/v) DMSO, which acts as a cryoprotectant that prevents cell 
damage caused due to ice crystal formation. The cells were frozen slowly, to allow for the 
sufficient efflux of water and prevent intracellular ice formation due to the high osmotic strength 
present. The vials were placed in a freezing container (Mr. Frosty®, Nalgene, Thermo-Fischer, 
UK) filled with 100% isopropyl alcohol and placed overnight at -80 °C, allowing for the 
temperature to decline at a rate of -1 °Cmin-1. The next day the cryogenic vials were 
submerged back to the liquid nitrogen tank. 
When the needed number of fibroblasts was reached, the cells were resuspended to the 
appropriate volume in DMEM, based on specific experiment requirements. Then, a 20 μL cells-
DMEM suspension was adjusted to a concentration of 1 × 105 (Chapter 4) or 2.5 × 105                 
(Chapter 5) HDFs per electrospun mat. The suspension was carefully placed in the centre of 
each sterilised scaffold, following the same pipetting motion to achieve the best possible cell 
distribution. Scaffolds consisting of PCL-only fibres and cells cultured directly on the bottom 
of tissue cultured 48-well plates were also seeded. The 20 μL cells-DMEM seeded scaffolds 
were left still for 2 h under the hood and then for 4 h within the incubator (37 °C and 5% CO2) 
to allow for the cells to adhere prior to warm fresh DMEM perfusion. DMEM was discarded 
and replaced every second day in a manner of 50/50 fresh/old to replenish nutrients provided 
by the media and at the same time, maintain positive growth factors secreted by the cells.  
 
3.5.3 Cell seeding efficiency (SE) 
The efficiency at which HDFs attach on the electrospun scaffolds was assessed as a 
prerequisite of cell proliferation and expansion. This was attained by calculating the number 
of living cells that did not attach on the scaffolds to the proportion of the cells that were initially 
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seeded. At 4 h post-seeding, the cell-containing scaffolds were carefully removed and placed 
on new culture plates, while the well's culture medium was transferred to a centrifuge tube. 
Trypsinization of the wells was also conducted to obtain any adherent cells and added to the 
corresponding centrifuge tube. The pellet obtained after centrifugation was resuspended, and 
the cells enumerated as described previously. Then, the cell seeding efficiency was calculated 
for each group based on the formula below, where the data are presented as average                    
values ± SD. The seeding efficiency of cells grown directly on tissue culture plates was also 
evaluated as a control group. 
SE (%) =
(No. of cells seeded) − (No. of unattached cells)
No. of cells seeded
× 100       (3.16) 
 
3.5.4 Cell proliferation 
The metabolic activity and proliferation of the cells after being attached to the electrospun 
membranes was determined by the colourimetric Alamar blue™ (AB) assay. The active agent 
of the AB assay is Resazurin (blue), a cell-permeable, weakly fluorescent, redox-sensitive 
compound. Metabolically active (viable) cells continuously chemically reduce Resazurin, 
intracellularly via mitochondrial dehydrogenase activity, to resorufin (purple, fluorescent 
compound). Subsequently, resorufin diffuses from the cells back into the surrounding medium 
[21]. This conversion of the compound occurs continuously from the viable cells, rapidly 
increasing the fluorescent signal, but is unable to occur from metabolically dysfunctional 
(dead) cells. 
The metabolic activity was determined 1, 3, 5, and 7 days after incubation. At each time 
interval, triplicates of each cell-containing electrospun mat group were carefully removed using 
sterile tweezers, transferred to new 24-well plates and rinsed three times with warm PBS for 
15 min. Unseeded scaffolds (blanks) were also produced as a negative control for the 
readings. As Resazurin is light-sensitive, the AB reagent was diluted 1 in 10 with DMEM, in 
the dark, to produce 10% (v/v) AB solution. Subsequently, 350 μL of 10% AB-DMEM was 
poured in each scaffold-containing well, wrapped in aluminium foil to avoid light exposure, and 
placed for 4 h at 37 °C / 5% CO2. Measurements were obtained by transferring 100 µL aliquots 
of each specimen in triplicates (including the negative control) to black-walled, clear-bottom 
96-well plates. The accumulation of reduced AB (resorufin) was determined using a microplate 
reader set at 560 nm excitation and 590 nm emission. The ‘‘real’’ fluorescence intensities were 
determined by subtracting the specimen readings from the negative control, to exclude any 
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fluorescence input due to the scaffold's composition. In some instances, the seeded scaffolds 
were then fixed for SEM imaging, as explained in Section 3.5.5. 
 
3.5.5 Fixing cells for SEM imaging 
The cellular attachment and spreading of the fibroblasts on the various electrospun mats were 
assessed by SEM. The seeded scaffolds at day 1, 3, and 5 were carefully transferred using 
sterile tweezers to fresh 24-well plates and thoroughly rinsed in warm Hank's balanced salt 
solution. Then, the cell-containing scaffolds were fixed overnight at 4 °C with 3% (v/v) 
glutaraldehyde prepared by diluting 25% glutaraldehyde in an SEM buffer consisting of sodium 
phosphate and 0.1 M sucrose at pH 7.4. The next day the scaffolds were thoroughly washed 
in the SEM buffer and gradually dehydrated in ethanol (20%, 35%, 50%, 70%, 95%, and 
100%, v/v) for 15-min increments, and left to chemically dry in hexamethyldisilasane. The dried 
specimens were cut using a scalpel, mounted on a metal stub using carbon tape, and 
sputtered with 10 nm Au. Images were taken at high magnifications to examine the 
morphological characteristics of the fibroblasts on the electrospun fibrous mats, and at low 
magnifications to assess the spreading efficiency (confluence). The ImageJ software was 
used to determine the confluence of the scaffolds (in %) via threshold analysis by determining 
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3.6 Antimicrobial testing on S2 pathogenic bacterial strains 
The antimicrobial efficacy of the electrospun hernia meshes was thoroughly assessed using 
four methods: (1) disc diffusion testing, (3) real-time spectrophotometry (bacterial growth 
kinetics), (3) live/dead staining using fluorescence and confocal microscopy and (4) 
morphological evaluation of fixed bacteria-contaminated scaffolds. Experiments were carried 
out on Staphylococcus aureus and Pseudomonas aeruginosa, the pathogenic bacterial 
species most commonly associated with surgical site infection, and by comparing the 
bicomponent antimicrobial NFs with commercially available hernia meshes and other forms of 
textile-based fibres using Escherichia coli. The techniques used to determine the antimicrobial 
efficiency of the variant electrospun mats are described in detail in the following sections. As 
the antimicrobial assessment was conducted on pathogenic bacteria strains, all the processes 
described below were carried on a biosafety level-2 (BSL-2) laboratory. E. coli was only used 
for a limited number of experiments, due to ongoing refurbishments significantly limiting the 
access to the BSL-2 facilities, and it was chosen as a similar Gram-negative organism to                        
P. aeruginosa. 
 
3.6.1 Disc diffusion susceptibility testing 
An initial appraisal of the antimicrobial effect of the core/shell dual antimicrobial system, as 
well as the single drug-loaded fibre mats, were evaluated via the disc diffusion method based 
on EN ISO 20645 "…for determining the effect of antibacterial treatments applied to woven, 
knitted and other flat textiles". The Kirby-Bauer disc diffusion susceptibility test assesses the 
effect of an antimicrobial compound on agar plates that have been inoculated with a specific 
pathogen, by the absence or presence of an inhibitory zone. 
All media and material were prepared as explained in the Methods Section 3.3.4 and 
sterilised using a pressure cooker (121 °C, 15 psi for 20 min). Initially, for each experiment, 
pure strains were isolated for each pathogen using standard Luria broth agar plates, prepared 
via the streak plate method. Then, the bacterial strains picked from isolated single colonies 
were cultivated in 10 mL of Lysogeny broth (LB) overnight at 37 °C on a rotary shaker                        
(160 rpm). The following day, 100 μL of the bacterial solution was spread using a sterilised 
plate spreader on Petri dishes containing Mueller-Hinton agar. Directly after, two 8 mm discs 
of each antimicrobial electrospun mat, weighing 1–2 mg, were placed firmly on the surface of 
each plate and incubated for 24 h at 37 °C. CS and PA6-only fibre discs were also prepared 
as control groups. Images were taken using a petri dish analyser on the following day, and the 
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radius of inhibition of each plate was measured using ImageJ. The zones of inhibition were 
measured as: 
Inhibition zone (IZ)  =
(D − d)
2
       (3.17) 
where, IZ the inhibition zone (in mm), D the total diameter of the antimicrobial disc including 
the inhibition zone and d the diameter of the antimicrobial disc. The results are presented as 
average values ± SD, based on two independent experiments, from different electrospun 
batches, carried in triplicate plates (two discs per plate) for S. aureus and P. aeruginosa. 
 
3.6.2 Bacterial growth kinetics using spectrophotometry 
The optical density (OD) that correlates to the number of living bacteria present within the 
culture after being exposed to the antimicrobial NFs was evaluated using a spectrophotometer 
at OD600nm absorbance.  
Pre-cultures of 100 µL S. aureus, P. aeruginosa and E. coli deriving from single colonies, 
were prepared in 5 mL Brain heart infusion broth (BHI) and incubated for 37 °C at 160 rpm. 
The following day, the pre-cultures were suspended to OD600 value 0.1 in BHI and incubated 
for 1 h to obtain exponentially growing cells. After, the culture was resuspended to OD600 value 
0.05 in 0.2% (v/v) BHI broth, corresponding to 2.2 × 107, 1.8 × 106, 2.0 × 107 colony forming 
units (CFU) per mL of P. aeruginosa, S. aureus and E. coli, respectively. Punched electrospun 
NF discs of each group examined were then placed on the bottom of a 96-well plate in 
triplicates and disinfected with UV radiation for 1 h. Subsequently, a bacterial solution of 
200 μL was carefully pipetted on each well following the same pipetting motion to ensure 
similar distribution, and the plate was incubated for a further 4 h at 37 °C/30 rpm.  
The ability of the pathogens to recover after being exposed on the antimicrobial scaffolds 
for 4 h was then determined by carefully pipetting from each scaffold-containing well, 20 μL of 
the bacterial supernatant, and transferring it to a new 96-well plate. A further 180 μL of “fresh” 
BHI was pipetted to each well for a final volume of 200 μL. The 96-well plate was then placed 
on the microplate spectrophotometer, where readings were obtained every 30 min for 24 h at 
37 °C at OD600nm. The control was prepared out of 180 μL BHI and 20 μL 0.2% (v/v) BHI broth. 
The collected real-time data from triplicates based on two independent experiments, from 
different electrospun batches, were then plotted on Matlab as average values ± SD based on 
the absorbance over time for each group examined. 
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3.6.3 Fluorescence and confocal microscopy (live/dead assay) 
Following the same procedure explained in Section 3.6.2, the antimicrobial electrospun discs 
were incubated for 6 h with bacterial inoculum at OD value of 0.1. After, the pathogen-
containing scaffolds were carefully transferred on a fresh 24-well plate and washed thoroughly 
with PBS. Then, a drop of equal volume mixture of SYTO9® (3.34 mM, Excitation 483 nm, 
emission 503 nm) and propidium iodide (PI; 20 mM, Excitation 535 nm, emission 617 nm) was 
placed in the centre of each scaffold and incubated at room temperature for 15-min. The 
fluorescence-labelled scaffolds were then washed three times with PBS and placed on 
microscope slides with no. 1 coverslips. Images were taken with a fluorescence microscope,  
using the 40× objective, and by a confocal microscope using the 63× objective at the 
aforementioned wavelengths. The relative fluorescent from the metadata was quantified by 
measuring the intensity of the mean relative brightness value, after subtracting the background 
signal using ImageJ. From this, the relative percentage (%) of live (Syto9, green)/dead                    
(PI, red) cells was determined as the average values ± SD in Matlab. 
 
3.6.4 Fixing bacteria for SEM imaging 
The morphology of the bacteria at the surface of the electrospun mats was assessed by SEM 
imaging. The bacteria-containing scaffolds used for the growth kinetic experiments (Section 
3.6.2) were carefully transferred to a fresh 24-well plate, washed thoroughly with PBS, and 
fixed in 4% (v/v) formaldehyde solution for 2-h at 4 °C. Subsequently, the fixed bacteria-
containing scaffolds were gradually dehydrated in ethanol in 1-h intervals (50%, 60%, 70%, 
80%, 90%, 95%, 100% v/v) and left to dry in hexamethyldisilazane (HDMS) overnight. The 
following day, the dried fixed electrospun mats were considered safe to handle outside the 
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3.7 Statistical analysis 
The results are expressed as mean (or average values) ± standard deviation (SD) in all the 
experiments. Statistical analysis was performed in SPSS (v.24, Statistical Package for Social 
Sciences, IBM, USA). Diameter distribution graphs were also produced using SPSS. Levene's 
test of equal variance and an interactive statistical test flowchart; to assess whether the data 
were normally distributed, were used for the selection of the appropriate statistical tests.  
The statistical tests used to assess the statistical significance of the difference between 
the mean values assuming a confidence level of 95% were: one-way analysis of variance 
(ANOVA) with post-hoc Tukey test and multiple Student's t-test with Bonferroni correction. 
Significance over post-hoc analysis of multiple groups was only accounted if the statistical 
tests were p≤ 0.05. Then statistical significance between the groups was determined by the 
post-hoc as p≤ 0.05 and p≤ 0.001, where statistically similar and dissimilar groups are 
distinguished with the use of letters (a, b, c) and symbols (✝, $, #). 
Graphs and tables were produced using Matlab (v.R2019a, MathWorks Inc., USA). The 
Korsmeyer-Peppas model fitting of the drug release data was determined using the solver 
parameters add-on in Excel (v. 2016, Microsoft, USA) to define the KP constant and calculate 
the exponent variable n. Fibre diameter, porosity, density, contact angle measurements, the 
radius of bacterial inhibition, and quantification of relative fluorescence intensity were analysed 
using ImageJ (v.1.52, National Institutes of Health, USA). Where additional software were 
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4. Nozzle-Free Electrospinning of
PVP/PGS Blends; Design, Fabrication & 
Characterisation 
4.1 Introduction 
This chapter describes the design and development of a nozzle-free roller electrospinning 
device and explores its potential to produce synthetic polymer-based nonwoven fibrous 
scaffolds as dermal substitutes consisting of variant proportions of PVP and PGS blends. Due 
to the non-linear, anisotropic and viscoelastic properties of the skin, which, as previously 
discussed, differ among different anatomical sites, in this work the mechanical properties of 
the electrospun mats were examined for variant compositions of PVP/PGS fibres by adjusting 
the blend ratio and the PVP’s molecular weight. Subsequently, the electrospun mats were 
submerged in a riboflavin solution and crosslinked using UV radiation to prevent the rapid 
degradation of the composite fibres, and, thus, be able to assess the wettability and 
biocompatibility of the biomaterial using human dermal fibroblasts (HDFs). 
The work presented in this chapter has been published in Medical Engineering and 
Physics (Keirouz et al., 2019), with a conference abstract presented at the Electrospin 2018 
conference in Stellenbosch, South Africa, where it was awarded first place for the best poster 
presentation (Appendix B). 
4.2 Methodology 
For full descriptions of the materials and methods used, please see the following sections in 
Chapter 3:  
• Materials (Section 3.3)
o Synthesis of PGS (Section 3.3.1)
o List of materials, cells, suppliers and equipment (Section 3.3.2)
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• Scaffold characterisation (Section 3.4) 
o Scanning electron microscopy (SEM) (Section 3.4.1) 
o Fourier transform infrared spectroscopy (FTIR) (Section 3.4.3) 
o X-ray photoelectron spectroscopy (XPS) (Section 3.4.4) 
o Mechanical testing (Section 3.4.5) 
o Water contact angle measurements (WCA) (Section 3.4.8) 
• In vitro evaluation (Section 3.5) 
o Scaffold sterilisation (Section 3.5.1) 
o Cell culture technique (Section 3.5.2) 
o Cell seeding efficiency (Section 3.5.3) 
o Cell proliferation (Section 3.5.4) 
o Fixing cells for SEM imaging (Section 3.5.5) 
The chapter-specific experimental methods are described, in detail, below. 
 
4.2.1 Device development 
A schematic of the nozzle-free electrospinning device developed for the work conducted in 
Chapters 4 and 5 is shown in Figure 4.1. The setup consists of a rectangular glass tank 
(aquarium), a three-layer lid assembly, a collector assembly, a spinneret assembly and 
electronics. Computer-aided designs (CADs) and photographs of the different assemblies can 
be found in Appendix A: Figure A-3, A-4, A-5 and A-6.  
As electrospinning uses high voltage to electrify the polymer solution and draw fibres, the 
non-conductive compartments of the setup were based on reinforced glass, 
polytetrafluoroethylene (PTFE; Teflon®) and poly(ether ketone) (PEEK) due to the materials ’  
good thermal, mechanical, and insulating properties. 
In total, 16 holes were carefully drilled in various compartments of the glass aquarium 
using a circular diamond-tipped drill bit hole saw and drill positioning tools. On the upper 
section, three holes were drilled to position the collector’s DC motor, at the same height and 
on the opposite side, four holes were made to position the metal bearing, one hole at the same 
height facing the rear of the device for the entry of the high-voltage electrode, and one hole 
for the exit of the safety interlock cables. On the lower part of the setup, an additional three 
holes were made to install the spinneret’s DC motor parallel to the collector ’s DC motor, and 
one hole at the same height facing the rear of the aquarium for the entry of the high-voltage 
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electrode. A wider hole was also made on the lower rear for the placement of the exhaust 
tubing. Finally, two holes were made below and antiparallel to the collector’s direction to place 
the safety rod. 
At the top of the glass tank, two rectangular acrylic pieces were glued on, using epoxy, 
facing inwards and parallel to each other, to support the placement of the lid. A safety interlock 
was mounted on one of the rectangular acrylic pieces, at the midsection between the top of 
the aquarium and the lid support, where the interlock cables were then soldered to prevent 
the onset of high voltage at the absence of the lid. 
The collector assembly consisted of a Teflon mandrel with a mid-section stainless-steel 
bearing cylinder being fitted through it, a motor and a stripped HV cable made into a loop. The 
collector was positioned on the upper section of the device through a metal bearing with a                       
3D-printed support from one side and a DC motor on the other side using flexible 3D-printed 
couplers. The collector was fitted with a brushed DC motor rated at 500 revolutions per minute 
(rpm) when unloaded, with the ability to adjust the rpm appropriately by utilising two controlling 
mechanisms, one being the speed controller and the other being the DC source feeding the 
circuit. The device was able to operate with an output voltage 12 V in 0.1 V increments and 
an output current between 0 and 5 A with 0.1 A increments. Finally, the HV electrode was 
positioned on the side of the stainless-steel cylinder allowing for good contact with the stripped 
HV wire. 
The spinneret assembly consisted of a Teflon bath, a solid stainless-steel cylinder, a Teflon 
rod, a PEEK coupler, a HV wire loop and a 12 V DC gear motor. As in free surface 
electrospinning, the fibres are generated in an upward motion; the Teflon pool was placed on 
the bottom of the aquarium, parallel to the centre of the collector’s surface. Wei et al. [1] found 
that the electric field intensity reaches the highest values at the ends of the cylinder spinneret 
and decreases towards the centre, which may hamper jet formation. Electric field profile and 
intensity simulations using COMSOL have demonstrated that, although the highest electric 
field profile is generated towards the centre of an annular spinneret, the electric field intensity 
is at least a 5-fold higher at the edges [1]. For this reason, the stainless-steel spindle presented 
smooth rounded edges to create a homogenous electric field distribution. A HV wire loop was 
made by soldering the HV electrode at a radius that provided good contact with the cylinder ’s 
surface while allowing it to rotate.  
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Figure 4.1 Schematic of the nozzle-free electrospinning device. (a) Gas flow provided via the lid 
assembly within an enclosed setup, (b) hot air flow provided via a heat gun, on an open setup. 
Values on the thermohydrometer and high-voltage power supplies are indicative. HV; high 
voltage. 
 
The solution bath was machined from a Teflon rod stock to form a rectangular pot that can 
facilitate the electrospinning of a 40 mL polymer solution (solution bath dimensions: 90 mm 
(length) × 30 mm (width) × 20 mm (depth)) while accommodating the HV electrode. A hole 
Chapter 4 | Nozzle-free electrospinning of PVP/PGS blends 135 
 
was drilled on the upper level of the rectangular pot to position the spinneret. Then, an opening 
was drilled through the other side, where a Teflon rod and a PEEK coupler were used to 
connect the spinneret with the DC motor. The solution bath, within which the spinneret was 
submerged, provided a 5% margin on each side of the spinneret to allow for its rotation and 
polymer coating, and a 10% margin on the coupler-rod side for the positioning of the HV loop. 
Allowing minimal exposure of the polymer solution is an important aspect of the device, which 
provides shelter to volatile solvents and allows consistency throughout the electrospinning 
process. The distance between the spinneret and the collector was 15 cm.  
The lid assembly was made up of three rectangular glass plates. The layered glass 
assembly ensured uniform distribution of air/nitrogen across the glass aquarium. The 
outermost glass layer had 55 holes of 3 mm diameter arranged at five rows and 11 columns, 
similar to a perforated glass. A rectangular glass piece was cut out from the middle glass plane 
at the same position where the 55 holes were presented on the bottom glass plane to allow 
for the gas distribution. The top glass plane presented two openings for Swagelok tube fittings 
from where the tubing linked to the gas supply was connected to the lid. An open setup, where 
a heat gun could be positioned on adjustable heights using a retort stand, was also included 
for solutions that require hot air rather than air/gas for electrospinning.  
Two high voltage DC power supplies, of adjustable output voltage, one of negative and 
one of positive voltage output were utilised to electrify the polymer solution and draw the fibres 
towards the collector. Both were able to be adjusted from 0 kV up to 35 kV, thus allowing the 
user to set a potential difference of up to 70 kV between the rotating collector and the 
spinneret. A thermohygrometer was also placed within the aquarium to monitor the 
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4.2.2 Preparation of PVP/PGS Blends 
The PGS polymer was synthesised as described in Section 3.3.2. Then, PGS was dissolved 
in HFIP to form 15% (w/v) polymer solution. PVP with molecular weights of 360,000 gmol-1 
and 1,300,000 gmol-1 were dissolved separately in a solvent system encompassing 1:1:0.25 
(v/v) ratio of DMF: ethanol: distilled water to form 11.75% (w/v) polymer solution.  
 
Table 4.1 Summary of the polymer blend constituents and blending ratios. 
Polymer blend Ratio (PVP/PGS) (w/w) 
i.   11.75% PVP (w/v) (MW = 1,300,000) 
+ 
15% (w/v) PGS 
& 
ii.   11.75% (w/v) PVP (MW = 360,000) 
+ 









All solutions were stirred overnight at room temperature before blending. Subsequently, 
blends of 100:0, 95:5, 90:10, 80:20, 70:30, 60:40 and 50:50 w/w ratio of PVP/PGS (Table 4.1) 
were prepared and mixed for an additional 12 h at room temperature before electrospinning.  
 
4.2.3 Scaffold fabrication and processing 
The nozzle-free electrospinning device described in Section 4.2.1 comprised of a rotating 
stainless steel cylinder electrode submerged within the Teflon pool containing the polymer 
solution blends, was used to produce fibres over a biased rotating collector electrode under 
constant hot air flow (working distance 15 cm, airflow 450 Lmin-1, and applied temperature 
150 °C). A potential difference of 60 kV DC was applied between the two rotating electrodes 
(+30 kV on the spinneret’s electrode and -30 kV on the collector’s electrode), resulting in the 
formation of multiple Taylor cones along the polymer solution-coated rotating electrode 
surface, from which jets stretched to form fibres in an upward motion. A cellulose-based 
commercial baking paper was used to collect the fibres. All experiments were carried out under 
ambient conditions at a relative humidity ranging from 30%–40% and room temperature of 
18–22 °C. Figure 4.2 summarises the PGS synthesis, blending and fabrication procedure. 
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Figure 4.2 Schematic illustration providing an overview of the PGS synthesis, solution 
preparation and electrospinning that results in stretchable semi-transparent fibrous mats. 
 
4.2.4 UV crosslinking of PVP/PGS mediated by riboflavin 
The dried PVP/PGS electrospun membranes were UV irradiated to induce crosslinking of the 
two polymers in the presence of a photoinitiator. Riboflavin solution (0.2 mM) was dissolved in 
a potassium phosphate buffer at pH 8.0 under constant agitation for 2 h and was used as the 
photosensitiser for crosslinking [2, 3]. Then, the electrospun membranes were submerged 
within the riboflavin solution and irradiated in the dose of 5 kGy for 30 and 60 min distributed 
from a 15 cm distance between the exposed surface and the halogen lamp. The light source 
produced an intensity of ~45 mWcm-2 using a UV lamp (Novascan, USA). The crosslinked 
membranes were then removed and washed in PBS at pH 7.4. 
Photochemical reactions are the result of the interaction between molecules and light. 
Molecules are able to absorb radiation, leading to different electronic transitions that depend 
on the particular structural characteristics of the molecule being radiated. In this regard, 
electrons can “jump”  between different molecular orbitals depending on the energy gap; if the 
energy of the light is equivalent to the energy difference between two molecular orbitals for a 
specific molecule, then an electronic transition will occur (See Figure 4.3) [4]. 
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Figure 4.3 Energy gaps of the different electronic transitions upon light absorption. Redrawn 
from [4]. 
 
Due to conjugation, which decreases the energy gap between non-bonding π electrons 
and the π* anti-bonding orbital, riboflavin is a molecule that is capable of absorbing radiation 
in the visible region of the spectrum, thus acquiring a yellow colour [5, 6]. Once blue or UVA 
light is absorbed, riboflavin is excited to a singlet state of higher energy (mainly by π → π*  
transitions) that transforms, then, into a triplet state by non-radiating phenomena [5, 6]. The 
singlet state is characterised by the existence of two unpaired electrons with paired spin, while, 
in the triplet state, the electron’s pin is unpaired. The triplet state has a larger lifespan in 
comparison to the singlet state. From the triplet excited state, the riboflavin molecule can 
induce several changes to its environment, mainly based on two routes: 
i. Type I reactions. In this type of reaction (Appendix A: Figure A-7), riboflavin 
interacts with a substrate and transfers an electron or hydrogen atom that leads to 
the formation of a radical substrate and radical riboflavin. The radical riboflavin then 
interacts with the dissolved oxygen in the medium, leading to the formation of 
reactive oxygen species that can further interact with the polymer to induce radical 
reactions, which can subsequently increase the crosslinking degree [5, 6]. In 
general, this route is more common when the dissolved oxygen concentration is 
low. 
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ii. Type II reactions. Riboflavin in the triplet excited state reacts directly with molecular
oxygen in the triplet (3O2) state (the most common and stable allotrope of oxygen)
to produce singlet oxygen, which is much more reactive than the triplet oxygen
allotrope (Appendix A: Figure A-8). This molecule can thereupon produce other
reactive oxygen species (hydroxyl, peroxide), which can react with the polymer,
inducing a greater degree of crosslinking [5, 6].
In both scenarios, the reaction pathway leads to the production of radicals and reactive 
oxygen species that ultimately allow the crosslinking of the polymer. In this regard, it is 
important to notice that the superoxide anion can produce new radicals, based on [7]: 
O2
∙− + O2
∙−  + 2H+ → H2O2 + O2
(4.1)
H2O2 + e
− + H+ →  H2O + OH ∙
 
Which ultimately induces this series of reactions: 
ROS ∙   +     RH →   ROS− + RH∙+
RH ∙+ + H2O → RH
∙ + H3O
+ (4.2)
RH ∙ + R′H ∙ → HRR′H
 
Where ROS is reactive oxygen species, R and R' (as illustrated in Appendix A: Figure A-9) 
can be any of the pendant groups of the crosslinked PGS. Thus, the addition of riboflavin 
enhances the crosslinking degree and can have a direct impact on the properties of the final 
polymer. The same crosslinking reaction also applies for the PVP chains, where the pendant 
groups may react with the sebacic acid residues of the PGS (Appendix A: Figure A-10). In 
accordance, below is a summary of the proposed reaction scheme that can describe the 
crosslinking between PGS and PVP facilitated by riboflavin under UV irradiation (See Figure 
4.4). 
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    In Figure 4.4, the third step of the reaction occurs after the PGS and PVP radical cations 
have transferred a proton to water (as described in the second reaction of equation 4.2). 
The scheme indicates one possibility among several others, depending on which bond or 
atom bears the unpaired electron. The riboflavin radical anion leads to the production of 
superoxide anions (as described in equation 4.1) that may also induce 
crosslinking reactions. Furthermore, the excited riboflavin decomposes, leading to the 
production of several other molecules that may also act as photosensitisers. Thus, as can 
be noted, many schemes in the presence of riboflavin can directly or indirectly induce the 
photocrosslinking of the PVP/PGS fibres. 
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Figure 4.4 Schematic representation of the PVP/PGS crosslinking mediated by riboflavin under 
UV light.  
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4.3 Results and discussion 
4.3.1 Production rate of the nozzle-free device 
Nozzle-free electrospinning allows jets to form and stretch from multiple locations at once, 
thus significantly increasing the production rate in comparison to the conventional needle-
based electrospinning setups. While electrospun fibres are vastly suitable for the fabrication 
of tissue engineering constructs, the low yield of the needle-based electrospinning devices 
limits the ability to scale up the production, even if this may not constitute a problem in a 
laboratory setting. The development of multi-needle apparatuses was proven ineffective due 
to overlapping electrostatic forces between the needles, affecting the travel path of the 
independent Taylor cone jets [8]. The production rate of the in-house built nozzle-free 
apparatus developed for this study was compared with a commercial single-nozzle 
electrospinning device under optimal conditions for an hour using 7.5% (w/v) PCL. As shown 
in Figure 4.5, the nozzle-free electrospinning device was able to produce and collect dry fibres 
at an 11-fold increased rate than the conventional electrospinning setup within the span of an 
hour. These findings are in agreement with a previously published work [9]. 
 
 
Figure 4.5 Comparison of the production rate between the in-house built nozzle-free 
electrospinning device, and a commercial needle-based electrospinning device. PCL 7.5% (w/v) 
dissolved in HFIP. Nozzle-free electrospinning: 60 kV, conventional electrospinning: 16 kV (+12/-
4, 10 μLmin−1), needle-tip-to-collector distance 15 cm. 
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4.3.2 The effect of varying the molecular weight of PVP on the fibre 
morphology 
Electrospinning thermosets, such as PGS, can be challenging since uncured pre-polymer 
forms tend to be very viscous and sticky, whereas their cured counterparts are insoluble in 
most organic solvents, owing to a low glass transition temperature (Tg), eventually forming 
non-fibrous plasticised scaffolds [10, 11]. By increasing the thermal condensation period 
during the polymerisation process, the esterification degree of the PGS polymer also 
increases, where the polar solvents HFIP and tetrahydrofuran (THF) are able to dissolve the 
chains of the PGS polymer, providing it is dissolved before setting into room temperature and 
while still in a less-viscous liquid form [12].  
Nevertheless, PGS cannot be electrospun without conjugating with polymers that can 
promptly form fibres [10, 13]. Several polymers, including PCL [14–16], gelatine [17, 18], PVA 
[10, 19], poly(L-lactide) (PLLA) [20] and PEO [21], have been used as carrier polymers to 
facilitate the formation of PGS fibres. In this work, PVP was incorporated within the polymer 
blends to improve the electrospinnability of the synthesised PGS. As PVP is a hydrophilic 
polymer – dissolvable in water, alcohols and polar solvents – the produced PVP/PGS 
electrospun mats were photocrosslinked to prevent the rapid degradation of the PVP and, 
thus, be able to assess cell growth and proliferation on HDFs [22].  
Figure 4.6 shows the average fibre diameters and SEM micrographs of the various groups 
of PVP/PGS electrospun mats produced for 1.3M and 360K gmol-1 PVP. For all the blends, 
the concentration of PGS is 15% (w/v), whereas the PVP is 11.75% (w/v). Morphologically, the 
fibre network displays a random ECM-like architecture. The cotton candy-like macroscopic 
morphology of the PVP mats transformed into paraffin-like scaffolds as the concentration of 
PGS gradually increased within the blends. This parafilm-like semi-transparent morphology, a 
trait that is difficult to obtain while attaining a fibrous micro/-nanostructure, can be of use during 
the wound healing process by allowing the visual monitoring of the wound bed. Figure 4.7 
presents photographs that depict the effect of the incremental increase of PGS within the 
polymer blends toward the transparency of the electrospun composite membranes. 
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Figure 4.6 Electrospun scaffolds morphology. (a) Average fibre diameters for the variant groups 
of PVP/PGS examined. Representative SEM micrographs of fibres produced with PVP (b) 360K 
gmol-1 and (c) 1.3M gmol-1. PVP/PGS ratios are as follows; (i) 100:0, (ii) 95:5, (iii) 90:10, (iv) 
80:20, (v) 70:30 and (vi) 60:40. Scaffolds photographs in Appendix A: Figure A-10. 
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Figure 4.7 Photographs depicting the transparency of the electrospun membranes apropos to the 
incremental increase in the proportion of PGS within the PVP/PGS blends; (a) 90/10,                           
(b) 80/20, (c) 70/30, (d) 40/60, and (e) 50/50 PVP/PGS. The electrospun membranes were 
produced using PVP 1.3M gmol-1. 
 
A more gelatinised morphology with less homogenous fibre appearance is present for the 
blends with increased PGS concentration, where the scaffolds appear to form porous gel-like 
mats, due to PGS being sprayed on the PVP fibres during the electrospinning process. The 
average fibre diameter of the PVP-only fibres was 0.97 ± 0.65 μm and 0.85 ± 0.58 μm for                    
1.3M and 360K gmol-1, respectively. The average fibre diameter between the blends did not 
appear to be significantly affected by increasing the PGS concentration; with the 50:50 (w/w) 
PVP/PGS blend ratio, the fibres appeared to have completely merged, forming a porous gel 
structure. Nonetheless, the mean pore area appeared to gradually decrease from                               
8.52 ± 0.65 μm2 for the pure PVP scaffolds to 0.70 ± 0.18 μm2 for the 50:50 PVP/PGS blends. 
The high density of the electrospun membranes in conjunction with the small-diameter pores 
could further form a barrier to bacterial colonising the wound bed, by (1) minimising exogenous 
microbial contamination and by (2) decreasing the bacterial load that can trespass to the 
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4.3.3 Chemical characterisation 
The FTIR was conducted to verify the synthesis of PGS and the presence of the two polymers 
within the composite fibre composition. The single signal immense loop at the 1740 cm-1 region 
suggests a very saturated (double-bonded) molecule of strong ester linkages (C=O). At 
approximately 3050 cm-1, a stretch is apparent between the hydrogen (X–H) region and the 
broad loop forming out of a single peak at 3460 cm-1, which indicates the presence of –OH 
groups. Two peaks are also present at approximately 2930 cm-1 and 2860 cm-1, characteristic 
of C-H sp2 and sp3 hybridisations, respectively. The results confirm the successful synthesis 
of PGS and are in agreement with previously published works [23, 24]. 
 For the PVP/PGS electrospun mats, the stretches at 2850 cm-1 and 1420 cm-1 can be 
assigned to C–H and –CH3 sp3 hybridisations, respectively, while the vibration at 1280 cm-1 to 
cyanide (CN) stretching of the PVP’s lactam ring [25–27]. The PVP/PGS fibres present the 
distinct peaks of both polymers, at similar intensities to the pristine materials, with no 
significant shifts present, indicative of successful blending of the two components in the 
composite fibres. The intense band present at 1650 cm-1 can be attributed to dipole (C=O) 
stretching of the primary amide and the strong signal at 1752 cm-1 to conjugated ester 
stretching (C=O), both indicative of the PVP/PGS fires crosslinking. The spectra of the 
composite fibres, polymers, glycerol and sebacic acid are presented in Figure 4.8. 
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Figure 4.8 ATR-FTIR spectra of sebacic acid (green); glycerol (yellow); PGS resin (blue);                         
PVP powder (red); and PVP/PGS 60:40 fibres (black). 
 
 The surface composition of the electrospun mats was examined by XPS incorporating an 
information depth of about 10 nm. Table 4.2 displays the elemental ratios of each composite 
fibre group after UV irradiation for 30 min. The surface elemental composition does not appear 
to be highly affected between the various composite fibres where the chemical distribution 
correlates to the theoretical composition values within a 5% margin of error. No differences in 
the ratio profile of each blend are apparent when comparing the two distinct molecular weights 
of the PVP. As PGS ((C13H22O5)n) does not contain nitrogen atoms, as in the case of PVP with 
a chemical structure of (C6H9NO)n, it is feasible to distinguish the latter one. The presence of 
the N1s peak between 398–399 eV in all the PVP/PGS samples confirms the presence of PVP 
within the composite fibres after submersion in riboflavin during photocrosslinking. In the case 
of blends with an increased concentration of PVP, the nitrogen content appears to be lower 
than the predicted values for a homogenous mixture. This depletion of nitrogen on the fibres ’ 
surface can be construed by the way the fibres are formulated during the electrospinning 
process, where rapid solvent evaporation and polymer chain migration of the longer PVP 
chains, in comparison to the PGS, shelter the nitrogen by moving it towards the core of the 
conjugated structure. 
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Table 4.2 Surface chemical composition of the electrospun PVP/PGS mats at different ratios for 
the two distinct molecular weights of PVP examined, compared to the theoretical elemental ratios. 
PVP/PGS Ratio 
(w/w) 
Outcome Elemental composition 
(Atomic ratio, %) 
PVP 1.3M (gmol-1)  C1s O1s N1s 
80:20 Experimental 78.7 15.0 6.3 
 Theoretical 74.4 15.6 10 
70:30 Experimental 70.5 21.7 7.8 
 Theoretical 74.2 17.3 8.5 
60:40 Experimental 75.3 17.1 7.6 
 Theoretical 73.8 18.7 7.5 
PVP 360K (gmol-1)  C1s O1s N1s 
80:20 Experimental 64.7 26.7 8.6 
 Theoretical 74.4 15.6 10 
70:30 Experimental 75.2 20.1 4.7 
 Theoretical 74.2 17.3 8.5 
60:40 Experimental 73.0 21.8 5.2 
 Theoretical 73.8 18.7 7.5 
 
4.3.4 Tuning the mechanical properties of the composite fibres  
PGS is a favourable biomaterial in TE due to its soft, robust and flexible nature, capable of 
coming in close proximity to the mechanical requirements of many soft tissues [28]. 
Nevertheless, most of the work that has been conducted surrounding PGS has focused on 
casted gel forms, as it is hard to be processed into fibres, due to the viscous, sticky nature of 
the material [29]. Here, the effects that the incremental increase in the concentration of PGS 
has on the tensile properties of the electrospun scaffolds are illustrated in Figure 4.9. By 
producing PVP/PGS fibres of similar diameter and porosity, it was feasible to attain variations 
in the tensile properties of the material based solely on the proportion of the two polymers 
within the electrospun blends and the MW of the PVP. The Young’s modulus, ultimate tensile 
strength (UTS) and elongation-at-break were assessed after conditioning the fibres for 48 h at 
standard atmospheric conditions (22 ± 2 °C and 65% ± 5% relative humidity). Stress-strain 
curves were obtained for the 80:20, 70:30, 60:40 and 50:50 PVP/PGS electrospun mats for 
the two distinct MW of PVP examined.  
For the hybrid fibres with high concentration of PVP (80:20, PVP/PGS), the tensile 
behaviour of the electrospun fibres, as expected, resembles that of neat PVP fibres with a 
UTS of 3.45 ± 0.3 MPa and 3.2 ± 0.3 MPa for 1.3M and 360K gmol-1 PVP, respectively [30]. 
The fibres on this group appeared stiffer due to the low proportion of PGS with an elongation-
at-break being 14.5% ± 2.8% and 3.1% ± 0.7% for 1.3M and 360K gmol-1 PVP, respectively. 
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Although the capacity of the material to persevere a high UTS gradually decreased as the 
concentration of PGS within the hybrid fibres increased, the elongation-at-break gradually 
increased from 29% ± 0.7% and 106% ± 5% for PVP/PGS 70:30 to 220% ± 19% and                       
328% ± 38% for PVP/PGS 50:50, where PVP is 360K and 1.3M gmol-1, respectively (Table 
4.3). This pattern relates not only to the PGS but also to the MW of the PVP. Nonetheless, the 
ability of the electrospun fibres to withstand linear deformation decreased by increasing the 
PGS concentration. The incorporation of PGS within composite fibres has been found to 
decrease the Young’s modulus and UTS sharply; as shown in a recent study where the 
Young’s modulus of collagen fibres decreased from 30.11 MPa to 4.24 MPa after the addition 
of the elastomer [31].  
 Targeting the mechanical properties of biomaterials for wound care has been shown to 
have a direct influence on the fate of cells and, subsequently, to the success of the wound 
healing process. Clinical evidence has shown that the time required, and quality of wound 
healing are strongly influenced by the tensile stress and stiffness of the material used [32]. For 
instance, mesenchymal stem cells have been found to present distinct patterns of 
differentiation in the presence of matrices of variant elasticities due to stiffness-related 
mechanisms [33]. Recently, it has been found that epithelial cells carry a mechanical memory 
mechanism, which actively influences the ability of the cells to migrate and adhere on a 
material [34]. This has been demonstrated by placing epithelial cells briefly on a hard 
substrate, subsequently transferring them on soft substrate, and assessing the effect on the 
epithelial phenotype in comparison with cells that were directly seeded on soft matrices [34]. 
 Biomaterials of aberrant mechano-transduction have been regarded as a driving force of 
fibrosis [35]. Furthermore, in chronic wounds, the influence of mechanical signals can affect 
the stiffness-sensing profile of the fibroblasts, ultimately affecting ECM remodelling [36], as 
well as the transport of growth factors during the trans-differentiation of fibroblasts to 
myofibroblasts, which coincides with the formation of hypertrophic scars [37]. Additionally, the 
tuning of the mechanical properties of the PVP/PGS electrospun mats could also indirectly 
provide a form of antimicrobial activity, as it has been shown that elastic substrates can 
upregulate the expression and patrolling behaviour of monocyte-derived macrophages [38]. 
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Figure 4.9 Representative tensile stress–strain curves of the various PVP/PGS fibrous 
membranes. PVP/PGS ratio of (a) 80:20, (b) 70:30, (c) 60:40 and (d) 50:50. Blue: PVP                            
360K gmol-1, Red: PVP 1.3M gmol-1. 
 





Elongation at  
Break (%) 
Young’s Modulus  
(MPa) 
PVP (gmol-1) 1.3M  360K 1.3M 360K 1.3M 360K 
80:20 3.5 ± 0.3 3.2 ± 0.3 14.5 ± 2.8 3.1 ± 0.7 169 ± 30 170 ± 38 
70:30 1.6 ± 0.1 2.1 ± 0.2 106 ± 5.0 29 ± 7.9 40 ± 8.4 38 ± 10 
60:40 1.9 ± 0.3 1.7 ± 0.3 225 ± 15 176 ± 23 1.3 ± 0.2 2.2 ± 0.5 
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4.3.5 Wettability 
Water contact angle (WCA) measurements were carried out to determine the hydrophobic-
hydrophilic characteristics and water absorption properties of the PVP/PGS electrospun mats 
prior and after being irradiated with UV light for 30 and 60 min. As shown in Figure 4.10, an 
increase in the static WCA is apparent for the electrospun mats that were irradiated, which 
correlates to the exposure time. The WCA of the PVP fibres was 20.2° ± 1.25°, while the 
PVP/PGS was 30.4° ± 1.73° for the untreated fibres, 35.4° ± 1.06° after 30 min of UV treatment 
and  51.9° ± 1.98° after 60 min. PVP electrospun fibres in the literature appear to have similar 
values [39].   
 
 
Figure 4.10 Water contact angle measurements of the electrospun PVP/PGS 60:40 fibres 
irradiated with ultraviolet light for 0, 30 and 60 min (n=8). The data are shown as the mean ± SD, 
where statistical significance is * p < 0.05. 
 
 In contrast, the WCA of PGS has been found to be between 53° and 70°; thus, PVP 
considerably influences the wettability of the electrospun mats, making the hybrid fibres 
increasingly hydrophilic [39–41]. In the majority of studies, UV treatment of electrospun fibres 
has been shown to reduce the hydrophobicity of materials such as PCL [42] and PLA [43]. 
However, the contrary is observed in this study. Poly(vinyl alcohol) (PVA) UV irradiation has 
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been previously shown to both increase and decrease the hydrophobicity of hydrogels due to 
an observed increase at the surface temperature of the material [44]. In this study, heat was 
not applied at the surface of the electrospun mats during this process, as initial observations 
showed apparent burning of the scaffolds, something that could be explained as PGS is a 
thermosetting polymer. Thermosets can retain strength and shape upon being heated, due to 
an increased degree of intramolecular interconnectivity, and will only burn at temperatures 
higher than the curing temperature, which is 120 °C for PGS. Based on these observations, 
in conjecture, possible, stable covalent carbon bond formation between the PVP and PGS 
side chains correlating to the time of exposure to UV light may have resulted in a surface with 
low surface energy. This indicates that the wettability of the PVP/PGS fibres can be 
manipulated to an extent via UV irradiation. UV photocrosslinking of PVP via the conjugation 
of the molecule’s monomers in an aqueous solution has been previously proven feasible for 
hydrogels [2]. A parametric study of the UV intensity and exposure time on the composite 
fibres could divulge the mechanism behind this phenomenon. This significant increase (p< 
0.05) of the WCA upon UV irradiation towards a less hydrophilic surface was required to 
produce a stable electrospun membrane in order to assess the material’s biocompatibility in 
vitro.  
 
4.3.6 Cellular behaviour of HDFs in response to the PVP/PGS 
scaffolds in vitro 
To appraise whether the UV-treated PVP/PGS fibre mats could be employed as a dermal 
substitute, HDFs were seeded and assessed in regard to their morphology, cytocompatibility, 
proliferation rate and attachment properties. As no significant difference was observed in the 
expansion of HDFs on the PVP/PGS mats produced with PVP 360K and 1.3M gmol-1, the 
results are presented as one group. Figure 4.11a depicts the fluorescence intensity of HDFs 
cultured on the PVP/PGS membranes using the cell viability Alamar blue® assay over a span 
of seven days. A steady increase in the fluorescence corresponding to the number of viable 
cells present was apparent, with a viability rate of ≥ 93% for all the time points examined. 
Based on these preliminary results, the scaffolds do not appear to induce any apparent 
cytotoxic effect on HDF and display excellent biocompatibility. 
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Figure 4.11 The proliferation of HDFs on the PVP/PGS scaffolds of variant proportions. (a) 
Quantitative analysis using Alamar blue cell viability assay 1, 3, 5 and 7 days after incubation 
(n=6); (b) Representative SEM micrographs displaying the influence of the scaffold design on the 
morphology and proliferation of the HDFs, 1, 4 and 5 days after incubation. PVP/PGS 80:20; 70:30; 
60:40 and 50:50 (w/w) for PVP 360K gmol-1. 
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 The morphology of the cells on the scaffold’s surface was obtained by SEM at day 1, 4 
and 5. The micrographs (see Figure 4.11b) indicate that the seeded fibroblasts carry a good 
polygonal, spindle morphology for PVP/PGS ratios of 80:20, 70:30, and 60:40 — characteristic 
of healthy fibroblasts — compared to the round morphology apparent for PVP/PGS 50:50. Cell 
attachment to the fibre surface was visibly apparent on the first day of incubation, with good 
surface interactions present between the HDF and the electrospun fibres, forming numerous 
attachment sites with the underlying fibrous scaffolds. The cells appear to have spread 
promptly over the electrospun mats, expanding and covering the scaffolds within five days. No 
cellular expansion was present for the 50:50 PVP/PGS merged fibre-gel, demonstrating the 
benefits of an ECM-like architecture towards the expansion of cells.  
 The cell adherence was evaluated by enumerating the number of non-adherent cells 4-h 
after seeding, compared to cells grown directly on tissue culture plates. The specimens 
assessed were pre-soaked in DMEM media (FBS-free) for 48 h, to allow for the removal of 
any entrapped residual solvents within the membranes. As indicated in Table 4.4, the 
PVP/PGS 80:20, 70:30, and 60:40 groups were able to adhere 2.10 ± 0.18,  2.75 ± 0.22, and 
1.92 ± 0.12-fold higher than the tissue culture plates. Interestingly, the merged fibres in the 
form of a gel (PVP/PGS 50:50 group) presented a 0.52 ± 0.08-fold decrease in cell attachment 
behaviour, coming into agreement with the SEM observations. The significantly higher 
(p<0.01) attachment properties of the 70:30 group compared to the other fibrous mats 
examined could possibly be attributed to the fact that moderately hydrophobic composite 
membranes have been shown to support greater attachment properties compared to 
hydrophilic polymers, as protein absorption is favoured by hydrophobic surfaces [12]. 
Furthermore, the adhesion ability of the cells on moderately hydrophobic surfaces arbitrates 
via strong interactions between ECM proteins, such as collagen and fibrin, secreted by the 
cells, as well as the chemical composition of the biomaterial’s matrix [45].  
 
Table 4.4 Rapid cell adhesion capability evaluated by comparing the number of non-adherent 
cells 4 h after seeding the HDFs in the surface of the electrospun mats over cells grown directly 















2.10 ± 0.18 
 
2.75 ± 0.22 
 
1.92 ± 0.12 
 
0.52 ± 0.08 
 
* s; electrospun scaffolds, c; 24-well culture plate (control) 
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 Figure 4.12 quantifies the cell spreading area occupied by HDFs on the electrospun mats 
at day 3 and 5. These measurements were conducted by measuring the area covered by cells 
from SEM micrographs on ImageJ through threshold values and evaluated from pixels per unit 
of area. There was a quantifiable increase observed for all groups examined between the two 
time points. The PVP/PGS 70:30 group presented the highest area of 2850 ± 320 μm2, 
followed by 2672 ± 245 μm2 for 80:20 and 2450 ± 450 μm2 for 60:40 at day 5. This pattern 
concurs with the cell adherence behaviour of the cells for the PVP/PGS 70:30 group. Overall, 
the PVP/PGS fibres are worth considering as a possible biomaterial for skin regeneration, 
although further work using an animal model could give insights to the wound closure 
efficiency on different anatomical sites, by evaluating wound contraction, inflammation and 
histological markers. 
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Figure 4.12 Cell spreading area occupied by the HDFs after 3 and 5 days of incubation on the 
electrospun PVP/PGS scaffolds of variant ratios. (a) Quantification of the cell spreading area 
(n=5), (b) Representative SEM images where cells are depicted with false pink colour. Scale bar, 
50 μm. 
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4.4 Conclusions 
This chapter describes, for the first time, the fabrication PVP/PGS electrospun fibres as an 
alternative route for the development of mechanically tuneable ECM-like skin substitute 
constructs. The composite’s morphological, physicochemical, mechanical and water contact 
angle properties, as well as HDF adhesion, proliferation and spreading, were assessed.  
A technical note provides a step-by-step guide, on how to build a nozzle-free 
electrospinning device capable of generating fibres at eleven times higher yield than 
conventional (needle-based) electrospinning setups. Subsequently, the device was employed 
to electrospin PVP/PGS blends of variant ratios. The mechanism responsible for the UV 
crosslinking of the membranes in the presence of riboflavin was divulged and verified via FTIR 
spectroscopy. The crosslinked fibrous membranes presented an increased hydrophobicity 
apropos to the time exposed under UV irradiation. 
It was determined that as the [PVP:PGS] ratio increased, so did the elongation-at-break 
of the corresponding composite scaffolds, while the Young’s modulus and ultimate tensile 
strength gradually decreased. The electrospun membranes produced using PVP 1.3M 
presented significantly improved elasticity, in comparison to the composites containing PVP 
360K. The elastic properties of the fibre mats were substantially improved with the addition of 
PGS; however, fibre uniformity was not preserved at proportions beyond 60:40 PVP/PGS.  
This study has identified knowledge gaps for further study. Firstly, additional work towards 
the cellular mechanisms in response to the surface chemistry of the developed electrospun 
constructs could give insights to the fibroblast differentiation pathways 
(fibroblasts/myofibroblasts) and any resulting upregulation in the expression of wound-related 
genes. Secondly, it would be worth assessing the effect of the polymer system’s degradability  
at 37 °C, as possible erosion of the composite structure, could have further elevated the pH, 
making the culture media more acidic. Thirdly, further investigations on the exact mechanism 
behind the relationship between UV exposure and time can provide better understanding 
towards its effect on the wettability and degradability of the PVP/PGS scaffolds, which could 
be beneficial in increasing the lifetime of the construct. 
The present study provides valuable input in the ability of PGS to tune the morphological 
properties and physicochemical behaviour of PVP fibres. This novel composite fibrous 
structure shows good potential for further investigations focused on improving wound 
contraction by facilitating elastic ECM-like synthetic dermal matrices analogous to the 
elasticities of different anatomical sites. 
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Chapter 5 
5. Nozzle-Free Electrospinning of Silk
Fibroin-Based Composite Scaffolds for Skin 
Regeneration 
5.1 Introduction 
The development of tissue-engineered skin substitutes and advanced wound dressing 
biomaterials requires that several criteria are met. First, these new materials must be 
biocompatible, to avoid the potential for immune rejection and inflammatory responses [1]. In 
addition, an appropriately hydrophilic interface between the tissue and the biomaterial is 
necessary to effectively facilitate cell adhesion and proliferation. Furthermore, the biomaterial 
must be lightweight, to minimise foreign body sensations. The material must also be 
biodegradable; to alleviate pain related to material-tissue adhesion, and present an 
architecture that allows for appropriate water retention, nutrient transport, breathability, and 
structural stability, to support an optimal regenerative niche [2, 3].  
To fulfil these requirements, a range of biocompatible materials have been extensively 
studied, with a particular focus on wound management and skin tissue repair [4]. Electrospun 
biomaterials are favourable for the reconstruction of fibrous skin-tissue-like scaffolds, 
promoting the development of structures that closely resemble the native ECM, facilitating 
cellular adherence, proliferation, and migration, and allowing for the induction of 
neovascularisation [5, 6]. Electrospinning represents an excellent and well-established 
technique, described in detail in Chapter 2, that can be used to fabricate constructs in the form 
of nonwoven fibre networks [7]. The net-like morphology of electrospun fibres, due to 
characteristics at both the micro- and nano-levels, can facilitate the absorption of exudates 
and support efficient gas exchange within the wound bed, while simultaneously modulating 
the adaptation and proliferation of dermal cells [8, 9]. These features can ultimately improve 
the care, recovery time, and healing processes of injured skin tissues. 
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The use of different materials in a polymer system can allow for the integration of unique 
properties and distinct features into the final composite structure. Therefore, a unique 
composite structure was developed, based on electrospun fibres and consisting of both 
synthetic and naturally derived materials. However, obtaining a stable Taylor cone during the 
electrospinning of natural polymers can be challenging due to low solution viscosities, MWs 
below the critical chain entanglement concentration, a much lower throughput during the 
fabrication process, as well as the diversity and greater distribution of the polymer chains 
giving room to fibre inconsistencies and secondary morphologies (e.g., beads, ejected 
polymer droplets, spider nets etc.). Therefore, an appropriate solvent system, the critical 
entanglement concentration of each polymer, and the necessary viscosity above the overlap 
concentration of the polymer-system were initially determined. 
In this study, non-acrylate pre-PGS (pPGS) and PGS were blended with a Bombyx mori-
derived fibroin-acidic system, in which PCL was incorporated as a backbone-polymer carrier, 
to stabilise and improve the electrospinnability of the polymer solution. To utilise the 
advantages of each material, this study systematically studied and employed the nozzle-free 
electrospinning technique, described in detail in Chapter 4, to formulate composite fibres, tune 
and characterise their properties, to demonstrate the effectiveness of composite electrospun 
structures towards skin tissue engineering.  
For the extraction of silk fibroin from B. mori cocoons, a variation of the traditional approach 
was developed that was found to yield much larger quantities than the conventional molecular 
cassette cut-off method at a third of the time needed [10]. The morphological and chemical 
properties of the developed electrospun membranes were assessed. A degradation study was 
conducted, and contact angle measurements were examined to determine the effects of PGS 
and SF on the hydrophilicity of the fibrous composite scaffolds incorporating PCL. Human 
dermal fibroblasts (HDFs) were used to examine the seeding efficiency, adhesion properties, 
and proliferation on the trinary electrospun membranes. 
This is the first study, in literature, to ever describe the development of composite fibres 
deriving from a three-polymer system using a high-throughput, free surface, electrospinning 
device. 
The work presented in this chapter has been published in Materials Science and 
Engineering C (Keirouz et al., 2020a), and a conference abstract was presented on this topic 
at Electrospin 2019, the 6th International Conference on Electrospinning, in Shanghai, China 
(Appendix B). 
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5.2 Methodology 
For full descriptions of the materials and methods used, please see the following sections in 
Chapter 3:  
• Materials (Section 3.3)
o Synthesis of PGS and pPGS (Section 3.3.1)
o List of materials, reagents, cells, suppliers, and equipment (Section 3.3.2)
• Scaffold characterisation (Section 3.4)
o Scanning electron microscopy (SEM) (Section 3.4.1)
o Fourier-transform infrared spectroscopy (FTIR) (Section 3.4.3)
o X-ray photoelectron spectroscopy (XPS) (Section 3.4.4)
o Water contact angle measurements (WCA) (Section 3.4.8)
o Degradation studies (Section 3.4.9)
• In vitro evaluation (Section 3.5)
o Scaffold sterilisation (Section 3.5.1)
o Cell culture technique (Section 3.5.2)
o Cell seeding efficiency (Section 3.5.3)
o Cell proliferation (Section 3.5.4)
o Fixing cells for SEM imaging (Section 3.5.5)
The chapter-specific experimental methods are described, in detail, below. 
5.2.1 Extraction and purification of the silk fibroin protein  
SF was extracted from Bombyx mori silkworm cocoons, using a newly developed alcohol 
precipitation method. Sericin was removed by degumming 10 g of cocoons in 0.02 M Na2CO3 
solution, at 100 °C for 30 min. The degummed silk cloth was then rinsed thoroughly with 
deionised water and left to dry under the fume hood overnight. The woven silk filaments were 
then dissolved in a 9.3 M LiBr aqueous solution, for 4 h at 50 °C, in a narrow beaker (to sustain 
the temperature produced by the exothermic reaction), to regenerate the SF. 
Instead of continuing with the conventional method, which involves the removal of the 
chaotropic LiBr salt by dialysis, using specific molecular-weight cut-off cassettes [11], ethanol 
was used to precipitate the SF and remove the LiBr. To achieve an efficient degree of fibroin 
precipitation, the volume of ethanol used was 30-fold the volume of the aqueous SF-LiBr 
solution. The dispersed SF solution was added dropwise to ethanol and stirred for 1 h, after 
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which, the SF residues were attained by filtration (Whatman grade 1573) and washed with 
ultrapure water. The filtered SF was washed continuously with water until the electrical 
conductivity of the filtered water was equal to the electrical conductivity of the ultrapure water, 
prior to washing (≤ 0.1 μScm-1), at which point SF was considered to be LiBr-free. The purity 
of the fibroin protein was also confirmed by X-ray photoelectron spectroscopy (XPS) 
measurements, which confirmed that traces of LiBr were not present on the material’s surface. 
The paste-like, wet, SF was dried in an oven at 50 °C and milled using a mortar to form a 





Figure 5.1 Silk fibroin extraction and processing to obtain the regenerated form. Initially, 
B. mori cocoons are cut into small pieces and degummed in 0.01 M Na2CO3, at 100 °C for 30 min. 
The degummed silk is rinsed in deionised water, 3 times for 20 min each, and left to dry at room 
temperature, overnight. Then, 9.3 M LiBr solution is added to the dried silk fibre mesh, at a ratio 
of 1:4 SF:LiBr solution (w/v), to dissolve the fibroin. The LiBr-SF solution is placed in an oven, for 
4 h at 50 °C. Afterwards, SF is precipitated by gradually adding the SF-LiBr solution, dropwise, to 
pure ethanol, until it reaches a ratio of 1:30 SF-LiBr:EtOH (v/v), under agitation conditions for 1 
h. Subsequently, LiBr residues are removed by filtration and washed with ultrapure water. The 
purified SF is oven-dried, at 50 °C. The dried SF is then milled into a powder, using a mortar, and 
dissolved in formic acid/CaCl2, to obtain a final SF concentration of 12% (w/v). 
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5.2.2 Preparation of binary and trinary electrospinning solutions  
PGS was synthesised based on the previously published polycondensation method [22], as 
described, in detail, in Section 3.3.2. 
PCL, at 15% (w/v), was dissolved in a solvent system consisting of 80:20 (w/w) 
1,1,1,3,3,3- hexafluoro-2-propanol (HFIP):formic acid. To prepare the SF solution, 12% (w/v), 
SF powder was dissolved in a solution of CaCl2 and formic acid. The ratio of SF:CaCl2 was                       
1:0.25 (w/w) [12]. All solutions were magnetically stirred (350 rpm), overnight at room 
temperature. After homogenously mixed solutions were obtained, a trinary blend, consisting 
of PCL-backbone SF:PGS, and SF:pPGS solutions were prepared. The mass ratio of SF was 
maintained constant for all blends. Binary blends of SF:PGS and SF:pPGS were also 
prepared. The blends, which were dissolved in a solvent system consisting of HFIP: formic 
acid:CaCl2, were then magnetically stirred, overnight at room temperature, before 
electrospinning. The electrical conductivity and pH values of the polymer solutions were 
measured before every experiment. Table 5.1 indicates the mass ratios for each trinary and 
binary blend. 
 
Table 5.1 Blend compositions. Trinary blends, consisting of PCL-backbone SF:(p)PGS, binary 
blends, consisting of SF:(p)PGS, and PCL alone. Total polymer solution concentration of                       
13.5% (w/v) for the trinary blend, 19.5% (w/v) for binary blends, and 15% (w/v) for the PCL. 
Polymer blend Ratio [w/w] 
 Silk fibroin 12% (w/v) PCL 15% (w/v) PGS 15% (w/v) 
SF:PCL:PGS 1 0.75 0.25 
        & 1 0.50 0.50 
SF:PCL:pPGS 1 0.25 0.75 
SF:PGS 2 - 1 
SF:pPGS 2 - 1 
PCL - 1 - 
In the polymer blend column “&” is meant to indicate that all top three rows represent the 
SF:PCL:(p)PGS ratio blends. The ratio among the blends refers to the proportion of column 1 (SF) 
towards column 2 (PCL) and column 3 (PGS) so that 1 part of [SF] is equal to 1 part of [PCL+PGS]. 
e.g., 𝑆𝐹: 𝑃𝐶𝐿: 𝑃𝐺𝑆 → 1: 0.75: 0.25 = (12% + [(0.75 × 15%) + (0.25 × 15%))/2 = 13.5%, and 
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5.2.3 High-throughput scaffold fabrication and processing 
Fibres were produced using the enclosed configuration of the nozzle-free electrospinning 
device, which was described in Section 4.2.1. The trinary and binary polymer blends were 
submerged within the Teflon pool – where the rotating electrode spinneret was coated with 
the polymer blend, counter to a biased rotating collector electrode, under constant N2 flow. A 
high-voltage power supply, with a potential difference of 60 kV (+30/-30 kV), was applied 
between the two rotating electrodes, which resulted in the formation of multiple Taylor cones 
stretching along the surface of the rotating electrode, forming fibres in an upward motion. The 




Figure 5.2 Schematic representation of the nozzle-free electrospinning process, showing a 
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5.3 Results and discussion 
5.3.1 Electrospun scaffold morphology 
The fibrous constructs were electrospun using the nozzle-free electrospinning apparatus, as 
described above, and the fibres were collected on cellulose-based (baking) paper. Appendix 
A: Table A-1 summarises the electrospinning and solution parameters used. When 
incorporating SF with other synthetic polymers, the inter/-intramolecular interactions that result 
in the formation of fibroin -sheets should be considered [13]. The electrospun mats were 
treated for 2 h, in an ethanol solution, to favour the development of -sheets. The temperature, 
pH, fibroin and salt concentrations, shear viscosity, and solvent system used were optimised, 
to prevent the gelation of the binary and trinary spinning solutions upon blending [14, 15]. 
The morphological properties of the trinary SF:PCL:(p)PGS and binary SF:(p)PGS blends, 
at different ratios, were evaluated by SEM imaging (Figure 5.3; Appendix A: Figure A-12). The 
fibre diameters and pore sizes are listed in Table 5.2. The PGS concentration within the blends 
played important roles in the morphology of the produced fibres. The images depicted clear 
differences in the fibre diameters among scaffolds prepared with the two variant forms of 
synthesised PGS. The trinary SF:PCL scaffolds containing PGS tended to have higher 
average fibre diameters, ranging from 2.11 ± 1.34 µm to 4.1 ± 3.0 µm (Figure 5.3c–e), whereas 
the pPGS scaffolds presented values in the range of 1.42 ± 0.66 µm to 1.62 ± 0.80 µm (Figure 
5.3f–h). Moreover, the average fibre diameters noticeably increased in blends with higher 
ratios of PGS (e.g., the ratio 1:0.25:0.75 resulted in the thickest fibres, at 4.1 ± 3.0 µm, Figure 
5.3c). 
PGS was initially difficult to electrospin due to its high viscosity. Moreover, the pPGS glass 
transition occurs below room temperature; therefore, independent fibres can easily become 
fused during the electrospinning process, thickening the fibre composition, as well as form 
secondary morphologies (e.g., beads). In this work, these issues were circumvented by the 
addition of PCL in the polymer mixture, which stabilised the electrospinnability of the 
elastomer. The pPGS form of the elastomer was found to produce smaller fibres, with a mean 
fibre diameter that decreased by 23%–65%, depending on the corresponding blend ratio. 
These results indicated that the elastomeric PGS characteristics affected fibre morphology. 
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Figure 5.3 Average fibre diameters of the (a) trinary, SF:PCL:PGS and SF:PCL:pPGS, and                            
(b) binary, SF:PGS and SF:pPGS, blends. Representative SEM micrographs of the trinary,                            
(c-e) SF:PCL:PGS and (f-h) SF:PCL:(p)PGS (d-h) and binary, (i) SF:PGS 2:1 (w/w) and (j) 
SF:(p)PGS 2:1 (w/w), scaffolds. The images were obtained after drying ethanol-treated 
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Table 5.2 The morphological properties of trinary and binary electrospun mats. Nozzle-free 
electrospinning was performed at a potential difference of 60 kV (+30/-30 kV), in an upward 







Pore size  
(µm) 
1:0.25:0.75 4.1 ± 3.0 70 ± 7.3 14.7 ± 7.7 
1:0.5:0.5 2.7 ± 1.7 73 ± 3.6 15.4 ± 6.2 







Pore size  
(µm) 
1:0.25:0.75 1.4 ± 0.7 58 ± 8.5 8.8 ± 4.3 
1:0.5:0.5 1.5 ± 0.8 61 ± 5.3 9.2 ± 5.4 
1:0.75:0.25 1.6 ± 0.8 63 ± 8.5 9.3 ± 7.0 
SF:PGS    
2:1 2.1 ± 1.8 58.8 ± 8.9 7.9 ± 3.9 
SF:pPGS    
2:1 1.0 ± 1.1 62 ± 7.1 6.3 ± 2.6 
 
The mean pore size (Table 5.2) of the trinary blends containing PGS was, on average, 
twice that of the pPGS-containing electrospun mats, with no significant differences observed 
among the various concentration of PGS within the blends. The SF:PCL:PGS blend presented 
a mean pore size of 15.6 ± 7.1 µm (porosity 74% ± 5.4%), whereas the SF:PCL:pPGS blend 
had a mean pore size of 9.1 ± 5.7 µm (porosity 61% ± 7.4%). Along with the choice of 
biomaterial, the pore size must be considered during the development of a scaffold, to promote 
cell migration, adhesion, and cell-to-cell contacts [16, 17]. The optimal pore size for fibroblast 
ingrowth is 5–15 µm, with wider, interconnected pores able to better facilitate the diffusion and 
ingrowth of nutrients [18]. Thus, these trinary blends fall within the optimal range for pore size 
to promote cellular infiltration. Although the porosity of the produced mats was determined to 
fall within the required gradient necessary to promote tissue reorganisation and govern 
effective tissue regeneration, porosity can also negatively affect the mechanical stability of the 
construct [19]. Consequently, the addition of PCL within trinary blends has been widely 
considered to represent a good approach for the stabilisation of fibre-based biomaterials [19, 
20]. 
To further analyse the effects of PGS on SF, binary blends of SF:(p)PGS and SF:PGS, at 
a ratio of 2:1 (w/w), were also electrospun, using the same apparatus under the same 
conditions. In contrast with the PCL-containing fibres, the distributions of fibres produced using 
these binary blends were more dispersed, losing their uniformity. The mean fibre diameter of 
the SF:PGS blend was 2.13 ± 1.50 µm (Figure 5.3i), whereas the mean fibre diameter of the 
SF:(p)PGS blend was 1.04 ± 0.30 µm (Figure 5.3j). The SF:(p)PGS fibres appear to consist 
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of a smoother fibre morphology compared with their PGS fibre counterparts; however, some 
fusion of the fibres remained apparent. According to several studies, the subsequent curing of 
the PGS increases the molecular weight of the polymer, which results in chain mobility 
restrictions, increased entanglement, and higher internal fluid friction, making jet extension 
more difficult [21]. These characteristics lead binary and trinary blends containing PGS to form 
thicker fibres. Furthermore, a correlation between viscosity and fibre diameter was confirmed 
by the studies reported by Drew et al. [22], and Fong et al. [23], in which increasing the solution 
viscosity tended to increase the fibre diameter during electrospinning. 
When blends with or without PCL were compared, both PCL-containing trinary groups of 
fibres appeared smoother and with increased diameters than the fibres from the SF:PGS and 
SF:(p)PGS blends, in most cases, which may be due to changes in the dielectric constant, 
which is 0.2 mScm-1 higher in PCL-containing blends. Generally, the solution conductivity of 
a solvent also plays a significant role in the electrospinning process, with higher dielectric 
values corresponding to smaller diameters among the resulting electrospun fibres [24]. PCL 
was dissolved in a binary solvent system, containing HFIP: formic acid at 80:20 (w/w). 
Because formic acid has a higher dielectric constant than HFIP, the mixture of these two 
solvents may increase the electrical conductivity of the PCL-containing blends, contributing to 
the fabrication of smoother fibres during electrospinning [25]. 
The nozzle-free electrospinning setup, using a cylinder spinneret, results in substantially 
increased fibre productivity and requires lower operational costs than conventional single or 
multi-needle spinnerets [26, 27]. However, nozzle-free systems are also comparatively more 
complex, requiring a range of new electrospinning parameters to be considered, including, but 
not limited to, the spinneret rotating speed, the electric field distribution, and spinneret 
geometry. Nonetheless, in this chapter, the development of composites fibres deriving from a 
three-polymer system was deemed successful, where the presence and physicochemical 
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5.3.2 Chemical analysis and fibre surface composition  
The spectra of SF, PCL, pPGS, and PGS polymers were analysed, along with those of the 
binary and trinary scaffolds, to determine the compositions of the developed scaffolds, using 
ATR-FTIR. The infrared spectra are presented in Figure 5.4. The defining peaks of the 
individual polymers can also be observed in the corresponding composite fibres, at lower 
intensities. PGS and pPGS share the same spectrum, with slightly lower peak intensities for 
pPGS. The peaks at 2934–2857 cm-1 can be attributed to –CH sp2 and sp3 hybridisation 
stretching motions. At approximately 3050 cm-1, a weak stretch is apparent between the 
hydrogen (X–H) region and the broad loop, which forms out of a single peak at 3455 cm -1, 
corresponding to -OH stretch. The sharp peak at 1753 cm-1, which corresponds to carbonyl 
stretching, indicates the presence of strong ester linkages (C=O).  
The spectrum of PCL exhibits all of the polymer’s characteristic peaks, with two peaks 
between 2939 and 2857 cm-1, attributed to asymmetric and symmetric –CH stretches, 
respectively. A sharp peak at 1724 cm -1 is likely due to carbonyl stretching, and the stretches 
centred between 1247 cm-1 and 1170 cm-1 are due to asymmetric and symmetric C–O–C ether 
stretches, respectively. The peak at 1293 cm -1 can be attributed to C–O and C–C stretches, 
whereas the medium intensity peak at 1364 cm -1 is likely associated with CH3 bending. 
The spectrum of the specific SF region can be found in Appendix A: Figure A-13. The SF 
powder spectrum, derived from B. mori exhibits a strong amide I peak, at 1641 cm -1, indicating 
a random coil structure of C=O stretching, which is typical of regenerated SF dissolved in 
strong chaotropic salts, such as LiBr. The amide II shows an absorption peak at 1535 cm-1, 
which corresponds to NH bending (-helix, random coil), and the band that appears at 
approximately 1120 cm-1 corresponds to amide III CN stretching. The ester functions of PGS 
and PCL can also be seen in Figure 5.4b, at approximately 1230 cm-1 and 1700 cm-1, 
corresponding to out-of-phase C–O–C and C=O stretching, respectively. 
 
 
174       Nozzle-free electrospinning of silk fibroin-based composite scaffolds | Chapter 5 
 
 
Figure 5.4 ATR-FTIR spectra of (a) the individual polymers and the (b) binary and trinary 
electrospun mats. Scaffolds that contain PGS are shown in blue, whereas scaffolds that contain 
pPGS are shown in pink. Binary blend ratios were SF:(p)PGS 2:1 (w/w), whereas the trinary 
SF:PCL:(p)PGS ratio was 1:0.5:0.5 (w/w). 
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Figure 5.5 XPS survey of the trinary SF:PCL:(p)PGS and binary SF:(p)PGS electrospun mats. 
 
The surface chemistries of the composite electrospun binary and trinary blends were 
evaluated by XPS analysis, at an information depth of approximately 10 nm. Figure 5.5 
displays the XPS spectra for the 1:0.5:0.5 SF:PCL:(p)PGS and 2:1 SF:(p)PGS fibrous mats. 
No peaks were apparent at the Li and Br regions of the surveys, verifying the successful 
removal of LiBr from the regenerated powdered SF, via ethanol precipitation followed by 
filtration with deionised water. Peak intensities for C1s, at 284 eV; O1s, at 531 eV; N1s, at 399 
eV; Ca2p, at 346 eV; Cl2p, at 196 eV; and Si2p, at 101 eV were present in all examined 
blends. As indicated in Table 5.3, although the calculated theoretical values for each blend fell 
within a margin of error (5%) for the predicted values, the nitrogen contents were considerably 
lower for all the blends examined. This suggests that the high in nitrogen content regions of 
SF polymer chains, at the surface of the fibres, are facing inwards and towards the core of the 
fibres. Further evaluation by atomic force microscopy in contact mode can shed light on this 
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observation. The presence of silica traces could be attributed to the use of baking paper to 
collect the fibres. 
Table 5.3 Surface chemical compositions of the electrospun trinary 1:0.5:0.5 (w/w) 
SF:PCL:(p)PGS and binary 2:1 (w/w) SF:(p)PGS mats, via XPS analysis. The percentages in 







  C1s O1s N1s Ca2p Cl2p 
SF:PCL:PGS Experimental 70.8 27.2 1.35 0.28 0.37 
 Theoretical (56.8) (25.7) (15.6) (0.70) (1.30) 
SF:PCL:pPGS Experimental 68.7 26.8 2.66 1.36 0.48 
 Theoretical (56.8) (25.7) (15.6) (0.65) (1.25) 
SF:PGS Experimental 70.1 24.2 4.50 0.31 0.89 
 Theoretical (56.7) (26.0) (15.4) (0.62) (1.28) 
SF:pPGS Experimental 67.4 28.3 3.20 0.63 0.47 
 Theoretical (56.7) (26.0) (15.4) (0.64) (1.26) 
 
5.3.3 The influence of PGS in the degradation of the electrospun 
mats 
The effect of PGS in the degradation profile of the trinary electrospun mats was assessed in 
a PBS (pH 7.2) solution at room temperature (22 ± 4 °C) as described in detail in Section 
3.4.9. At specific time points, pre-weighed scaffolds were removed from the PBS solution and 
vacuum dried, followed by determining the net weight loss (%) from time point zero to time 
point X. 
The PGS specimens (Figure 5.6a, Appendix A: Table A-2) retained most of their original 
mass during 3 days of incubation, with a minimum weight loss of 3%, observed after 30 min 
of incubation, and a maximum weight loss of 42.6%, after one month of incubation. Within this 
group, a clear trend towards mass loss was observed with decreasing amounts of PCL within 
the scaffolds. 
A similar pattern was observed for the pPGS group (Figure 5.6b, Appendix A: Table A-2), 
in which samples with lower PCL ratios demonstrated higher degrees of degradation. A similar 
finding was reported by Liu et al., in which PCL-containing fibres presented slower degradation 
rates than PGS-containing fibres [28]. Therefore, by using the two variant forms of PGS and 
adjusting its ratio within the polymer blends, the degradation of the composite electrospun 
mats can be modulated. This process can eventually be used to calibrate the breakdown of 
Chapter 5 | Nozzle-free electrospinning of silk fibroin-based composite scaffolds       177 
 
the ECM-like fibre structure, to occur at an appropriate rate that complements the natural ECM 
reorganisation during the wound healing process. 
The initial lack of degradation observed for PCL-backbone SF:PGS blends was expected, 
as many studies have shown that PCL can withstand hydrolytic degradation due to its 
hydrophobic nature [29–31]. Polyesters, such as PCL, degrade significantly faster via enzyme-
mediated hydrolysis [29] and have been shown to have poor degradation behaviour in PBS 
[30]. Nadim et al. reported only 26% mass loss over 30 days for a fibrous PCL:PGS mat 
containing an equal mass ratio [32], which is similar to the degradation behaviour observed 
for the 1:0.5:0.5 SF:PCL:(p)PGS mat in this study (Figure 5.6). The weight loss observed for 
the SF:PCL:PGS group is lower than that reported by Nadim et al., as the incorporation of SF 
into the blend, made the resulting fibres even more resistant to water degradation – illustrating 
one of the ways that the integration of a natural polymer can influence the degradation 
properties of composite structures [33]. 
 
 
Figure 5.6 Percentage of mass loss for the PGS-containing fibres, at varying incubation times. 
Blend (w/w) ratios of (a) SF:PCL:PGS, and (b) SF:PCL:(p)PGS. The fibres were submerged in PBS 
solution, pH 7.2, at room temperature (22 ± 4 °C). A photograph of the specimens used for the 
weight loss analysis can be found in Appendix A: Figure A-14. 
 
One advantage of SF is its stability in water, which may prevent the premature dissolution 
of composite electrospun mats. Furthermore, the ethanol treatment of acid-based SF blends 
can promote the formation of hydrogen-bonded -sheet structures (silk II), which can be used 
to manipulate hydrophilicity and improve the scaffold's degradation in aqueous environments 
[33, 34]. The macroscopic assessment of trinary electrospun mats after ethanol treatment is 
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displayed in Figure 5.7. Silk II structures have been shown to exhibit higher hydrophobicity, 
based on the contact angle measurements conducted by Jin et al. [34], which indicated 
improved stability in PBS solution and would explain the lower degradability of the trinary 
SF:PCL:PGS composite fibres compared with that of the binary PCL:PGS fibrous mats, not 
containing SF. 
Initially, extended incubation periods were expected to result in additional hydrolysation 
time, resulting in the increased mass loss of the scaffolds. Although this behaviour was 
observed for the PGS groups, the opposite event appears to occur for the pPGS groups, for 
which an inverse correlation between the incubation time and degradation can be observed. 
The data displayed in Figure 5.6 refer to the average values of the measured degradation of 
each specimen, rather than the sum of all previously measured degradation. 
 
 
Figure 5.7 Fibroin crystallinity. Macroscopic observation of the effects of ethanol, (a) before and 
(b) after the treatment of SF:PCL:(p)PGS electrospun mats. Upon immersion in ethanol for 2 h, 
the induced crystallinity of the silk fibroin protein affects the random coil configuration of the 
molecules, forming -sheet blocks of amino acids via hydrogen bonding. 
 
A higher degree of esterification density within the PGS structure was expected to hamper 
degradation relative to structures containing pPGS, but no significant differences were 
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observed for mass loss between the PGS and pPGS blends, as assessed by the minimum 
and maximum weight loss values, which agrees with the findings reported by Pomerantseva 
et al. [35]. However, they further reported that water uptake decreased as the curing time of 
PGS increased; therefore, pPGS likely displays reduced degradability compared with PGS. 
Furthermore, the water uptake of PGS was reported to decrease as the curing time of the 
elastomer increased [35]. Because the pPGS group appears to have a greater capacity to 
retain water, it may retain water mass, even after the dehydration process, explaining the lower 
mass loss of pPGS compared with PGS. The scaffold's ability to retain water can be 
associated with its wettability, which is recognised as a primary factor that governs protein 
adsorption and cell adhesion [36, 37]. 
A dressing that readily retains water may dehydrate the wound bed, increasing the 
likelihood of scarring, whereas a low degree of water retention may increase the risk of 
infection and halt the healing process due to the build-up of exudates in the wound bed; thus, 
finding the optimal balance between the two states can be challenging [38]. These results 
demonstrated that the tuning of all three polymers within the composite fibre structure could 
influence the upper and lower bounds – that is necessary to identify the appropriate conditions 
required to control the rate of degradation. Further evaluation of the degradation rate in the 
presence of the culture media (DMEM-complete), could provide valuable insights towards the 
degradability of the scaffolds during the in vitro cell culture experiments. 
 
5.3.4 Wettability 
Surface wettability is a crucial characteristic of polymeric biomaterials, playing critical roles in 
cellular adhesion, proliferation, migration, and survival [39]. Interactions between the 
biomaterial and cells can be especially important when determining whether a construct or a 
device can regulate inflammatory responses and can determine the degree of tissue 
adhesiveness [40]. Cell attachment is mostly governed by alterations in surface energy, with 
higher-energy hydrophilic surfaces encouraging adhesion, whereas low-surface-energy 
substrates typically inhibit cellular adhesion [37]. Moderately hydrophilic/hydrophobic surfaces 
favour the adsorption of surface proteins, mediating cellular adhesion and activating 
downstream signalling responses following the activation of specific cell adhesion receptors, 
which, in turn, induce the deposition of the ECM structural components required for tissue 
regeneration [37, 41]. Moderately hydrophilising a hydrophobic surface, such as PCL, can 
alter the surface energy of the biomaterial, improving the adsorption of surface-related proteins 
and the diffusion of nutrients, which can lead to optimal adhesion, increased cellular infiltration, 
and tissue in-growth in a wounded area [42]. 
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The contact angles were determined for each binary, trinary, and PCL scaffold examined 
in this study, to investigate the effects of PGS and SF on the hydrophobicity of PCL. Figure 
5.8 presents the contact angle values determined for each group, which were examined 
following the settlement of a 5-µL water droplet on the surface of the electrospun mats, and 
the differences among groups were examined. The hydrophobicity of the PCL-only fibres was 
confirmed, with a high contact angle of 125.9° ± 6.5°. 
 
 
Figure 5.8 Water contact angle over time. PCL, binary SF:PGS and SF:pPGS and trinary PCL-
backbone SF:PGS and SF:pPGS electrospun mats. Time intervals 0, 5, 10, 20, and 30 s. S1: PCL; S2: 
SF:PGS; S3: SF:pPGS; S4: PCL-backbone SF:PGS; and S5: PCL-backbone SF:pPGS. The letters 
indicate the ratios of the trinary blends, where the SF:PCL: (p)PGS ratio is (a) 1:0.75:0.25, (b) 
1:0.50:0.50, and (c) 1:0.25:0.75. Red arrows indicate changes in (p)PGS concentrations and green 
arrows indicate changes in PCL concentrations.  
 




Figure X. Water contact angle over time of PCL, binary SF/PGS, SF/pPGS and trinary PCL-backbone SF/PGS 
and SF/pPGS electrospun mats. Time intervals 0, 5, 10, 20 and 30 sec. S1: PCL, S2: SF/PGS, S3: SF/pPGS, S4: 
PCL-backbone SF/PGS, S5: PCL-backbone SF/pPGS. Letters indicate the ratio of the trinary blends, whereas 
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The hydrophilicity/hydrophobicity ratio of a fibrous scaffold affects the adhesion and 
proliferation behaviours of the cells [43]. By integrating a natural polymer with synthetic, 
hydrophobic polymers, such as PCL, the contact angle of the fibres can be reduced, improving 
the hydrophilicity of the final construct. SF fibres can be increasingly hydrophilic due to the 
high number of amino acid and carboxylic domains that they contain [44]. Based on the XPS 
analysis, the nitrogen content at the surface of the fibres was significantly lower than the 
calculated theoretical values, suggesting that the N-rich regions of the SF chains were facing 
inwards. This concurrently insinuates that the majority of the carboxylic domains of the SF 
polymer chains will be facing outwards, and thus can directly affect the hydrophilicity of the 
composite constructs. 
The random coil conformation of the fibres can be stabilised through the formation of -
sheets with the Ca2+ present between the fibroin domains, which occurs during both the 
electrospinning process and post-treatment with ethanol [45, 46]. PGS is also well-known for 
its hydrophilicity due to the presence of hydroxyl groups on the polyester backbone. The 
titration of the total acid numbers can be adjusted by functionalising the elastomer, making it 
possible to increase the hydrophilicity [47, 48]. As the number of ester linkages increases 
during esterification, the hydrophilicity of PGS in the composite scaffold is also expected to 
increase, relative to its pre-polymerised counterpart. 
As Figure 5.8 indicates, the addition of higher concentrations of PGS to the composite 
electrospun membranes increased the wettability of the corresponding scaffolds over a period 
of 30 s. Additionally, higher concentrations of PGS increased the water absorbability of the 
trinary scaffolds, in comparison to the mats containing pPGS. For the binary SF:PGS and 
SF:pPGS scaffolds, which presented contact angles of 83° ± 10.6° and 124.5° ± 8.02°, 
respectively, the PGS-containing membranes concurred with the trinary electrospun mats 
observations, demonstrating increased wettability and reduced contact angles in comparison 
to the pPGS-containing mats. Figure 5.9 shows the WCA measurements 0, 5, 10, 20 and 30 
s after the application of a deionised water droplet at the surface of each electrospun 
membrane examined. 
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Figure 5.9 Water contact angle measurements of the trinary SF:PCL:(p)PGS, binary SF:(p)PGS 
and PCL electrospun mats. Blue, yellow, red, green, and purple bars represent the contact angles 
measured for a 5-µL deionised water droplet settling on the surface of electrospun mats after 0, 
5, 10, 20, and 30 s, respectively. The symbols (✝, $, #) - indicate significant differences and similar 
values (one-way ANOVA with Tukey multiple comparison test) for time point 10 s between the 
various groups examined (n = 6, p ≤ 0.05). For instance, SF:PGS presented similar ($, p ≥ 0.05) 
contact angle values with SF:pPGS, SF:PCL:PGS 1:0.75:0.25, SF:PCL:pPGS 1:0.75:0.25 and 
1:0.5:0.5, significantly lower contact angle values (✝, p ≤ 0.05) than PCL, and significantly higher 
(#, p ≤ 0.05) contact angle values than SF:PCL:PGS 1:0.55:0.5 and 1:0.25:0.75, and SF:PCL:pPGS 
1:0.25:0.75 for time point 10 s. 
 
5.3.5 Cell adhesion, viability, and proliferation 
Human dermal fibroblasts were passaged in supplemented DMEM and seeded on the 
electrospun mats. Figure 5.10a depicts the cell growth and expansion of each electrospun 
SF:PCL:(p)PGS mat composition, 1, 3, 5, and 7 days after initial seeding. The Alamar blue  
cell viability assay was used to assess cell proliferation on each electrospun membrane. Viable 
cells reduce the non-fluorescent Resazurin (blue) to a fluorescent, red-coloured complex, 
called resorufin. The metabolic activity is proportional to cell viability, where resorufin act as 
an electron acceptor for enzymes (NADP and FADH) during oxygen consumption [49]. 
Because growth followed the same patterns, with no significant differences in the extent to 
which seeded cells reduced the reagent between the pPGS and PGS, the results were merged 
for clarity. 
The proliferative properties of the SF:PCL:(p)PGS electrospun membranes were analysed 
by establishing a relationship between cell growth and the incubation period. The cell viability 
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on electrospun mats formed from the three tested SF:PCL:(p)PGS ratios were examined and 
compared with the cell viability on PCL-only electrospun mats. The fibroblasts appeared to 
gradually expand on the trinary scaffolds, with a consistent and significant (p < 0.05) increase 
in the number of cells present as the number of days in culture increased, compared with the 
growth of cells in the PCL-only group. This linear increase in cell viability was apparent for all 
examined blends. Thus, the composite fibres appeared to provide a matrix on which fibroblasts 
were able to proliferate rapidly. 
 
 
Figure 5.10 Attachment and proliferation of HDFs on trinary electrospun membranes. (a) 
Alamar blue™ cell viability assay of the SF:PCL:(p)PGS scaffolds. Values represent the mean ± SD 
(n = 9, p < 0.05). a, b, c indicates significant differences and similar values (ANOVA). (*) - indicates 
significant differences between the PCL-only and trinary electrospun mat groups (b) SEM images 
of HDFs seeded morphology on trinary SF:PCL:(p)PGS 1:0.5:0.5 electrospun scaffolds.                               
Scale bar, 10 µm. 
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The proliferative and adhesive properties of the electrospun SF:PCL:PGS and 
SF:PCL:pPGS mats, at the tested ratio of 1:0.5:0.5, were further assessed by fixing the 
fibroblast seeded scaffolds and examining cell morphology, using SEM imaging (Figure 
5.10b). The SEM micrographs presented fibroblasts with polygonal morphology and elongated 
spindles, which are characteristic of healthy fibroblasts, unlike the spheroid cells that are 
predominately found among fibroblasts grown on synthetic materials, such as the pure PCL 
electrospun membranes, as illustrated in Figure 5.11. Cell attachment to the fibre surface was 
visibly apparent on the day of inoculation. A good surface interaction occurs between the 
adherent cells and the electrospun fibres, as shown in the SEM images. This morphological 
characteristic can be attributed to the addition of the biocompatible PGS and SF protein. The 
cells appeared to spread quickly over the electrospun mats and were capable of expanding 
and covering the scaffolds within 5 days, as observed on the SEM micrographs.  
 
 
Figure 5.11 Comparisons of fibroblast morphologies, assessed by SEM, after seeding on (a, c) 
trinary SF:PCL:(p)PGS or (b, d) PCL electrospun mats. The characteristic polygonal and elongated 
fibroblast morphologies, corresponding to a healthy, spindle-shaped fibroblast, is apparent upon 
interaction with the biocompatible SF protein, in contrast to the round fibroblast morphology 
observed for cells seeded on the synthetic PCL polymer fibres. Scale bar, 10 µm. 
 
The cryo-SEM micrographs of seeded cells on the electrospun scaffolds were further 
obtained, imaged by FIB-SEM using an acceleration voltage of 10 kV. To examine cellular 
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infiltration, a region covered by 5-day cultured fibroblasts was chosen, and the surface was 
subsequently milled via the ion beam, and the specimen was tilted through a “slice and view” 
process. Although the presence of crystals was apparent on the surface of the cells, due to 
the crystallisation of the intracellular fluid, the surface morphology and corresponding 
infiltration of the cells within the scaffolds can be observed. 
Figure 5.12 displays the cryo-SEM micrographs of FIB incisions, obtained for the HDF-
seeded trinary, composite fibre mats. Fibroblast ingrowth along the fibrous network of the 
scaffold indicates the complete ingrowth of the electrospun mats on day 5. These results 





Figure 5.12 Cryo-FIB-SEM micrographs obtained from trinary SF: PCL: (p)PGS scaffolds, 5-days 
after being seeded with fibroblasts. The specimens were initially submerged in liquid nitrogen. 
The figure depicts nanoscale tomography cross-sections of cell-containing scaffolds after being 
milled with a cryo-focused ion beam milling scanning electron microscope (Zeiss Crossbeam 550 
FIB/SEM, Carl Zeiss AG, Germany). (a) Top view of the FIB lift-out region of the specimen at 
milling depth of approximately 15 μm. (b-c) Tilted views of the cross-section area that depicts the 
bidirectional growth of the cells within the scaffold. (d) A magnified region from micrograph (c). 
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The red arrows indicate the polymeric fibres; the yellow arrows indicate fibroblasts. The cells 
present a well-defined lipid membrane due to variations between the phases of lipid and 
cytoplasmic fluid crystallization, allowing for the cells to be distinguished. The micrographs were 
obtained with the assistance of the instrument scientist, Dr Thomas Glen, in the School of Physics 
at the University of Edinburgh. 
 
5.4 Conclusions 
Although PCL has been extensively used for tissue engineering applications because of its 
good mechanical properties and ability to mimic many aspects of the natural ECM architecture, 
its hydrophobicity makes it an unfavourable candidate, as a biomaterial. To address this 
problem, PCL-backbone SF:PGS electrospun mats were fabricated, which collectively 
improved the physicochemical properties of the biomaterial system.  
The composite fibres displayed smooth morphologies, with controllable fibre diameters, 
appropriate pore sizes for fibroblast expansion, and tuneable hydrophobicity/hydrophilicity 
adjutant to the form and proportion of PGS within the blends. The trinary scaffolds appeared 
to be biocompatible, allowing for fibroblasts to effectively adhere and proliferate at high viability 
numbers. The developed nozzle-free electrospinning technology also addresses key 
challenges encountered during the fabrication of electrospun biomaterials, such as the meagre 
production rate associated with conventional needle-based setups. In addition, the 
straightforward SF extraction method developed, minimises the time required to obtain and 
purify the protein.  
This is the first time in literature that electrospun composite fibres deriving from a three-
polymer system have been successfully generated through free surface high-throughput 
electrospinning. The collective properties presented by the PCL-backbone SF:(p)PGS fibres 
can be recognised as a skin substitute, where, as a next step, further assessment on an animal 
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6. Core/Shell Bicomponent Antimicrobial 
Nanofibres for the Prevention of Mesh-




As described in Chapter 2, hernia repair is one of the most commonly performed elective 
operations, for which hernia reduction using suture closures is associated with high 
reherniation rates; whilst, synthetic and bioprosthetic mesh closures are linked to several 
serious complications [1]. Among which, foreign body sensation due to being heavyweight, 
the development of fibrosis due to excessive strength leading to increased inflammation and 
loss of elasticity, tissue adhesion resulting to enterocutaneous fistula formation, as well as 
post-surgical deep mesh infections [1, 3]. 
The use of hernia meshes has been reported to reduce recurrence by 30%–50% 
compared with suture closure [2, 3]. In general, the intravenous and oral administration of 
prophylactic antibiotics, cannot ensure sufficient protection against surgical site infections 
(SSIs), especially those associated with deep incisional infected meshes [4]. In reviewing the 
different material design approaches that can be employed to produce a hernia mesh capable 
of addressing the aforementioned challenges, faced by the biomaterials utilised for hernia 
repair today, electrospun nanofibrous constructs are worth investigating. 
 Nanofibrous scaffolds, developed via the electrospinning process can represent a 
valuable step towards the development of an antimicrobial hernia mesh because the NFs 
formed through this process are lightweight, can attain a large surface area per unit mass, and 
present controllable fibre configurations [5]. Further, through the co-axial electrospinning 
technique, the incorporation of antimicrobial agents, in a spatially controlled, bilayer format, is 
also feasible. The utilisation of the co-axial electrospinning technique can provide further 
advantages over single-nozzle electrospinning, as selected properties can be combined within 
a bicomponent fibre, including the following: (1) the fabrication of electrospun membranes that 
incorporate a hydrophilic surface within a hydrophobic core in a single-core/sheath fibre; (2) 
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the encapsulation and protection of sensitive substances from the outer environment, by 
placing the active agent within the fibre core; (3) the design of programmable release kinetics 
from the fibre core, tailored for sustained release kinetics; and (4) obtain the controlled release 
of defined concentrations of pharmaceutical compounds [6–8]. Furthermore, by integrating a 
mechanically adapted polymer into the fibre core, the subsequent mechanical behaviour of 
the bicomponent fibre can be improved, while concurrently preventing it from influencing the 
fibre surface properties. 
In this study, chitosan (CS) and nylon-6 (PA6) were selected to formulate the shell and 
core regions of the core/shell NFs, respectively, where polyethylene oxide (PEO) was added 
to the CS solution, as a carrier polymer, to stabilise and improve its electrospinnability and 
produce more homogenous fibres. Then, the antimicrobial substances 5-chloro-8-
hydroxyquinoline (5CLO8Q) and polyhexanide (PHMB) were loaded within the polymer 
solutions of CS and PA6, respectively. The co-axial electrospinning process was subsequently 
employed to develop a bicomponent, nanostructured, hernia mesh biomaterial. Single-drug 
CS-5CLO8Q and PA6-PHMB electrospun NFs were also produced, and their 
physicochemical, mechanical and antimicrobial responses were compared against the 
composite core/shell PA6-PHMB/CS-5CLO8Q structure. The reasons underlying the choices 
of CS and PA6, as well as the antimicrobial agents 5CLO8Q and PHMB were delineated in 
Sections 3.3.2 and 3.3.3. 
The main goal of this study was the design of a nanostructured mesh construct that 
incorporates a dual drug delivery system of antimicrobial substances, combined with the 
mechanical stability of PA6 and the cytocompatibility of CS. The mechanical performance of 
the biomaterial was evaluated through tensile testing. To obtain further insights regarding the 
parameters that affect the release of the two substances, the electrospun membranes were 
evaluated physiochemically, and through drug release kinetic experiments in vitro.  
The two bacteria species most commonly associated with deep-incisional SSI of hernia 
meshes; Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative 
Pseudomonas aeruginosa (P. aeruginosa), were chosen to assess the antimicrobial 
properties of the electrospun NFs. The antimicrobial efficiency of electrospun membranes was 
evaluated quantitatively and qualitatively via zones of inhibition, growth kinetics, live/dead 
fluorescence and confocal microscopy, and SEM imaging of bacteria-contaminated 
specimens. Furthermore, the antimicrobial properties of the core/shell PA6-PHMB/CS-
5CLO8Q composite NFs were compared with commercially available synthetic and biologic 
meshes and other forms of micro polymer-based fibres, using the Gram-negative Escherichia 
coli (E. coli) as a model organism that responds in a similar manner to P. aeruginosa.  
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The work presented in this chapter has been previously published in the Journal of 
Nanobiotechnology (Keirouz et al., 2020b), presented with two oral abstracts, at the 
Electrospin 2019, 6th International Conference on Electrospinning, in Shanghai, China and the 
BioMedEng19 Conference, in Imperial College, London, United Kingdom, and as a poster 
presentation at the Engineering School's Postgraduate Research Conference 2019, 
Edinburgh, United Kingdom (Appendix B). 
 
6.2 Methodology 
For a full description of the materials and methods used, please see the following sections in 
Chapter 3:  
• Literature Review 
• Information about the polymers used for the development of the hernia mesh construct 
(Section 2.8.2) 
• Antimicrobial agents (Section 2.8.3) 
• Materials (Section 3.3) 
o Lists of materials, cells, suppliers, and equipment (Section 3.3.2) 
 
• Scaffold characterisation (Section 3.4) 
o Scanning electron microscopy (SEM) (Section 3.4.1) 
o Transmission electron microscopy (TEM) (Section 3.4.2) 
o Fourier-transform infrared spectroscopy (FTIR) (Section 3.4.3) 
o X-ray photoelectron spectroscopy (XPS) (Section 3.4.4) 
o Mechanical testing (Section 3.4.5) 
o Thermogravimetric analysis (TGA) (Section 3.4.6) 
o Differential scanning calorimetry (DSC) (Section 3.4.7) 
o Water contact angle measurements (WCA) (Section 3.4.8) 
o In vitro drug release studies (Section 3.4.10) 
 
• Antimicrobial testing on S2 pathogenic bacterial strains (Section 3.6) 
o Disc diffusion susceptibility testing (Section 3.6.1) 
o Bacterial growth kinetics using spectrophotometry (Section 3.6.2) 
o Fluorescence and confocal microscopy (live/dead assay) (Section 3.6.3) 
o Fixing bacteria for SEM imaging (Section 3.6.4) 
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Details of the chapter-specific experimental methods are described, in detail, below. A 




Figure 6.1. Schematic diagram depicting the fabrication methodology used to produce the 
core/shell PA6-PHMB/CS-5CLO8Q nanofibrous mats and the subsequent experimental and 
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6.2.1 Solution preparation 
Master solutions were prepared by dissolving 3% (w/v) total concentration of CS/PEO, at an 
80/20 CS:PEO (w/w) ratio, in 50% (v/v) aqueous acetic acid and 21% (w/v) PA6 in formic acid. 
For simplification and clarity, throughout this research chapter, CS:PEO is referred to as CS. 
All the CS solutions electrospun to formulate fibres (including core/shell, drug-free and drug-
containing NFs) consist of CS:PEO 80/20 (w/w). Then, 15% (w/w) 5CLO8Q and 0.3% (w/v) 
PHMB of the total polymer weight of the CS and PA6 solutions, respectively, were added and 
thoroughly mixed using a vortex mixer. The solutions were placed on a shaker, at  200 rpm, 
and left overnight at room temperature to obtain homogeneous solutions. 
 
6.2.2 Co-axial electrospinning 
A parametric study was conducted, until the appropriate polymer solution concentration, 
CS:PEO proportion within the blend, solvent system and electrospinning parameters were 
determined to obtain homogeneous nanofibrous mats, of consistent fibre diameters, with a 
standard deviation of less than 10%, as assessed by SEM. Several short-listed polymers and 
solvent systems were initially explored as suitable candidates for the core material, based on 
their compatibility with shell material (CS) during the formation of the core/shell Taylor cone 
and the jet’s stability during electrospinning. The other polymers that were assessed before 
selecting PA6 were PLLA, PCL, and TPU. The PA6/CS (CS, 85/100 deacetylation degree) 
system, was ultimately chosen to develop the bicomponent NFs, due to the good solvent 
system compatibility, stable Taylor cone formation, and excessively assessed in literature, 
biocompatibility of the two polymers. The process is illustrated in Figure 6.2, and a photograph 
of the setup can be found in Appendix A: Figure A-15. 
The CS and PA6 solutions were electrospun using a horizontal electrospinning setup, with 
a 0.9-mm diameter co-axial feeding nozzle for the shell and 0.57-mm diameter nozzle for the 
core, inserted concentrically to the shell solution’s needle. The fibres were deposited onto 
cellulose-based baking paper, which was mounted on a collector, rotating at 500 rpm. The 
solutions were fed into the core-shell needle, via two separate automatic pumps. The flow rate 
was set to 2.5 µLmin-1, for the core, and 5 µLmin-1, for the shell solution. Single CS-5CLO8Q 
and PA6-PHMB, in addition to CS and PA6 solutions alone, were also electrospun, using a 
0.58-mm needle (8 µLmin-1 flow rate). For all of the experiments conducted, the distance 
between the tip of the nozzle and the surface of the collector was set to 20 cm, and 
electrospinning was conducted under a potential difference of 22 kV (+18 kV nozzle, -4 kV 
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collector), using a DC power supply, at a 0.1 mA current. The relative humidity was maintained 
between 15%–20%, and the temperature was kept between 20–22 °C, using a climatic 
chamber. In order to produce uniform, nonwoven, electrospun mats, each experiment ran for 
4–6 h.  
 
 
Figure 6.2. Schematic representation of the co-axial, electrospinning setup used for the 
production of core/shell PA6-PHMB/CS-5CLO8Q nanofibrous membranes. The core to shell feed 
rate was 2.5 to 5.0 µLmin−1, with potential difference set to 22 kV (+18/-4 kV), and working 
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6.3 Results and discussion 
6.3.1 Electrospun fibre morphology and core/shell structure 
All electrospinning experiments were optimised in terms of the electrospinning parameters 
(humidity, temperature, flow rate, the distance between the tip of the needle and the collector, 
potential difference, and needle diameter), as well as by tailoring the solution parameters 
(blend ratio, molecular weight, polymer concentration, viscosity, solvent system selection, and 
compatibility) through the performance of parametric studies. The electrospinning system 
produced jets of single and core/shell fibres from a stable Taylor cone, in a continuous and 
homogenous manner.  
The morphologies and corresponding fibre-diameter distribution plots of the electrospun 
NFs are shown in the micrographs in Figures 6.3 and 6.4, respectively. To improve the 
homogeneity and fabrication throughput of the CS NFs during the electrospinning process, an 
80:20 (w/w) ratio of CS:PEO was added directly to the dissolved CS polymer solution, in all 
the experiments [9]. As CS is a polycationic polymer, in an aqueous solution, the 
electrospinnability of the polymer solution quickly becomes unstable due to polyelectric effects 
[10]. Numerous studies have shown that the repulsive forces between the ionic groups found 
on the chitosan backbone become stronger during the electrospinning process, affecting the 
homogeneous production of fibres [11]. The addition of PEO as a backbone carrier polymer, 
reduces the repulsion of the CS chains, due to the formation of H-bonds between the –OH of 
PEO, which acts as a proton acceptor for the water molecules within an aqueous solvent 
system [10]. This reaction ultimately reduces the polyelectric effect and increases the degree 
of backbone chain entanglement, allowing for continuous and stable fibre production.  
The SEM analysis (Figure 6.3) demonstrated that all of the produced fibres showed 
smooth morphologies, with no beads or major secondary artefacts and a randomised fibre-
matrix architecture. For all groups, the fibres appeared to be uniformly distributed. All scaffolds 
revealed randomly oriented fibres that were collected on a rotating collector, at a low speed 
(500 rpm). A collector drum can be used at low rotation speed to improve the deposition of 
fibres on the collector surface, thus increasing the efficiency of fibre collection during the 
electrospinning process [12].  
A randomised ECM-like matrix morphology was retained by appropriately adjusting the 
polymer concentration, potential difference, flying pathway (the distance between the needle 
and the collector) and the rpm of the rotating collector. 
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Figure 6.3. Nanofibre structures and surface morphologies of the electrospun mats. (a) 
Macrograph of the electrospun mat. SEM micrographs of (b) CS, (c) PA6, (d) CS-5CLO8Q, (e) PA6-
PHMB, and (f) core/shell PA6-PHMB/CS-5CLO8Q electrospun mats. (g–i) TEM micrographs of 
the core/shell PA6-PHMB/CS-5CLO8Q nanofibrous mats. (Core to shell feed rate: 2.5 to 5.0 
µLmin−1). 
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Figure 6.4. Fibre diameter distributions of the electrospun (a) CS, (b) PA6, (c) CS-5CLO8Q, 
(d) PA6-PHMB, and (e) core/shell PA6-PHMB/CS-5CLO8Q nanofibrous mats. 
 
As illustrated in Figure 6.3b, homogenous, bead-free CS NFs, with an average fibre 
diameter of 101 ± 12 nm, were successfully developed. PA6-only NFs (Figure 6.3c) presented 
the smallest fibres, with an average fibre diameter of 88 ± 11 nm. Interestingly, CS NFs that 
contained 15% (w/w) 5CLO8Q (Figure 6.3d), with a mean fibre thickness of 210 ± 31 nm, were 
twice the diameter of the drug-free CS NFs, under the same electrospinning parameters. The 
addition of 5CLO8Q to the solution further upsurges the polycationic charges of the backbone 
chitosan chain, which can additionally influence both Ohmic flow and convective flow, affecting 
the electrospinning behaviour. Similarly, PA6 NFs that contained 0.3% (w/v) PHMB                      
(Figure 6.3e) had an average diameter of 181 ± 22 nm, which was twice as thick as the drug-
free PA6 NFs (88 ± 11 nm). Fibre thickness is generally influenced by the electrical 
conductivity of the polymer solution. Here, the addition of antimicrobial substances increased 
the electrical conductivity, resulting in the production of thicker fibres [13].  
The drug-containing core/shell PA6-PHMB/CS-5CLO8Q NFs (Figure 6.3f) had a slightly 
larger average fibre diameter than their single-drug containing counter-polymers, at 270 ± 68 
nm. Compared with fibres made from single polymer solutions, co-axial electrospinning has 
been demonstrated to increase the overall solution concentration (of the two separate polymer 
solutions) on the Taylor cone, which increases the overall fibre diameter [11]. The porosity 
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was consistent at approximately 80%–90% for all of the produced nanofibrous scaffolds. The 
morphological properties of the electrospun mats are summarised in Table 6.1. 
The electrospun membranes weighed between 5–10 g.m-2 falling within the extra-light 
region of the ultralight-weight (≤ 35 g.m-2) classification of hernia meshes, which are 
associated with reduced post-operative pain and long-term foreign body sensation [1, 3]. 
 
Table 6.1. The morphological properties of the single and core/shell electrospun mats. 
Electrospinning was performed at 22 kV potential (+18/-4 kV), from a needle tip-to-collector 











PA6-PHMB 8.0 181 ± 22 4.05 ± 1.5 90 ± 3.2 
CS-5CLO8Q 8.0 210 ± 31 1.83 ± 0.6 80 ± 4.5 
PA6-PHMB/CS-5CLO8Q* 2.5 / 5.0 270 ± 68 1.56 ± 0.5 80 ± 4.4 
Nylon-6 (PA6) 8.0 88 ± 11 1.54 ± 0.6 90 ± 1.8 
Chitosan (CS) 8.0 101 ± 12 1.08 ± 0.3 91 ± 2.3 
*Core/shell nanofibres. 
 
The TEM analysis of the core/shell NFs was conducted by depositing electrospun fibres 
directly on to TEM grids, in a thin layer. The obtained micrographs can be observed in Figure 
6.3 (g–i). A distinct morphology was observed, in which a continuous CS phase was apparent 
in the shell of the fibres, surrounding a discontinuous PA6-PHMB phase, presenting unique, 
consistent, and well-distributed PA6 particles along the core of the fibres, possibly due to 
differences in the electric field-induced phase separation and surface tension between the two 
materials. In this work, this unique fibre structure, which is described for the first time in 
literature as a single-step formulation process, is referred to as “beads-in-fibres” architecture. 
Kinetic factors associated with rapid solvent evaporation, caused by differences between the 
solvent-systems used for the core and shell polymer solutions, may also have played key roles 
in the formation of this structure [14, 15]. Polymer solutions with concentration below the 
corresponding polymer entanglement concentration (φ0) have also been previously shown to 
yield electrospun NFs with beads-on-a-string configurations, caused by the jet's increased 
volatility and related to Rayleigh instabilities [16]. This morphology may also indicate that the 
core-material was encapsulated independently and phase-separated from the matrix wall of 
the shell material. To further evaluate this unique structure, core/shell NFs were also produced 
using different flow rates, under the same electrospinning parameters; however, no changes 
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in the morphological configurations of the core were observed, unaffected of the flow rates 
used, as shown in Figure 6.5. 
 
 
Figure 6.5. TEM micrographs of the PA6-PHMB/CS-5CLO8Q core/shell NFs formulated using 
various flow rates, under the aforementioned electrospinning and solution parameters. Core to 
shell feed rate of (a) 3.0 to 6.0, (b) 5.0 to 8.0, and (c) 5.0 to 10.0 µLmin-1. 
 
Water contact angle (WCA) measurements were determined to evaluate the wettability 
properties of the core/shell NFs, which represents an important parameter for determining the 
drug-release kinetics and antimicrobial behaviours of NFs. The results presented in Figure 6.6 
indicated that the CS NFs that contained 5CLO8Q presented a WCA of 66° ± 9°, compared 
with 75° ± 5° for the drug-free CS NFs. As expected, the addition of PHMB to the PA6 NFs 
increased the hydrophobicity of the produced scaffolds, likely due to the inherent 
hydrophobicity of the pure PHMB compound. The core/shell NFs presented the lowest contact 
angle, 50° ± 8°, which indicated that the composite structure presents improved wettability 
properties compared to the other examined fibres. Similarities between the core/shell and the 
CS-5CLO8Q NFs, in terms of pore area, and the improved pore distribution of the core/shell 
NFs may play key roles in improving the wettability of the composite structure. Several studies 
have demonstrated that hydrophilic NF surfaces may encourage better eukaryotic cellular 
attachment behaviours and improved proliferation than hydrophobic surfaces [17]. Hydrophilic 
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surfaces have been demonstrated to provide better binding sites that incite cellular adhesion, 
leading to more efficient scaffold expansion, thus making them suitable substrates for cell 
growth [18]. Interestingly, the adhesion of bacterial cells on hydrophilic materials has been 
shown to be influenced by the surface energy of the media (peritoneal fluid, blood, etc.) in 
which the bacteria are suspended; however, the surface energy of most media is substantially 
inferior to the native bacterial surface energy [19]. In general, bacteria attach widely to 
moderately hydrophobic surfaces with lower surface energies [19]. Furthermore, increasingly 
hydrophilic substrates present low zeta potential values, which limit bacterial binding by 
introducing repulsive interactions [20]. 
 
 
Figure 6.6. Water contact angles of the electrospun NFs, both with and without antimicrobial 
agents, and the drug-containing core/shell nanofibres. Error bars = standard deviations, where 
star symbol indicates a significant difference between the core/shell NFs and the other groups, 
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6.3.2 Chemical composition of the core/shell electrospun NFs  
FTIR spectroscopy was performed to characterise the functional groups present on the CS-
5CLO8Q, PA6-PHMB, and core/shell nanofibrous mats (Figure 6.7). The IR spectrum of the 
CS-5CLO8Q fibres indicated the presence of a broad band between 3150–3500 cm-1, which 
is characteristic of –OH stretching and the –NH stretches associated with primary amino 
groups (Amine I). Intermolecular –OH and –CH2OH hydrogen bond interactions between 
5CLO8Q and CS can explain the broadness of the band in the region corresponding to 3380–
3420 cm-1 [21]. The peak observed at 2867 cm -1 can be attributed to –CH stretching, whereas 
the peak at 1557 cm−1 may correspond to amide II C–N stretching, coupled with –NH in-plane 
deformation [22]. The sharp bands present near 1033 cm -1 may refer to –C–O–C stretching of 
the polysaccharide [23]. Based on the region-specific spectral scans (2000–1200 cm-1), the 
amide I characteristic C=O stretching of the N-acetyl group of the CS backbone is apparent at 
1651 cm-1 (Appendix A: Figure A-16a). The peaks at 1414 cm−1 and 1367 cm−1 may 
correspond to the bending of –CH2 and –OH, respectively. For comparison, the FTIR spectra 
of the pristine antimicrobial substances; 5CLO8Q and PHMB can be found in Appendix A: 
Figure A-16b. 
The PA6-PHMB spectrum presented a strong band at 1639 cm -1, which corresponds 
to C=O stretching, whereas the peak at 1542 cm−1 clearly corresponds to the characteristic in-
plane N–H bending of amide groups. The weak trans amide conformations between 1310–
1350 cm-1 and 1440–1490 cm-1 indicated that the amide region is in a gauche-conformation 
[23, 24]. The two medium peaks at 2930 and 2855 cm -1 represent C–H stretches of the 
polyamide backbone. In addition, the peak at 1263 cm-1 can be attributed to the amide’s C–N 
stretching. 
The spectrum of the core/shell PA6-PHMB/CS-5CLO8Q NFs confirmed the presence of 
both polymers in the final composite structure. All the characteristic peaks of the two polymers 
were present at the spectrum of the core/shell structure. The –NH stretching appears to have 
been slightly broadened and less intense, at 3292 cm -1, which could be due to hydrogen bond 
interactions between the two polymers. The C=O and –CH stretches of the polyamide 
appeared to remain stable, at 1638 and 1542 cm -1, respectively, but at lower intensities. All of 
the CS-specific absorption bands appear to be present in the core/shell nanofibrous mats but 
at lower intensities. No new peaks were observed for the composite core/shell structure. 
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Figure 6.7. FTIR-ATR spectra of the produced (a) core/shell, PA6-PHMB and CS-5CLO8Q drug-
containing NFs, and (b) drug-free 3% (w/v) CS [CS:PEO at 80:20 (w/w)] NFs, 21% (w/v) PA6 
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6.3.3 Surface chemistry of the core/shell PA6-PHMB/CS-5CL8Q 
NFs 
An XPS analysis, incorporating an information depth of approximately 10 nm, was conducted 
to determine and compare the elemental composition of the electrospun NFs surface and to 
further support the measurements obtained by TEM in regard to the core/shell structure. The 
survey scans for CS-5CLO8Q, PA6-PHMB, and the core/shell NFs are presented in Table 6.2           
(Appendix A: Figure A-17, A-18). The PA6-PHMB and CS-5CLO8Q NFs were evaluated 
based on theoretical values. Effectively, the core/shell fibres appeared to feature similar values 
to those determined for CS, with high atomic content of O1s and lower N1s contents, as 
opposed to the PA6-PHMB fibres. Further, chlorine (Cl 2p), a selective element found in 
5CLO8Q, was not apparent in the CS-5CLO8Q or core/shell fibres, indicating the successful 
entrapment of the antimicrobial substance towards the CS core (XPS delivers information of 
the top 10 nm layer). The 1.3% increase in the amount of nitrogen present in the core/shell 
composite, compared with the nitrogen contents of CS-5CLO8Q, could denote small 
irregularities at the fibre surface, due to the stabilisation period of the Taylor cone during the 
co-axial electrospinning process. Finally, high-resolution scans of the C1s binding energies of 
the core/shell NFs (Table 6.3) revealed the same carbon bonding structures with the CS-only 
NFs (margin of error 10%) further confirming the successful interruption of PA6 within the core 
of the fibres. 
 
Table 6.2. Surface chemical compositions of the electrospun NFs. The percentages in brackets 
refer to the theoretical values of each polymer. 
Fibres 
(group) 
C1s N1s O1s 
























(75) (13) (12) 
Core/shell* 284.5 65.8 398.1 4.2 530.8 30.0 
CS-only 284.5 72.3 399.1 2.1 530.8 25.6 
PA6-only 284.4 77.0 399.0 11.3 532.3 11.9 
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Table 6.3. XPS analysis of the carbon C1s binding energies.  
Bending Energy (eV) Group Peaks 
(Bond) 
Chitosan-5CLO8Q 
At. Conc. (%) 
284.5 C-C, C-H 23.1 
285.5 C=O 22.3 
286.5 C-N, C-O 54.6 
eV Group Nylon-6-PHMB 
 At. Conc. (%) 
284.4 C-C, C-H 68.5 
287.3 C=O 16.4 
285.4 C-N 15.1 
eV Group Core/Shell* 
 At. Conc. (%) 
285.7 C-N, C-O 47.2 
286.3 C=O 25.0 
284.2 C-C, C-H 27.8 
*Core/shell is PA6-PHMB/CS-5CLO8Q. At. Conc. (%) = atomic concentration (%). 
 
6.3.4 Thermal properties and PA6 content within the core/shell 
NFs  
Owing to the distinct thermochemical behaviours of CS and PA6, comprehensive thermal 
analyses were performed, employing TGA (Figure 6.8) and DSC (Figure 6.9). In addition, 
quantitative analysis was conducted to evaluate the amount of PA6 present within the core of 
the core/shell NFs. Table 6.4, at the end of the section, outlines the thermal properties of the 
produced electrospun membranes containing the antimicrobial substances, in addition to the 
drug-free NFs and raw materials.  
The Flory-Huggins theory explains that the compatibility and miscibility of polymer blends 
depend on the potential of the mixed polymers to form coherent hydrogen bond interactions 
[25]. Steric impacts and the hydrogen bonding intensity play vital roles in defining the 
compatibility and thermal properties of the core/shell NFs [25]. 
The CS powder (deacetylation rate 85/100) used in this study consisted of polymer chains, 
varying in length from 200,000 to 300,000 gmol-1 (according to the manufacturer's 
specifications). According to the TGA results, raw chitosan (85/100) exhibited degradation in 
two phases, with a first broad peak at approximately 100 °C, which can be attributed to the 
loss of bound water moisture vapour, desorbed by the CS backbone. In general, CS is known 
for its high tendency to form hydrogen bonds, often becoming even more hygroscopic when 
blended with other polymers [26]. The second degradation phase began at 208 °C and can 
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be ascribed to the mass loss associated with polymer dehydration and the formation of 
hydrogen bonds in the saccharide rings [27]. 
 
 
Figure 6.8. TGA analysis of (a) the pristine CS powder, PA6 pellets, PEO powder, 5CLO8Q powder, 
PHMB powder, and the drug-free nanofibrous mats consisting of 3% (w/v) CS [CS:PEO at 80:20 
(w/w)] (CS NFs) and 21% (w/v) PA6 (PA6 NFs); (b) the drug-containing core/shell, CS-5CLO8Q 
and PA6-PHMB NFs. 
 
The electrospun blends containing CS-only [CS:PEO at 80:20 (w/w)] presented a 
decomposition peak, at 260 °C, whereas PEO powder exhibited an onset degradation, in one 
step, at 340 °C. The pristine PA6 pellets used to prepare NFs had a melting temperature (Tm) 
at 224 °C, whereas PA6-only NFs showed less mobile polymer chains, with an increased Tm 
at 231 °C. The PA6-PHMB NFs appeared to have been influenced by the presence of PHMB, 
which has been reported in the literature to have a Tm at 205-210 °C, [28] leading to a more 
mobile PA6 chain configuration, with a Tm at 218 °C. 
The onset of PA6 degradation was observed at 365 °C, whereas the onset of PA6-PHMB 
NF degradation was observed at 340 °C. The core/shell NFs presented two degradation 
phases, observed at 58.8 and 214 °C, which are similar to the PEO and PA6 temperature 
configurations, respectively. Furthermore, the core/shell NFs exhibited melting onsets at 240 
°C and 365 °C, which are similar to the initial decomposition temperatures observed for CS-
5CLO8Q and PA6-PHMB, respectively. 
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Figure 6.9. DSC analysis of (a) the pristine CS powder, PA6 pellets, PEO powder, 5CLO8Q powder, 
PHMB powder, and the drug-free nanofibre mats composed of 3% (w/v) CS [CS:PEO at 80:20 
(w/w)] (CS NFs) and 21% (w/v) PA6 (PA6 NFs); (b) the drug-containing core/shell, CS-5CLO8Q 
and PA6-PHMB NFs. 
 
Changes in the crystallinity of the electrospun NFs were investigated by DSC. The glass 
transition (Tg) of pure CS has been described very vaguely in the literature, with values ranging 
from -23 to 220 °C, due to its semi-crystalline nature and variations in the ratios of intra and 
intermolecular hydrogen bonds that occur in the polysaccharide as the polymer decomposes                  
[29, 30]. In this study, the Tg of pure CS (85/100) powder was determined, displaying an 
endothermic peak at 203 °C, which agrees with previously published work performed using 
96% deacetylated chitosan of a similar MW [31]. Similarly, CS-5CLO8Q NFs showed no 
apparent changes in their Tg values, compared to the CS-only NFs. 
The pristine PA6 pellets presented a Tg at 60 °C, coming into agreement with the 
manufacturer's report (Sigma-Aldrich). The Tg values of the PA6-only and PA6-PHMB NFs 
were determined to be 50 and 47 °C, respectively, indicating a slight decrease. This could be 
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attributed to the nanofibrous configuration increasing the chain mobility in the amorphous 
phase, and due to the integration of PHMB affecting the reorganization of the PA6 chains [32]. 
The composite PA6-PHMB/CS-5CLO8Q core/shell NFs presented an evident change in 
Tg (equal to an approximate 11 °C increase), with an exothermic peak at 214 °C. This 
significant increase in the Tg value for the composite core/shell structure can be attributed to 
possible intermolecular interactions and folding rearrangements that occur among the CS 
polymer chains, along the PA6 core [33, 34]. Furthermore, dissimilarities in the nucleation and 
growth of crystallisation between the core and shell material may have also influenced the Tg 
transition [24]. 
Based on the enthalpy change (ΔHm), assuming that the values for PA6 and the core/shell 
PA6-PHMB/CS-5CLO8Q NFs correspond to the polyamide melting enthalpy, it was feasible 







× 100                              (6.1) 
 
where ΔHm(core/shell) and ΔHm(PA6) represent the heat of fusion values for the core/shell and                     
PA6-PHMB electrospun mats, respectively. The proportion of PA6 within the cores of the fibres 
was determined to be 48.5%. 
 
 
Table 6.4. Thermal properties of the electrospun nanofibrous scaffolds. All chitosan solutions 
were made as 80:20 (w/w) CS:PEO. The values in parenthesis ( ) refer to transitions of the 
composite fibres, corresponding to the PEO present within the CS blends. 
Sample Tm (°C) ΔHm (J/g) Tg (°C) Tonset (°C) 
CS-5CLO8Q (NFs) (58.4) (83) 203 240 
PA6-PHMB (NFs) 218 188.4 47 340 
Core/shell* (NFs) (58.8), 226 (54.5), 91.4 214 285 
CS-only (NFs) (60) (101) 203 260 
CS 85/100 (powder) --- --- 200 290 
PA6-only (NFs) 231 180.5 50 340 
PA6 (pellets) 224 305 60 365 
PEO 900K Da (powder) 70 168 -65 340 
Abbreviations: Tm, melting temperature. ΔHm, heat of fusion. Tg, glass transition temperature. Tonset, 
decomposition onset temperature. *Core/shell is PA6-PHMB/CS-5CLO8Q 
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6.3.5 Mechanical characteristics of the produced core/shell NFs 
The mechanical properties of the CS-5CLO8Q, PA6-PHMB, and core/shell NFs are shown in 
Figures 6.10 and Table 6.5. As demonstrated by the representative stress/strain curves shown 
in Figure 6.10a, the addition of PA6 within the core of the core/shell NFs successfully improved 
the overall mechanical stability of the construct. 
The CS-5CLO8Q and PA6-PHMB nonwoven electrospun mats presented an ultimate 
tensile strength (UTS) of 7.3 ± 1.4 MPa and 11.6 ± 0.7 MPa, respectively. The UTS of the 
drug-free electrospun mats were similar to those for the drug-containing NFs, whereas the 
UTS of the thicker-in-diameter core/shell NFs outperformed the single polymer fibres, at                       
20.7 ± 2.5 MPa. The PA6-PHMB NFs presented the highest fracture strain at 36.3% ± 7.5%, 
whereas the PA6-only NFs appeared to be stiffer, with an elongation-at-break at                                         
20.3% ± 2.8%, likely due fibre-to-fibre interaction variations associated with differences in the 
fibre diameters among the two groups. The core/shell NFs appeared to be influenced by the 
presence of CS, and were stiffer than the PA6-PHMB group, with an elongation-at-break at 
14.1% ± 2.1%, which represented an improvement over the value of 10.4% ± 1.4% recorded 
for the CS-5CLO8Q electrospun mats. The Young's modulus of the composite core/shell fibres 
demonstrated a four-fold increase, to 217.5 ± 12.6 MPa, compared with 50.3 ± 5.4 MPa and 
41.0 ± 8.8 MPa, for CS-5CLO8Q and PA6-PHMB, respectively. 
The mechanical properties identified for the electrospun PA6-containing NFs agree with 
those reported in previously published studies [35]. However, PA6 nanofibrous mats produced 
via electrospinning appear to be inferior to those produced by microfibre fabrication 
techniques, such as melt spinning, which may be due to the lower degree of chain orientation 
that occurs during the formation of asymmetrically electrospun (as-spun) NFs [36, 37]. Further 
investigations of single fibres and fibre-to-fibre friction properties could provide additional 
insights. The relatively low mechanical properties of the as-spun CS-containing nonwoven 
mats also concur with previous stress/strain studies that examined NFs produced from CS 
blends that incorporated PEO [37, 38]. Interestingly, the tensile properties of the core/shell 
NFs exceeded those for both CS and PA6.  
Composite NFs present higher tensile strengths than their single-component counterparts, 
potentially due to improved molecular orientations and conformations, increased crystallinity, 
and increased intermolecular interactions [37]. The produced bicomponent NFs displayed 
increased fibre diameters relative to the single-polymer fibres, a morphological trait that plays 
a critical role in improving the mechanical stability of composite fibrous structures [35, 36]. 
Additionally, energy dissipation, caused by the phase-separated "beads-in-fibre" morphology, 
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may also positively influence the toughness of the composite fibres [16]. These interactions 
may facilitate a better distribution of the energy crossing through the PA6-containing core, 
stabilising the CS-containing sheath, thus retarding its fracture. 
 
 
Figure 6.10. Mechanical properties (a) Representative tensile stress-strain curves of the drug-
containing, drug-free, and core/shell electrospun mats. (b) Ultimate tensile strength and (c) 
Young's modulus of the drug-containing and core/shell NFs. Error bars show the standard 
deviations. *** p < 0.001 and * p < 0.05. Core/shell represents PA6-PHMB/CS-5CLO8Q. 
 
Table 6.5. Overview of the mechanical properties of the electrospun scaffolds. 
Nanofibrous scaffold Ultimate Tensile 
Strength (MPa) 




Chitosan (CS) 6.6 ± 0.8 12.5 ± 4.1 50.5 ± 8.3 
Nylon-6 (PA6) 10.7 ± 0.6 20.3 ± 2.8 64.9 ± 7.8 
CS-5CLO8Q 7.3 ± 1.4 10.4 ± 1.4 50.3 ± 5.4 
PA6-PHMB 11.6 ± 0.7 36.3 ± 7.5 41.0 ± 8.8 
Core/shell* 20.7 ± 2.5 14.1 ± 2.1 217.5 ± 12.6 
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6.3.6 Drug release mechanism of the antimicrobial NFs 
Generally, electrospun NFs that are produced through the blending of a polymer with a drug 
typically display a rapid burst of the drug, released into the medium through small diffusion 
pathways, which can be influenced by the drug to polymer affinity and the solubility of the drug 
in the release medium [39]. In contrast, co-axially electrospun, drug-loaded systems allow for 
the encapsulation of antimicrobial agents within the fibre cores, increasing the diffusion 
pathway and, thus, retarding part of the initial burst and sustaining a more modulated release. 
The release kinetics were examined at pH 7.2 and 6.2 to resemble a physiological and a 
slightly more acidic environment that could exist in an intra-abdominal diseased bacterial 
infected tissue [40], respectively. 
 
6.3.6.1 The release kinetics of the single-drug containing NFs 
For the CS NFs containing 5CLO8Q, initial bursts of 7.1% ± 0.68%, at pH 6.2, and                             
6.3% ± 0.27%, at pH 7.2, were observed within the first 6 h of incubation, followed by the slow 
release of 15% of the total 5CLO8Q loaded within 14 days (Figures 6.11a). Quinolines are 
poorly water-soluble; and thus, strongly affected by the release media present in their 
surroundings. The release of 5CLO8Q from CS appeared to follow a non-Fickian release (n = 
0.81, at pH 7.2, and 0.85, at pH 6.2) pattern, based on the Korsmeyer-Peppas model 
(described in detail in Section 3.4.10), which indicated that CS erosion, swelling, and 
dissolution are critical for the release of 5CLO8Q. Furthermore, the entrapment of the 5CLO8Q 
molecule near the core of the CS fibres would also explain this phenomenon, as the XPS 
results did not identify the chlorine molecule, which can be found in the benzene ring of the 
5CLO8Q molecule, near the NF surface, which is supported by the hydrogen bonding 
interactions observed between CS and 5CLO8Q, based on the FTIR analysis. The same 
pattern, as expected, was observed for the 5CLO8Q present in the core/shell NFs, as the 
antimicrobial agent was present within the CS-sheath. The 60-nm difference in fibre diameter 
between the CS-5CLO8Q and core/shell NFs did not appear to affect the release profile of the 
5CLO8Q. 
In the PA6 NFs that contained PHMB, the release of the antimicrobial substance appeared 
to be strongly affected by the pH of the medium (Figure 6.11b). At pH 7.2, a burst release, 
corresponding to 56.7% ± 3.20%, was observed during the first 6 h, and 100% of the PHMB 
contained by the fibres was released within 4 days. However, at pH 6.2, an initial release of      
30.6% ± 2.70% occurred during the first 6 h, with 63.5% ± 1.20% of the contained drug being 
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released within 14 days. The release of PHMB from PA6 fibres followed a Fickian diffusion 
pattern (n = 0.26, at pH 7.2, and 0.40, at pH 6.2). The cationic nature of the very basic 
biguanide molecules results in PHMB gradually becoming positively charged as the pH 
decreases. In an aqueous environment, the PHMB conformation alternates with the 
hydrophobic methylenic region facing inwards and the biguanide groups facing outwards [41]. 
Polyamides have been shown to be significantly affected by pH, and the isoelectric point 
identified at pH 7.2 shifts as the pH acidifies, due to pH-dependent protonation, which 
ultimately causes swelling when the pH exceeds the pKa of the polymer [42, 43]. The increase 
in the net charge of biguanides could ultimately shift the isoelectric equilibrium present at pH 
7.2, increasing the susceptibility of chemical interactions between the two molecules, retarding 
the release of PHMB at pH 6.2. 
 
 
Figure 6.11. Comparative cumulative release of (a) 5CLO8Q and (b) PHMB, from the 
antimicrobial CS and core/shell NFs, at pH 7.2 and 6.2. Error bars represent standard deviations. 
n = 6, derived from two independent drug release studies, conducted using fibre mats from 
different electrospinning batches. *Core/shell is PA6-PHMB/CS-5CLO8Q 
 
6.3.6.2 The effect or the core/shell structure in the release of 
PHMB 
The core/shell NFs follow a release pattern for the PHMB loaded in the core, which does not 
appear to be not influenced by pH (Figure 6.11b). First, a small burst release occurs within the 
first 6 h, representing approximately 20.3% ± 2.2%, at pH 7.2, and 17.9% ± 4.6% at pH 6.2, 
of the encapsulated PHMB, which may be due to some proportion of the electrospun drug 
appearing near or at the surface of the core/shell fibres [44], as well as due to the presence of 
inconsistencies that may occur at the beginning of the electrospinning process. Afterwards, a 
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steady release was evident, at similar rates for both pH 6.2 and 7.2, over a period of 14 days, 
with a maximal release of 36.45% ± 3.5% at pH 7.2 and 40.2% ± 3.4% at pH 6.2. The core/shell 
NFs appeared to follow a non-Fickian release mechanism (n = 0.85, for both pH 7.2 and pH 
6.2), which confirmed that the CS present in the sheath governed the release of PHMB from 
the core/shell structure. The positively charged CS permits the absorption of water molecules 
and the simultaneous diffusion of PHMB into the release medium. Under this model and these 
conditions, assuming that CS undergoes a consistent level of degradation, we can estimate 
the complete, theoretical release of PHMB into the media within a period of 45 ± 5 days, at pH 
7.2, and within 36 ± 4 days, at pH 6.2. This modified-release delivery system consisting of the 
reduction of the initial burst release of the two antimicrobial agents, followed by the subsequent 
sustain release over the aforementioned periods, can provide the appropriate antimicrobial 
protection required by the system in the long-term, as well as at the onset, where a higher 
bacterial-load is apparent directly after the implementation of a mesh [3]. 
 
6.3.7 Antimicrobial activity of the single and core/shell NFs  
The antimicrobial effects of the electrospun NFs were investigated against S. aureus and                        
P. aeruginosa, the two most frequently encountered pathogens associated with mesh-specific 
SSIs. The growth inhibition zones, shown in Figure 6.12a, indicated no zone of inhibition for 
the PA6-only nanofibrous mats, whereas a zone of clearing, due to the accumulation of dead 
bacteria, was observed for the CS-only electrospun mats. Because the inhibitory potency was 
only apparent surrounding the borders of the CS-only discs, it was denoted that no chitosan 
derivatives were secreted into the surrounding area. 
The CS-5CLO8Q NFs showed the larger inhibitions zones against S. aureus, whereas the 
PA6-PHMB fibres presented the strongest inhibition against P. aeruginosa. The core/shell NFs 
appeared to be effective at inhibiting the growth of both bacterial strains. The polymer matrix 
material in which the biocide agent is incorporated largely impacts the degradation rate of the 
electrospun mat [45]. Therefore, the zones of inhibition for the composite core/shell NFs 
cannot be directly compared against those for the single polymer-drug systems examined, as 
the degradation rates differ, according to the polymer system composition and corresponding 
fibre properties. 
 Only a small fraction of studies that have investigated the effects of electrospun 
antimicrobial fibres have used P. aeruginosa, as it is much less susceptible to antibiotics and 
antimicrobial agents than E. coli, which is a Gram-negative, representative model organism 
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that has commonly been used in similar studies [46]. Different responses between these two 
strains are anticipated because they differ greatly in terms of structural morphology, shape, 
and metabolic responses. The inhibition zones indicated that the core/shell antimicrobial 
scaffold showed a less robust response against P. aeruginosa compared to S. aureus, but 
effectively presented clear zones of inhibition, even if less intense. 
To further evaluate and quantify the bactericidal responses of the electrospun mats, 12-h                   
real-time monitoring growth kinetic experiments (Figure 6.12b; S. aureus, Figure 6.12c; P. 
aeruginosa) were performed for each bacterial species assessed after being exposed on the 
electrospun membranes. S. aureus appears to be partially susceptible to the CS-5CLO8Q 
NFs, with a retarded growth time and lower optical density in comparison with the PA6-only 
and CS-only electrospun mats. Interestingly, the PA6-PHMB and core/shell NFs effectively 
suppressed the growth of the bacteria upon exposure to the antimicrobial NFs. The more 
resilient P. aeruginosa strain was not affected by the presence of the CS-only NFs, whereas 
the CS-5CLO8Q NFs resulted in reduced optical density compared with both the CS-only and 
PA6-only electrospun mats. The PHMB containing core/shell and PA6-PHMB NFs both 
successfully eliminated the growth of this Gram-negative bacteria, upon exposure.  
The bacterial kinetic experiments contradicted the inhibition zone observations, in which                
CS-5CLO8Q appeared to be the most effective for inhibiting the growth of the examined 
bacteria. This discrepancy may be due to CS-5CLO8Q electrospun mats being capable of 
secreting the antimicrobial substance onto solid-agar plates, thus repelling bacterial growth in 
the surrounding areas; however, the same fibres may be less effective in preventing bacterial 
growth when the bacteria are inoculated directly on the nanofibrous matrix surface. These 
results indicated the strong bactericidal activity presented by PHMB, even at low concentration 
[0.3% (w/v)]. The composite core/shell NFs appeared to completely halt the growth of the two 
pathogens, effectively displaying an anti-bacterial surface, due to the synergic antimicrobial 
activity of PHMB and 5CLO8Q. 
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Figure 6.12. Antimicrobial properties of the electrospun mats. (a) Macrographs of the disc 
diffusion test, with the corresponding radius values for the zone of inhibition below each image 
(presented as the mean ± SD). (b) S. aureus and (c) P. aeruginosa growth, reflected as optical 
density (OD600nm) over time, in the presence of the electrospun CS, CS-5CLO8Q, PA6, PA6-PHMB, 
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and core/shell NFs and negative control (no bacteria containing media). (d) Fluorescence 
microscopy assessments, via live/dead BacLight Syto9®/Propidium iodide (PI) bacterial viability 
assays. (e–f) The relative percentages of living (green) and dead (red) cells following exposure to 
the various groups of electrospun fibres, quantified according to the fluorescent intensity of 
microscopic images. All data are shown as the mean ± SD from two independent experiments (n 
= 6). *core/shell is PA6-PHMB/CS-5CLO8Q. 
 
The susceptibility of S. aureus and P. aeruginosa to the core/shell NFs were further 
evaluated through live/dead staining fluorescence microscopy, followed by the investigation 
of bacterial morphological characteristics, via SEM microscopy. Syto9 (green) penetrates 
bacterial membranes and binds to nucleic acid in both living and dead bacteria, whereas PI is 
impermeable to intact membranes and can only penetrate damaged bacteria to bind nucleic 
acid manner. As observed in Figure 6.12d, upon exposure to the antimicrobial NFs, the 
core/shell mats elicited the most potent bactericidal effect, with the majority of the dye binding 
to cytoplasmic nucleic acids exposed by damaged membranes. Figure 6.12(e-f) indicate the 
relative percentage of live/dead bacteria following 4-h exposure to the various electrospun 
mats, as quantified by fluorescent images, which indicated that exposure to the core/shell 
structure was the most effective for decimating the growth of the two bacterial species 
examined (≥ 98% bactericidal activity).  
The robust antimicrobial activity of the core/shell NFs was then compared against a 
bacteria-contaminated biologic mesh (Strattice®, porcine collagen-based), synthetic mesh 
(Parietex®, polyester-based), and CS and PLLA fibres, ranging between 1-10 µm and 450-
800 nm, in diameter, respectively. The Gram-negative, rod-shaped, E. coli (strain DSMZ 
30083) was used to compare the bacteria-contaminated materials via growth kinetics and 
Syto9-stained confocal microscopy. However, because the antimicrobial efficacy had already 
been assessed against the pathogenic bacterial strains, these assays were conducted to 
demonstrate the superiority of the bicomponent core/shell NFs over commercially available 
meshes and other textile fabrics. As can be observed in Figure 6.13, during the 12-h growth 
kinetics experiment, performed following the exposure of the various materials to E. coli for 2 
h, the core/shell NFs was the only tested material capable of completely preventing bacterial 
re-growth, followed by the CS 10-50 µm group, which was able to retard the exponential 
growth of E. coli for only 6 h. These findings further stipulate the ineffectiveness of the currently 
used hernia meshes to provide a form of antimicrobial protection. This note, based merely on 
the in vitro assessment performed in this study, does not take into account the innate immune 
system (that would have played a crucial role in attempting to prevent an infection from 
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settling), but rather solely highlights the lack of an active role towards the prevention of surface 
colonization and biofilm formation by prostheses today. 
 
 
Figure 6.13. Escherichia coli growth kinetics assessment on different textiles. Comparison of the 
core/shell NFs with variant forms of microfibres, a polyester-based hernia mesh, and a biologic 
hernia mesh. The bacteria growth on hernia meshes and other textile forms were assessed using 
E. coli. PLLA: poly (L-lactic acid). All data are shown as the mean ± SD from two independent 
experiments (n = 6). 
 
Finally, the SEM micrographs presented in Figures 6.14, which compare the PA6-only 
fibres with the core/shell antimicrobial NFs in the presence of S. aureus and P. aeruginosa, 
and the confocal Syto9® images of the variant materials exposed to E. coli, in Figure 6.15, 
indicate the distinct morphological differences that can be observed between healthy and dead 
bacteria upon exposure to electrospun mats and the inefficiency of the other tested materials 
to provide antimicrobial protection. The normal cocci and rod morphologies observed for S. 
aureus and P. aeruginosa, respectively, can be observed for these species on the PA6 NF 
surface. In contrast, characteristic cytoplasmic inclusions, indicating dead bacterial matter, 
were observed for bacteria exposed to the antimicrobial core/shell electrospun mats. 
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Figure 6.14. SEM micrographs of S. aureus and P. aeruginosa morphological properties upon 
exposure for 6 h to the electrospun core/shell and PA6 (control) nanofibrous mats. Red arrows 
indicate cytoplasmic inclusions, indicative of dead or membrane-damaged cells 
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Figure 6.15. Confocal laser scanning microscopy (CLSM) images of variant textiles, hernia 
meshes and the developed core/shell antimicrobial NFs after being incubated for 2-h with E. coli. 
The cells were stained with 5 µM SYTO9 live stain, and the images assessing bacteria attachment 
and infiltration on variant material surfaces were obtained with the 63x stack. The figure depicts 
images from three areas of one specimen per group. Scale bar, 20 µm. PET, Poly(ethylene 
terephthalate); PLLA, poly (L-lactic acid). 
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6.4 Conclusions 
In summary, a novel nanofibre-based antimicrobial system was successfully developed, by 
carefully selecting each constituent, tailoring the material properties, electrospinning 
parameters and fibre structure, resulting in the development of the core/shell PA6-PHMB/CS-
5CLO8Q NFs.  
The core/shell electrospun mats presented a homogeneous randomly oriented 
morphology, with a smooth fibre surface. For the first time in literature, in a single-step 
fabrication process, a consistent "beads-in-fibre" architecture was observed along the core of 
the bicomponent NFs, as determined by TEM imaging. The core/shell structure was further 
validated by assessing the surface chemistry and thermal properties of the composite NFs. 
This unique architecture gave the PA6 present in the core the right molecular configuration, 
and to the CS present in the shell the appropriate fibre morphology, to provide enhanced 
mechanical strength and elasticity to the composite structure, an essential feature for the 
development of a hernia mesh implant.  
The in vitro evaluation of antimicrobial activity via agar disc-diffusion testing, dynamic 
growth kinetics, live/dead staining, and SEM microscopy, illustrated that the composite 
nanofibrous system developed elicited strong bactericidal activity against S. aureus, P. 
aeruginosa and E. coli, which was in all cases superior to that presented by the other 
nanostructured groups developed, as well as micro-structured fibre-based textiles, including 
a synthetic and a biologic mesh currently used for hernia repair. 
The binary antimicrobial system presented spatiotemporal controlled release of the 
antimicrobial agents, which followed a non-Fickian release model, directed by the CS present 
in the shell of the structure. This study underlines strong antimicrobial properties of 5CLO8Q 
and PHMB, and their respective possibilities for the encapsulation, which can lead to tailor 
drug release kinetics. In addition, these findings advocate the great potential uses of the co-
axial electrospinning fabrication technique for the development of advanced NF-based drug-
delivery systems. Further, this study depicted the ineffectiveness of synthetic and biologic 
meshes in actively preventing bacterial contamination, through the assessment of two 
commonly used mesh material; a 100 USD polyester-based multifilament synthetic mesh, and 
a 35,000 USD collagen-derived reconstructive tissue matrix (biologic mesh).  
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The ultralight-weight bicomponent drug-eluting nanostructured antimicrobial hernia mesh 
designed in this study may ultimately be applicable for the prevention of bacterial infections 
related to prostheses while merging a new microarchitecture that falls between synthetic and 
biologic meshes. Further work will have to focus on assessing the compatibility of the system 
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7. Conclusions & Recommendations
7.1 Concluding remarks 
The central focus of this doctoral thesis was to explore material-oriented strategies to address 
existing challenges associated with (1) wound healing and (2) mesh-associated surgical site 
infections following hernia surgery. The project aimed to develop advanced, fibre-based 
biomaterials, at micro/nano-dimensions, with tuneable compositions, morphological, physical, 
mechanical, and biological properties.  
The specific objectives of this thesis were: 
1. The manufacturing of electrospun fibre-based composite biomaterials, by integrating
natural and synthetic polymer blends, with adjustable properties.
2. The evaluation of the impact of the electrospun scaffolds architecture regarding
physiochemical and mechanical stability, biocompatibility (in the case of skin-like
substitutes), and drug release profile and antimicrobial efficiency (in the case of hernia
meshes).
3. The design and build a nozzle-free electrospinning device intended to augment the
meagre fibre production associated with lab-based electrospinning equipment.
4. Assess the effect of the PGS proportion and degree of polymerisation towards the
mechanics and wetting properties of the composite scaffolds.
5. Describe the photocrosslinking of the PVP/PGS fibres in the presence of riboflavin.
6. Develop an alternative, straightforward, and rapid protocol for the extraction of silk
fibroin from Bombyx mori silkworm cocoons.
7. Compare the antimicrobial properties of the developed drug-eluting nanostructured
hernia mesh to those of commercially available prosthesis and other forms of textiles.
The fabrication process used for biomaterial design was the electrospinning technique, 
which is a fibre production method capable of formulating scaffolds with a microarchitecture 
that resembles the fibrillar configuration of the ECM of human tissues. 
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The research on which this thesis is based, investigated the microstructural, 
physicochemical, and mechanical properties of novel composite ECM-like scaffolds for use as 
skin substitutes and the influence of the fibroblast behaviours of these composites on cell 
adhesion, proliferation and morphology (Chapters 4 and 5). Subsequently, a nanofibrous, 
bicomponent, antimicrobial, hernia mesh, capable of facilitating the two-compartment release 
of antimicrobial substances, was designed and evaluated for its ability to attain the appropriate 
mechanics of a hernia mesh and to inhibit pathogenic bacteria from instigating infection 
(Chapter 6). 
The body of work conducted in this thesis successfully expands upon the field of 
biomedical engineering and fulfils the aforementioned aims and objectives, by expanding the 
applications of the electrospinning process for the development of advanced composite fibre-
based biomaterials. 
For clarity, the discussion and concluding remarks below separately address (1) the                  
high-throughput production of electrospun scaffolds designed to act as skin substitutes and 
(2) the co-axially electrospun, antimicrobial hernia mesh NFs designed to prevent bacterial 
adherence, colonisation and subsequent mesh-associated SSI. 
 
7.1.1 Conclusions regarding the skin-substitute, biomaterials 
Clinical constraints continue to hinder the development of efficient skin substitute products for 
the management of cutaneous wounds. Skin tissue engineering is a well-established and 
rapidly evolving field that presents multifaceted challenges. Several scaffolds have been 
developed during the past decades that offer therapeutic benefits or facilitate the regeneration 
capacities of injured skin. However, the development of a truly clinically viable, biomimetic 
biomaterial remains a necessary goal, as the scaffolds currently in use today present 
simplistic, non-biomimetic architectures that do not fulfil all the requirements or originate from 
human or animal xenografts/allographs or tissue-derived sources, a complicated and 
expensive process that carries its own limitations. Thus, advanced biomimetic scaffolds that 
can be produced efficiently and cost-effectively remain necessary to generate an environment 
that is conducive to tissue regeneration. 
This portion of the project focused on the production of polymer scaffolds that closely 
resembled decellularised skin, while simultaneously providing mechanical and structural 
integrity that facilitates cell attachment and proliferation. The wide array of physical and 
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biochemical attributes that must be met for a skin substitute to be effective has allowed for the 
exploration of many different avenues, combining various characteristics, in the search for the 
optimal technology. The nonwoven ECM-like scaffolds that were developed for this project, 
fabricated using the high-throughput, nozzle-free, electrospinning technology, demonstrated 
the feasibility and potential uses of electrospun biomaterials to address the challenges 
associated with skin grafting and tissue-derived skin substitution products, under many 
circumstances, by employing an alternative production route.  
 This is the first time reported that free surface electrospinning was successfully adapted 
to produce continuous microfibres deriving from trinary polymer blends, rather than single-
polymer solutions such as PCL, PVP and PVA. This key contribution is of significance as it 
demonstrates that it is feasible to high-throughput generate composite fibres out of more 
complex polymer systems, using a nozzle-free electrospinning device, something that has 
only been reported with conventional nozzle-based setups. 
The selected polymers used in these studies have been well-established in tissue 
engineering research due to their good mechanics, biocompatibility and biodegradability, ease 
of manufacturing, and low costs. However, many of the designed material systems 
subsequently posed difficulties associated with the complexity of material fabrication and 
characterisation. The positive effects of composite electrospun fibres compared with single-
synthetic-polymer material systems were illustrated for both of the material systems developed 
in these studies: PVP/PGS and PCL-backbone SF/(p)PGS.  
The benefits of the fibrous structure of the biomaterial systems were initially illustrated by 
the ability of the PVP/PGS fibres to better imitate a cellular microenvironment, which supported 
HDF growth and scaffold expansion. HDFs were found to adhere four times more efficiently 
on PVP/PGS electrospun mats than on PGS gels that lacked the ECM-like fibril complexity of 
the electrospun materials and the corresponding superiority in terms of physical and structural 
integrity.  
These properties were demonstrated microscopically when assessing the morphologies 
of HDFs grown on PCL-only fibres, which resembled spheroid, fibroblast-like cells, compared 
with cells grown on the trinary PCL-backbone SF/(p)PGS substrate, which presented a 
healthy, polygonal, spindle-shaped, elongated morphology. SF-containing scaffolds supported 
cell proliferation and viability, in vitro, to a significantly better degree than PCL-only fibres. 
In Chapter 4, elongation-at-break and Young’s modulus of the PVP/PGS fibres exhibited 
proportional relationships with the molecular weight of PVP and with the proportion of PGS 
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within the blends, such that PVP/PGS at 50:50 demonstrated a 20-fold increase in elasticity 
compared with the 80:20 group. As described in Table 2.1 (Chapter 2), which represents the 
skin’s tensile properties, this adjustable elasticity may be beneficial for future research in an 
animal model, to assess the effects of the various composite groups developed for use in 
wound closure applications for injuries induced at mechanically dissimilar anatomical sites. 
For instance, the more supple skin present in the arm could be assessed using the PVP/PGS 
60:40 group, whereas the stiffer anatomical regions, such as the forehead and the back, could 
be evaluated using the PVP/PGS 80:20 and 70:30 groups. Electrospun fibres present a very 
high aspect ratio making them much more malleable than other forms of biomaterials that are 
used for wound healing [6]. The ability to tune the mechanics of these scaffolds by simply 
adjusting the proportions of the two polymers while retaining their fibrous morphology is 
advantageous for skin TE applications and the replacement of dermal tissue, allowing the 
regulation of correct fate decisions among the cell populations during the wound healing 
process [1].  
The successful photocrosslinking of the PVP/PGS fibres facilitated the assessment of their 
biocompatibility with HDFs by retarding the otherwise rapid degradation of PVP by cellular 
media and represented a novel process, described for the first time in this thesis. Maintaining 
the integrity of the PVP/PGS fibres revealed that PVP/PGS 70:30 presented the most efficient 
adherence and proliferation properties.  
Cell attachment and proliferation were not found to depend on the fibre diameter or the 
proportion of PGS within the composite fibres, up to the point at which the scaffold’s fibrous 
morphology was lost. The PVP/PGS scaffolds that retained the fibrous morphology 
significantly improved cell-material interactions, cell adhesion on the material’s surface, 
proliferation and spreading. This comes into agreement with previously published works that 
compared solid PCL films with PCL fibres through cell culture and animal model experiments. 
Metwally et al. [2], attributed this incident to the better surface potential due to the fibrous 
topography — 574.4 ± 11.2 mV for PCL fibres, as opposed to 220.6 ± 6.7 mV PCL films) —and 
the increased roughness associated with the films. The PCL membranes adhesiveness was 
significantly improved for PCL fibres with cells present filopodia cells, as opposed to the films 
that presented spheroid cells with poor filopodia formation and weak adhesion. Denchai et al. 
[3] compared randomly-oriented PCL fibres with PCL cast films on the subcutaneous tissue of 
rats. The authors reported a significantly greater proportion of proinflammatory macrophages 
(M1) due to improved protein absorption, and subsequent exponential increase of pro-healing 
M2 macrophages that directed MSCs migration and differentiation, between days four and 
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seven. In the case of the PCL films, a large population of M1 cells was retained throughout 
the duration of the study. 
For both systems, variations in the fibre diameter (± 20%) within the same composite 
groups did not appear to have significant effects on the HDF attachment properties or cellular 
viability. However, viability appeared to correlate with the proportions of the subsequent 
polymers used within the composite structure. 
In Chapter 5, an SF-based biomaterial system, SF:PCL:(p)PGS, which integrated the 
regenerated SF with PCL to increase the structural integrity of the scaffold and contained two 
different polymerised forms of PGS, permitted the development of a composite structure with 
wettability properties that could be modulated and that presented good in vitro stability. The 
ability to adjust the hydrophobicity of biomaterials is crucially important for obtaining the 
appropriate conditions necessary for cellular adhesion, proliferation, and the reduction of 
inflammation [4, 5]. The fibrous topography of electrospun membranes has been found to 
significantly increase the material’s surface hydrophilicity compared to other topographies 
such as films [6]. 
The electrospun construct presented adjustable wettability properties due to the 
incorporation of PGS, which can be beneficial for the retention of a moist area and the uptake 
of wound exudates. Further, the sizes of the pores and porosity could contribute to a surface 
capable of reducing bacterial contamination from the external environment and, thus, 
diminishing the risks of infection. Furthermore, the addition of PCL generated more easily 
handled and stable construct, whereas the incorporation of silk fibroin increased the in vitro 
biocompatibility of HDFs. 
Biocompatibility was assessed by measuring metabolic activity, using Alamar blue®. 
Studies have shown that Alamar blue and MTT assays are equally suitable as high-throughput 
screening assays for the determination of cytotoxicity [7–9]. In this study, the Resazurin-based 
assay was found to be useful for determining cell viability and cell growth on electrospun 
membranes and provided consistency during the experiments. Cell viability was further 
assessed by examining cellular morphology and expansion, and consistency between imaging 
and assay-based techniques provided increasing confidence in the assessment. 
In this study, the skin fibroblast cell-line (BJ5ta; ATCC® CRL4001TM) donated for this work, 
was chosen as it was of human origin and economically viable because it required fewer media 
supplements. Unfortunately, no literature was identified using this cell-line for similar studies. 
Because the BJ5ta cells represent an hTERT-immortalised cell line, variations may exist in 
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the physiological attributes between those observed in primary cells and those presented by 
this continuous cell-line. Although these immortalised cells can retain critical morphological 
features, they tend to be more adherent, more readily viable, and, in some instances, express 
a broader range of chemokines and other markers [10]. However, for the scope of the work 
conducted and as a proof-of-concept study, this immortalised cell-line provided consistent and 
reproducible results for a genetically identical and homogeneous population of fibroblasts, 
which was deemed to be sufficient. 
 
7.1.2 Conclusions regarding the nanostructured drug-eluting 
antimicrobial hernia mesh 
This thesis also focused on the development of a nanofibre-inspired hernia mesh, designed 
to prevent infections caused due to mesh contamination. Here, for the first time in the literature, 
a bicomponent, nanofibrous system, comprised of chitosan and nylon-6, was used to 
demonstrate how the selected antimicrobial agents, 5CLO8Q and PHMB, can work 
synergistically to prevent bacterial colonisation on surfaces.  
This study was guided by a surgical team at the Innospital University Hospital, in Berne, 
Switzerland, which offered valuable insights regarding the significant challenges faced during 
and after hernia repair, and what is needed to overcome these challenges, from a surgical 
perspective. Currently, hernia meshes are made of natural (e.g., collagen) or synthetic 
materials (such as PP or PE) [11, 12]. As described in detail in the literature, biologic meshes 
can be costly, limited to the animal source, carry ethical challenges and complicated to obtain, 
whereas synthetic meshes are associated with a wide array of limitations, from material, 
biological, and mechanical standpoints. Today, there is no synthetic mesh that has been 
developed that is morphologically similar to biologic meshes, and able to provide antimicrobial 
protection, while retaining the appropriate mechanical requirements. 
The ultralight-weight bicomponent, nanofibrous, hernia mesh assessed in this study was 
developed through the co-axial electrospinning technique. The core/shell NFs produced, with 
an average fibre diameter of 270 ± 68 nm, incorporated a dual antimicrobial system with a 
nylon-6-core and biocompatible chitosan in the shell (on the fibre surface). A unique structure, 
consisting of a “beads-in-fibres” morphology, first time reported through a single-step 
fabrication process, was described and verified by TEM and XPS and by evaluating the 
enthalpy transition of nylon-6 between the core/shell and single nylon-6 NFs.  
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The drug release profile of the bicomponent nanofibrous mesh was obtained under the 
two most relevant pH conditions, while the drug release profile was described, in-depth. By 
finely selecting the polymer-drug combos, so that a hydrophilic polymer is paired with a 
hydrophobic drug and vice versa, the increased drug affinity allowed for the sustained release 
of the antimicrobial agents from two-compartments; the surface and the core of the NFs. 
The large surface area of nanofibrous membranes, and by increasing the diffusion 
pathways through the core/shell morphology, co-axial fibres have been proven to elicit 
controllable drug release profiles and improved bactericidal properties than loaded films [13, 
14] 
Finally, the effectiveness of the nanostructured composite system against S. aureus, P. 
aeruginosa and E. coli was thoroughly determined, through the assessment of inhibition 
zones, growth kinetics, live/dead staining, and microscopic evaluations, comparing the 
antimicrobial fibres against synthetic fibres, biologic and synthetic hernia meshes. The 
developed antimicrobial mesh presented a robust bactericidal activity across all the examined 
pathogens. The developed construct reported antimicrobial responses similar to porcine 
dermal graft (bioprosthesis) containing rifampin and minocycline (XenmatrixTM AB) and PP 
meshes coated with rifampicin and ofloxacin [15]. Nevertheless, the use of antimicrobial 
agents and antiseptics rather than antibiotics that steadily increase the emerge of new 
resistant subtypes of MRSA is a valid approach that can provide long-term protection against 
infection [16].  
The use of chlorhexidine and allicin through the soaking of PP meshes [17]  and triclosan-
chitosan combo in the form of PP-embedded gels [18] have reported partial bacteria clearance 
and three-log reduction of bacterial contamination, respectively, in the earlier works. However, 
the integration of the antimicrobial substances with the ECM-like nanotopography and 
improved drug release profile, given by the electrospun matrices, allows for the fabrication of 
synthetic-based meshes that accommodate antimicrobial protection, while retaining a 
biosynthetic-like morphology, which subsequent studies could prove to be overall beneficial 
towards the healing process of the fascia at the affected area. 
By comparing the nanostructured construct with different forms of commercially available 
prosthesis, the findings came into agreement with previously published appraisals [15, 19] that 
denote the inability of the available material system to provide active antimicrobial protection; 
a novel path expanding towards research surrounding implantable devices. 
The minimum inhibitory concentrations of the tested antimicrobial agents have previously 
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been assessed in the literature, reported at 0.2 gm·L-1 for PHMB [20, 21] and 0.4 gm·L-1 for 
5CLO8Q [22]. The antimicrobial activity of the composite antimicrobial NFs was robust – able 
to suppress the growth of the two pathogenic bacterial species (S. aureus and P. aeruginosa) 
that account for more than 90% of all infections reported on contaminated surgical meshes. 
The drug concentrations used in this study were based on regulations established by the FDA 
and the European Commission [22–24]. 
 
7.1.3 Research and experimental limitations 
This thesis has potential limitations that should be noted. Due to the nature of the research 
questions that were formed, and as the work was conducted at the Institute for Materials and 
Processes of the Engineering School, the material development and characterisation areas of 
the research prevail the in vitro assessment of the developed biomaterials. In addition, limited 
space at the Institute for Bioengineering facilities due to refurbishments and subsequent 
closure and reopening with limited capacity due to the COVID-19 pandemic, render the 
continuation of the in vitro assessment of the biomaterials using more advanced models. 
The use of a continuous cell-line rather than primary cells further limited the extent of the 
in vitro assessment. This was due to budget constraints. The initial research question behind 
the work conducted in Chapter 4, was built on observations made by Martino and Forte [25], 
Nasrollahi et al. [26], and the Dennis Discher’s group (Engler et al. [27]) surrounding cell 
lineage specification and differentiation, cellular mechanical memory and the ability of dermal 
cells to adapt and reconstruct the ECM at an injured site based on the mechanics of the skin.  
Initially, the electrospun membranes would have been seeded with primary fibroblasts, 
followed by identifying the various subpopulations through phenotypic characterisation, which 
would have allowed for the determination of the proportion and capability of the matrices to 
control fibroblast-to-myofibroblasts differentiation [28]. This can be done molecularly by 
quantifying the expression levels of α-smooth muscle actin (α-SMA), and, more recently, 
through the surface enzyme amine oxidase, copper containing 3 (AOC3) [29], as well as via 
fluorescence microscopy by staining the nuclei with DAPI, rhodamine-conjugated phalloidin for 
F-actin, and FITC-labelled anti–SMA [30]. Keratinocytes could have also been used to assess 
mobility and migration on the electrospun matrices. Through the cell culturing of macrophages, 
functional polarisation (M1/M2) could further be evaluated, which would be a great indicator 
of the ability of the biomaterial to regulate inflammation and avoid excessive collagen 
deposition, especially in chronic wounds [31, 32] 
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The degradation studies were conducted by submerging the electrospun mats in PBS at 
pH 7.2. This was done predominately as the pH was the same as the culture media. 
Nevertheless, this approach did not take into account scaffold degradation that could have 
been mediated by the 10% w/v FBS present within the culture media. In addition, intact skin 
presents a slightly acidic pH ranging from 4.0 to 6.0, while the pH fluctuates after a wound 
occurs, due to the skins acidic milieu, making it for a brief period — at the early stages of the 
wound healing process — neutral. On the other hand, the environment of a chronic wound is 
alkaline ranging between pH 7.2 to 8.9, with yet more alkaline environment being introduced 
after an infection has settled [33, 34]. Moreover, the degradation studies were assessed in 
room temperature; the human skin temperature varies and is generally a few centigrade below 
the body’s temperature at approximately 33 °C [35]. Considering these, further assessment of 
the polymer degradation and stability of the material systems should take into account 
enzyme-mediated degradation, alkaline and acidic pH values, as well as conditioning the 
media to skin-relevant temperature.  
As described in more detail in the future work section below, an animal study can affirm 
whether the reasoning behind the development of mechanically tuneable elasticities and 
variations in the hydrophilicity can positively impact the wound healing responses of the tissue 
and the contraction time, in vivo.   
In regard to the nanostructured hernia mesh developed, the most significant limitation of 
this study was the absence of an in vitro cell culture evaluation. This would have been of great 
importance towards the biomaterial’s biocompatibility, even in the form of simplistic 
toxicological evaluation. Unfortunately, while working in the S2 laboratory at Empa, access to 
the mammalian cell culture facilities was not granted concurrently due to anti-contamination 
regulations. However, the polymers used to produce the bicomponent core/shell NFs are 
considered to be biocompatible in the literature, and the tested concentrations of PHMB and 
5CLO8Q were based on existing guidelines and represent doses that do not elicit toxic 
responses. That said, it does not exclude that adverse responses may be observed due to the 
combination of the two antimicrobial agents within the composite structure. 
The nanostructured construct was mechanically assessed via tensile testing. The 
specimens were conditioned in standard atmospheric conditions, under were tested under dry 
conditions. Along with assessing the ability of the material to retain sutures and the burst 
pressure, it would be of interest to examine the material under wet conditions at 37 °C, as well 
as, at different time points upon submersion in a solution. The nanostructured construct 
presented tensile properties relevant to those of commercially available hernia meshes, but a 
low elongation-at-break, similar to heavy-weight meshes that present a high young modulus 
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but are less elastic. A 10-20% increase at the elastic break of the material by adjusting the 
composition of the core/shell structure would be required. 
Moreover, from bench to bedside (clinic), to transform this material system onto a 
preclinical product will require for further assessment of the construct in an animal model. This 
can provide further insights towards the induced inflammatory responses, collagen deposition 
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7.2 Thesis contributions 
The primary contributions of this thesis are the three unprecedented material systems 
developed: PVP/PGS, SF:PCL:(p)PGS, and PA6-PHMB/CS-5CLO8Q. This thesis was able 
to address, to a substantial degree, the aims outlined in Section 1.2 Thesis Aims and 
Objectives. Along the journey of this research work, several processes were instigated to 
resolve side issues that arose, leading to some additional novel methods, observations, and 
findings. The main outcomes are enumerated below. Based on the studies conducted during 
the course of this thesis research, the following conclusions can be drawn: 
Development of nozzle-free electrospinning device 
1. A step-by-step guide was provided describing the design and development of a free-
surface, roller-based, electrospinning device that expands on the conventional 
electrospinning technique by permitting the high-throughput production of polymer 
micro/nanofibrous materials, at an 11-fold higher rate than conventional 
electrospinning and in a cost-effective manner. This is the first time that a free surface 
electrospinning device is reported to have successfully produced continuous 
composite fibres deriving from binary and trinary polymer blends. 
PVP/PGS electrospun mats 
2. The PVP/PGS fibrous scaffolds developed in Chapter 4, describe the UV-facilitated 
crosslinking of the composite fibres in the presence of a photoinitiator, riboflavin, where 
the crosslinking process is described in detail. This was evident by FTIR analysis and 
by determining the effect that the duration of UV treatment has on the water contact 
angle of the scaffold, which prevented the rapid degradation of PVP and allowed the 
assessment of the biomaterial in vitro. 
3. The PVP/PGS fibres presented tuneable mechanical properties, which were 
modulated by adjusting the [PVP:PGS] ratio and the molecular weight of the                            
PVP — increasing the concentration of PGS within the blends, correlated to an 
increase in the elongation-at-break point of the electrospun mats and subsequent 
reduction of the tensile strength. The fibres produced using the highest proportion of 
PVP within the blends presented a ten-fold increase in the Young’s modulus (on 
average) compared with the fibres that presented the highest proportion of PGS, where 
the elongation-at-break followed an inverse correlation among the proportionality of 
the two polymers. 
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4. The PVP/PGS fibrous scaffolds adhered to the HDFs and allowed them to expand four 
times more efficiently than PVP/PGS gels that did not retain the ECM-like morphology. 
SF:PCL:(p)PGS electrospun mats 
5. Trinary, biocompatible, silk fibroin-based electrospun fibres, with an ECM-like 
morphology, were successfully produced, and the presence of the counterpart 
polymers within the final composite was validated by FTIR and XPS. 
6. In Chapter 5, a fast, straightforward protocol for the extraction of silk fibroin from 
Bombyx mori cocoons was described, utilising Na2CO3 to degum the cocoons, LiBr to 
dissolve the fibroin and ethanol to precipitate the protein from LiBr. The protocol was 
capable of extracting higher quantities of the protein in one-third of the time required 
by the molecular cassette cut-off method, representing a more economically viable 
method than those currently in a laboratory setting. 
7. The integration of either pPGS or PGS within the composite fibres was found to 
influence the wetting properties of the fibrous membranes. Increasing the 
concentration of PGS within the trinary blends gradually lowered the water contact 
angle of the scaffolds, with the phenomenon occurring at an earlier time point (upon 
settlement of a water droplet) in electrospun mats produced with PGS rather than 
pPGS. The improved wetting behaviour of the PGS in comparison to pPGS could be 
explained by the greater number of ester linkages. 
8. The integration of the biocompatible, regenerated silk fibroin protein into the trinary 
blends was demonstrated microscopically to facilitate the expansion of HDFs at a 
significantly increased rate compared with PCL-only fibres. 
9. SEM observations of the silk fibroin-containing composite electrospun mats presented 
a healthy, polygonal HDF morphology with multiple long spindles expanding, 
compared with the spheroid-shaped fibroblasts grown on the PCL-only fibre substrate. 
Antimicrobial nanofibrous mesh: PA6-PHMB/CS-5CLO8Q 
10. Co-axially electrospun NFs, which integrated a dual antimicrobial system facilitated by 
the nanoencapsulation of PHMB and 5CLO8Q within a PA6 core and a CS shell, 
respectively, were successfully fabricated. The concentrations of the antimicrobial 
substances within the fibres were based on the FDA and EEA maximum toxicity level 
guidelines. 
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11. TEM observations illustrated the consistent fabrication of a “beads-in-fibres” 
morphology, derived from the merger of a continuous shell and a discontinuous core, 
a fibre configuration that was described for the first time through a single-step 
fabrication process. 
12. The “beads-in-fibres” core/shell structure of specimens electrospun at various flow 
rates was confirmed by TEM imaging and by XPS analysis, by evaluating the 
theoretical atomic value of each material within the system. Furthermore, due to the 
amorphous nature of CS, in contrast to PA6, which is thermoset, the amount of PA6 
within the core of the fibres was evaluated, based on the enthalpies of the PA6-only 
and the core/shell NFs (~ 48.5%). 
13. The composite fibres presented increased thermal stability compared to the bulk 
materials and the single-polymer fibres. The nanofibrous construct weighed between 
5–10 g.m-2 appertain to ultralight-weight (≤ 35 g.m-2) hernia meshes. 
14. The core/shell structure successfully improved the tensile properties and mechanical 
stability of the CS fibres, presenting a two-fold increase in tensile strength, at                                
20.7 ± 2.5 MPa, and a four-fold increase in Young’s modulus, at 217.5 ± 12.6 MPa, 
compared with the nylon-6-only NFs, but by sacrificing the elongation-at-break                      
(14.1% ± 2.1%) which remained in similar value with the CS-only NFs. These values 
fell within the mechanical requirements for a hernia mesh, which were described in 
detail in Section 2.5.1 Hernia Mesh Architecture: Morphological, Physiochemical and 
Mechanical Properties. 
15. The bicomponent nanofibrous system was found to provide a two-step sequential 
release model of the two antimicrobial substances, which combined a small burst 
release (accounting for approximately 20% of the total drug-loaded) followed by the 
sustained release of the drug over the span of one month. This approach can provide 
antimicrobial protection directly after mesh implementation, where a higher bacterial-
load is present, as well as in the long-term; taking into account spore-forming bacteria 
that may initially lie dormant. Further exploration of the drug release mechanism 
indicated that the co-axial fibres followed a non-Fickian model, indicating that, in 
contrast to the PA6-PHMB drug-containing NFs, the drug-release mechanism of the 
core/shell NFs was influenced by the swelling behaviour of the CS present in the shell. 
16. Initially, the antimicrobial efficiency of the system was assessed using the disc diffusion 
technique against two pathogenic species: S. aureus and P. aeruginosa. These 
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findings indicated that although the disc diffusion test can be used to determine 
whether a specific pathogen is susceptible to an antimicrobial substance or an 
antibiotic, it cannot be used for the direct comparison of the effects elicited by distinct 
substances contained within dissimilar polymers/substrates. These findings represent 
a useful observation for the evaluation of antimicrobial electrospun fibres, which has 
been neglected in the presentation of antimicrobial efficacy in the literature. 
17. The superiority of the bicomponent composite construct towards its ability to eliminate 
and prevent the growth of Gram-positive and Gram-negative bacterial strains was 
confirmed by a 12-h growth kinetics experiments. The results showed no subsequent 
growth, and live/dead fluorescence testing indicated 98% cell death, whereas SEM 
imaging of the fixed bacteria showed the formation of cytoplasmic inclusions upon 
contact with the antimicrobial fibres. 
18. Finally, the antimicrobial efficacy of the developed construct was evaluated against 
micro and nanofibres composed of synthetic polymers, and biologic and synthetic 
hernia meshes that are currently used on the market for hernia repair. The growth 
kinetics results and Syto9® confocal images agreed with the pictures depicted in Figure 
2.6 of Chapter 2 Literature Review, demonstrating the failure of the available hernia 
prostheses to prevent an infection from occurring, while simultaneously affirming the 
superiority of the developed bicomponent NFs. The developed nanofibrous system 
could be an economically viable new approach that brings together structural and 
morphological traits of synthetic and biologic meshes, along with antimicrobial 
protection in a single construct. 
 
Overall, this thesis was deemed to be successful by contributing valuable knowledge to the 
research areas of biomaterials, skin tissue engineering, nanoencapsulation, drug release, 
antimicrobial surfaces, and through the description of an alternative strategy for the 
development of antimicrobial biomimetic surgical prostheses. The studies described here can 
provide future researchers with constructive insights into the development of advanced fibre-
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7.3 Recommendations and future directions  
The work presented in this thesis forms the basis for the development of novel electrospun 
composite biomaterials for wound management and antimicrobial prosthesis, and subsequent 
work can be directed by these developments. Encouraged by the research outcomes 
presented in this thesis, the following are areas that could be further investigated.  
 
Skin tissue engineering 
1. Further validation of viability was intended, through the quantitation of dsDNA using 
NanoDrop® spectrophotometric quantification. Additionally, the ability of the scaffolds 
to support differentiation could be analysed by quantifying the relative mRNA 
expression of wound-healing genes (Collagen I, -SMA, VEGF, HIF-2, TGF-B1, 
GAPDH, SCF, SDF-1 and HSP-90) via RT-PCR, using the appropriate primers [36]. 
Understanding changes in gene expression could reveal the elicited responses of 
fibroblasts in the presence of the composite fibres and the degree to which the 
scaffolds influence cellular responses. Unfortunately, this work could not be completed 
due to the extended time spent refurbishing the Institute for Bioengineering facilities at 
the University of Edinburgh and the subsequent closure due to the COVID-19 outbreak 
following my return from a year-long placement at Empa, St. Gallen, Switzerland.  
2. A wound-healing assay, such as a simple, in vitro scratch test, could also provide some 
preliminary understanding of collective cell migration and cell-matrix interactions that 
occur in the presence of electrospun mats [37].  
3. The in vitro evidence presented in this thesis allows for an initial appraisal of the 
feasibility of using these novel fibrous membranes, prior to performing the animal 
sacrifices that would be required to test the in vivo performance of these biomaterials. 
The in vitro platform used to assess the biocompatibility of the developed electrospun 
mats represents the first step towards preclinical and future clinical translation. The 
use of an animal model would allow the assessment of wound contraction (in wound 
area over days), histological neo-epithelium, granulation, and scar tissue analyses, 
using haematoxylin and eosin and picrosirius red staining, and immunohistochemistry 
analyses to examine M1/M2 macrophages, blood vessel formation, and immune cell 
infiltrates. 
4. Although the inherently porous structure of electrospun scaffolds provides 
fenestrations that are inadequate for the passage of most cell types, they are sufficient 
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for nutrient and cytokine transport. Whilst cellular expansion in the form of a monolayer 
is not problematic for the development of wound dressings and skin substitutes, as the 
construct is merely meant to facilitate cell migration and proliferation at the surface of 
the skin, three-dimensional (3D) structures can further enhance fluid retention and 
exudate absorption. However, macroporous scaffolds may be less beneficial because 
they would likely increase the risk of infection from a contaminated outer surface. The 
developed composite blends could be further assessed in the form of 3D electrospun 
structures, by combining 3D printing and electrospinning [38], freeze-drying 
electrospun fibres into moulds to form 3D structures [39], or gas-foaming to expand 
the scaffold’s 2D structure [40]. These 3D constructs could be used to further assess 
the interplay between keratinocytes and fibroblasts, in bilayer or multilayer constructs 
that could further provide insights regarding the abilities of the developed biomaterials 
to reduce fibrosis.  
5. In addition to the regenerative capacities of the developed material system, which is 
the primary focus of treatment for skin loss or damage, these biomaterials could also 
be used as the basis for developing artificial skin constructs that can act as soft sensors 
and for tactile sensing. Although such an approach surrounds biosensing and electrical 
engineering rather than influencing and attempting to control cellular responses, skin 
sensors, could allow for applications such as wireless health monitoring and the 
integration of wearable sensors that can monitor and measure pertinent skin 
parameters (such as temperature, oxygen, pH, lactate, glucose and cytokines, 
including IL-6) [16]. 
6. Through the integration of metal nanoparticles (NPs), such a material system could be 
used to assess pH variations, in the form of electrochemical or colourimetric 
biosensing. Determining the pH of a wound is a good indicator of infection that could 
be used to monitor chronic wounds. In preliminary studies, Tungsten oxide (WO3) NPs 
were integrated within the polymer blends developed in this thesis to generate an 
electrochemical pH-skin sensor. During the initial stage, WO3-NPs were incorporated 
within the polymer blends and electrospun. Then, one-side of the electrospun mat was 
sputter-coated with a 1-μm-thick Au layer. An Ag paste was used to introduce a copper 
wire or conductive fabric into the WO3-containing side of the construct. After, a pseudo-
reference electrode was glued in the Au-side, incorporating a platinum-based counter 
electrode as reference. The use of WO3-NPs can further provide a form of antimicrobial 
protection [17]. This construct is still in the design stage and has not been yet 
evaluated. 
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Hernia mesh engineering 
1. The mechanics of the nanofibrous mesh could be further assessed for burst strength, 
which could be a good indicator of determining the intraabdominal wall pressure 
limitations of the material [18]. Furthermore, the nanofibrous construct should be 
assessed for its ability to retain sutures, staples, and tacks for mesh fixation. Due to 
the high dissimilarity with commercial hernia meshes, such as differences in knitting, 
fibre diameter, the polymer chemistry, and porosity, evaluating the mechanics under 
similar conditions can be difficult and may not provide decisive conclusions, when 
compared with the nanofibrous hernia mesh developed. 
2. To avoid cells treating the bicomponent antimicrobial mesh as a flat sheet and to 
enhance cell infiltration, several techniques can be employed to widen the pores of the 
nanofibrous structure. For a successful hernia closure and limiting the chances 
reherniation, the integration of the mesh material by the host tissue is crucial for 
determining the time required for the partial or full absorption of the material. To 
strengthen a patient’s attenuated fascia, appropriate tissue ingrowth is required, and 
determining an optimal balance between inflammation, cellular and vascular 
infiltration, and matrix remodelling is crucial for determining the time required for 
construct resorption and preventing excessive collagen deposition. The following 
approaches could be used to change the configuration of the pores, allowing the in-
depth penetration of cells into the scaffold and overcoming the small pore size 
constraints associated with the electrospinning process.  
a. Cryogenic electrospinning is a technique that uses a sub-zero (in °C) 
temperature collector to facilitate the simultaneous formation of nanofibres and 
ice crystals. The scaffold’s porosity can be adjusted from 10–500 μm, 
depending on various controllable factors, such as size and the amount of ice 
crystals. The ice crystals are then removed by freeze-drying the fibrous 
scaffolds, leaving large void spaces, which permit cell infiltration [19]. 
b. Gas foaming has been widely used to formulate porous scaffolds. This method 
introduces gas (most commonly CO2) into a polymer matrix. The rapid release 
of CO2 creates gas bubbles that allow the formation of large pores, averaging                 
300 µm in diameter [20].  
3. Among general surgeons, there is an ongoing debate about whether a permanent 
hernia mesh is more appropriate than a bioabsorbable material that degrades at a 
similar rate at which the fascia is regenerated. One potential approach would be the 
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direct coating of electrospun fibres onto the surface of a synthetic mesh, subsequently 
offering antimicrobial protection against bacteria contamination, while retaining the 
mechanical stability of the synthetic mesh (Figure 7.1). 
4. Finally, based on the robust activity of the bicomponent antimicrobial mesh that was 
developed in this study, another potential approach would be to chemically graft the 
antimicrobial agent onto the surface of the NFs. This could ultimately generate an 
antimicrobial surface capable of preventing infection through contact killing, leaching 
or a repelling surface, without the potential cytotoxic effects associated with the release 
of the antimicrobials. A considerable amount of work has already been conducted in 
this direction, which can be found in Appendix C (Grafting PHMB on O-
carboxymethylated chitosan), describing, for the first time, the grafting of PHMB onto 




Figure 7.1 Schematic representation depicting the direct electrospinning of antimicrobial 
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Figure A-1 Absorbance spectra of 5-chloro-8-quinolinol (5CLO8Q) (top) and poly(hexanide) 
(PHMB) (bottom). 
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Figure A-2 Standard curves of PHMB (236 nm) and 5CLO8Q (247 and 257 nm) at pH 7.2 and 6.2. 
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Figure A-3 CAD designs of the nozzle-free electrospinning device.  (a) Multi-channel gas lid; 
(i) mid glass plane, (ii) top glass plane with two 8 mm holes (iii) bottom glass plane with 55 holes 
of 3 mm diameter and (iv) complete lid assembly. (b) Spinneret assembly; (i) stainless steel roller 
electrode, (ii) Teflon® bath and (iii) complete spinneret assembly. 
252     Chapter 4 | Appendix A 
 
 
Figure A-4 The nozzle-free electrospinning setup spinneret assembly. (a) 2D design of the 
stainless-steel cylinder. Photographs of (b) the cylinder within the Teflon® bath; (c) after 
inserting the high-voltage electrode; (d) PEEK connector; and (e) the high-voltage cable soldered 
to form a ring. 
 




Figure A-5 The nozzle-free electrospinning setup collector assembly. Photographs of the 
collector assembly (a) front view and (b) plan view. Photographs of the (c) 3D printed metallic 
bearing; (d) device’s safety interlock (RS Components, UK); (e) 12 V DC motor fitted to the 
collector (15 Ncm-1, 6 rpm, RS Components, UK) powered by an adjustable power supply (DPPS-
16-30, Voltcraft, Germany), and a 12 V DC motor fitted to the spinneret (6 Ncm-1, 4500 rpm, 
Bosch, Germany) rotating at a constant speed of 10 rpm; and (f) high-voltage collector’s electrode.  
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Figure A-6 Photographs of the nozzle-free electrospinning device. (a) Gas flow is provided via 
the lid assembly at the enclosed setup, whereas (b) hot airflow is provided via a heat gun at the 
open setup. (c) The high voltage DC power supplies (HV350REG(-) and HV350REG(+), 
Information Unlimited, Amherst, USA) used to charge the spinneret and collector. 














































Figure A-10 Riboflavin-induced photocrosslinking of polyvinylpyrrolidone (PVP).  
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Figure A-11 Silk fibroin extraction with photographs. (a) Bombyx mori silkworm cocoons 
after dissecting the worm, (b) cut into small pieces, (c) weighed and (d) 0 min of degumming the 
cocoons in 0.01 M Na2CO3, at 100 °C for 30 min, (e) after 30 min, (f) rinsing the degummed silk in 
deionised water, 3 times for 20 min each, (g) left to dry at room temperature, overnight. (h) Then, 
9.3 M LiBr solution is added to the dried silk fibre mesh, at a ratio of 1:4 SF:LiBr solution (w/v), 
to dissolve the fibroin, and placed in an oven, for 4 h at 50 °C. (i) SF is precipitated by gradually 
adding the SF-LiBr solution, dropwise, to pure ethanol in a ratio of 1:30 SF-LiBr:EtOH (v/v), under 
agitation conditions for 1 h. (j-k) LiBr residues were removed by filtration and washed with 
ultrapure water. (l) The purified SF is oven-dried, at 50 °C. (m-n) The dried SF is then milled into 
a powder, using a mortar, and (o) dissolved in formic acid/CaCl2, to obtain a final SF concentration 
of 12% (w/v). 
 




Figure A-12 SEM images and fibre diameters distribution graphs of the trinary; SF:PCL:PGS and 
SF:PCL:pPGS, and binary; SF:PGS and SF:pPGS, electrospun mats. 
 
260    Chapter 5 | Appendix A 
 
Table A-1 Electrospinning and solution parameters. 
Process parameters Measurements 
Solution conductivity (mS.cm-1) 0.2 – 0.4 
pH 6.2 ± 1.5 
Relative Humidity (%) 30-60 
Temperature (℃) 18-28 
Distance between electrodes (cm) 15 
Atmosphere N2 
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Table A-2 Degradation analysis of the PCL-backbone SF:PGS and pPGS trinary scaffolds of the 
various blend ratios over time. 
SF:PCL:PGS SF:PCL:pPGS 
Weight Loss (%) Weight Loss (%) 
 Time 1:0.75:0.25 1:0.5:0.5 1:0.25:0.75 1:0.75:0.25 1:0.5:0.5 1:0.25:0.75 
30 m 3.0 19.8 26.1 19.5 24.4 34.3 
1 h 7.0 22.8 28.9 16.0 26.2 33.6 
4 h 7.8 25.0 29.2 16.3 24.3 32.1 
24 h 9.9 22.0 31.9 17.1 25.2 34.3 
3 d 9.5 24.4 33.4 14.1 19.6 26.1 
7 d 15.0 22.9 33.6 12.1 25.6 30.8 
21 d 26.9 18.0 33.1 11.2 16.9 28.7 




Figure A-14 Photograph of the degradation study of the PCL-backbone SF:PGS and pPGS trinary 
scaffolds of various blend ratios over time. 
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Figure A-15 Co-axial electrospinning. Photographs of (a) the co-axial electrospinning setup 
used to produce core/shell PA6-PHMB/CS-5CLO8Q nanofibrous membranes; and (b) the co-axial 
spinneret consisting of a 0.9-mm diameter nozzle (outer) for the shell solution and 0.57-mm 
diameter nozzle (inner) for the core solution. The core to shell feed rate was 2.5 to 5.0 µLmin−1, 
with the potential difference set to 22 kV (+18 kV to charge the spinneret and -4 kV to charge the 
collector).  
 




Figure A-16 FTIR-ATR analysis of (a) region-specific spectra (1200-2000 cm-1) of the drug-
containing CS-5CLO8Q, PA6-PHMB, and core/shell NFs, and (b) the pristine antimicrobial 
substances; 5CLO8Q and PHMB powders. 
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Carboxymethylation of chitosan 
Chitosan (degree of de-acetylation 85/100) was first O-carboxymethylated (O-CMCS), the 
procedure of which, is outlined here. First, chitosan (10 g) was dissolved with sodium 
hydroxide (27 g) in water (200 mL). The solution was left for 24 h at -20 °C to swell and alkalise. 
Then, monochloroacetic acid (30 g) in isopropanol (40 mL) was added dropwise for 30 min 
and reacted at 50 °C for 7 h. After stopping the reaction by the addition of absolute ethanol 
(20 mL), the resultant product was separated by filtration in ethanol 70% (v/v) and dehydrated 
in absolute ethanol. The primary product of the CMCS sodium salt (CSMS-OCH2COONa) was 
converted into its acid form by protonation in 32% (v/v) HCl(ac). The resultant suspension was 
collected by filtration (Cola-Palmer filtration centrifugal tubes) and centrifuged for 20 min at 
5000 rpm. The process was based on two previously published protocols [1, 2]. The reaction 
scheme is shown in Figure C-1. Experiments carried out in later stages were conducted using 
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CS-g-PHMB grafting using EDC/sulfo-NHS amide coupling 
Firstly, 10 mg·mL-1 O-CMCS were dissolved in 0.1 M MES [2-(N-morpholino)ethane sulfonic 
acid] buffer (pH 4.7-6.0) to achieve complete solubilisation of the polymer. The solution was 
mixed thoroughly at room temperature, and EDC [1-(3-dimethylaminopropyl)-N’-ethyl-
carbodiimide hydrochloride] was added to the resultant solution. EDC's final concentration was 
at a ten-fold molar excess in relation to the O-CMCS. This allowed for the formation of an 
unstable ester intermediate between the carboxylic acid at C-2 of the O-CMCS molecule and 
the EDC crosslinker. Then, sulfo-NHS (sulfo-N-hydroxysuccinimide) was added to the reaction 
medium until a final concentration of 5 mM was reached. The proportion of [EDC : sulfo-NHS] 
was maintained at 1:1 M. sulfo-NHS was chosen over NHS to increase the solubility of the 
carboxylate molecule and to retard its rapid hydrolysis.  
Then, PHMB was dissolved in the same buffer employed for the dissolution of the                           
O-CMCS. The final concentration of PHMB was determined based on the degree of 
substitution as described in the Additional methodology information section below. The 
subsequent reaction was left for 24 h at room temperature under magnetic stirring. The MES 
buffer was adjusted with PBS to increase the pH to 7-8. The reasoning behind the reaction 
been uninterrupted for an extended period is because successful conjugation is dependent on 
the PHMB’s nucleophilicity, which is relatively “low” due to nitrogen electron pair conjugation. 
This allowed for a stable amide conjugate to form, referred to as PHMB-g-CMCS, between 
the amine-reactive Sulfo-NHS ester and the PHMB amine. The resultant product was purified 
dropwise in ethanol, subsequently centrifugated and filtered. The reaction scheme is 
summarised in Figure C-2 below. 
The final product was assessed with FTIR and Nuclear magnetic resonance (NMR). The 
results from the NMR of the grafted polymer were deemed inconclusive due to the poor 
solubility of the product in DMF, and the NMR spectrum presenting traits of non-reacted                      
O-CMCS. 
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Figure C-2 The reaction scheme summarises the grafting PHMB on O-Carboxymethylated 
chitosan (O-CMCS) using EDC/sulfo-NHS chemistry. (a) A nitrogen atom from the EDC's 
carbodiimide group subtracts the hydrogen from the carboxyl present in the O-CMCS polymer. 
The resultant carboxylate attacks the nitrogen atom (which bears a partial positive charge) from 
the carbodiimide group, resulting in the O-acylisourea intermediate observed in the first step of 
the reaction scheme. (b) The intermediate product then reacts with the NHS to form an active 
ester through the nucleophilic attack of the hydroxyl present in the NHS’s carbonyl group. (c) 
This results in the activated amine sulfo-NHS-chitosan ester complex, which is capable to 
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Additional methodology information 
Information about the suppliers and materials used can be found in Table 3.2, in Section 3.3.4 
Stock chemicals, reagents, cells and equipment. 
MW(O-CMCS)= 100,000 – 300,000 g·mol-1, MW(O-CMCS)n = 249.12 g·mol-1 (C10H19NO6)n 
MW(PHMB) = 213.33 g·mol-1 (C8H17N5)n, MW(Sulfo-NHS) = 217.13 g·mol-1, MW(EDC) = 115.09 g·mol-1 




 = 0.0005 mole 
𝑚(𝑃𝐻𝑀𝐵) = 0.002 × 213.33 = 0.4266 g 
To make a 1:1 M ratio: [O-CMCS: sulfo-NHS] → 1< n → msulfo-NHS = m(O-CMCS) X MW(Sulfo-NHS), 
which can then be precipitated in polar protic solvents. 
To prepare 0.1 M phosphate-buffered saline (pH 7.4): Dissolve 21.324 g KH2PO4 and                      
90.690 g Na2HPO4 into distilled water and bring to 2 L. From this solution, 250 mL will be taken 
and brought to 1 L to prepare 0.1 M PBS. 
To prepare 0.1 M MES buffer (pH 5.0): Dissolve 21.3 g of MES monohydrate in 900 mL of 
water. Add 1 M NaOH solution until pH 5 is brought to 1 L. 
 
Solution preparation and electrospinning 
The conjugated CS-g-PHMB polymer (240 mg) was dissolved with 40 mg of PEO                     
900,000 g·mol-1 in 5 mL of acetic acid 10% (v/v) in distilled water under magnetic stirring in 
room temperature. The polymer solution was then electrospun in a controlled 
temperature/humidity chamber. The relative humidity was kept at 20% and the temperature at 
20 °C. A parametric study was conducted to determine the most stable electrospinning 
conditions and the corresponding morphology of the produced fibres. The parametric study is 
summarised in Table C-1. SEM micrographs of the NFs produced under the optimised 





Appendix C | Grafting PHMB on O-carboxymethylated chitosan  291  
 
Table C-1 Parametric study assessing the stability of the Taylor cone during electrospinning and 
the fibre morphology of the final product electrospun using the CS-g-PHMB/PEO in 10% (v/v) 
AcOH solution. The potential difference values represent (+) kV for the nozzle-tip and (-) kV for 
the flat collector’s surface. Working distance refers to the distance of the electrospinning path; 
from the nozzle-tip to the surface of the collector. Needle inner diameter: 21G is 0.71 mm, 22G is 
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Figure C-3 SEM micrographs of CS-g-PHMB/PEO electrospun NFs produced using a conventional 
electrospinning device at +15/-5 kV, 20 cm working distance, 15 μl·min-1, using a 27G needle. 
Average fibre diameter of 177 ± 20 nm.  
 
FTIR analysis of the synthesised CS-g-PHMB 
The Figure C-4 below shows the FTIR spectra obtained for the O-CMCS, the PHMB, and the 
synthesised CS-g-PHMB. The peaks at 1484 cm -1 and 1589 cm-1 of the O-CMCS spectrum 
can be attributed to the COO- group symmetric and asymmetric stretching vibrations, 
respectively. The strong peak at 1589 cm -1 could also overlap with the deforming NH2 
vibration. At 1052 cm-1 the absorption peak of the secondary -OH can be observed. Where 
the cluster band forming at approximately 1150 cm -1 represents the various C-O-C stretching 
vibrations of the sugar ring. The successful synthesis of O-CMCS at C-2, comes into 
agreement with previously published research [3, 4]. 
In the PHMB spectrum, the biguanide structure can be identified with the characteristic C-
H and C-C vibrations at 2320 cm-1 and 2355 cm-1, respectively. Additionally, the intense peak 
at 1537 cm-1 and 1650 cm-1 can be attributed to the -OH stretching and -NH bend vibrations, 
respectively. Whereas the peaks at 1435 cm-1 and 1463 cm-1 are associated with the -CN 
stretching of the primary amine/methylene combination (-NH/-CH) and the secondary amine, 
respectively. Finally, the strong peak at 2847 cm−1 and the peak at 3290 cm−1 could be 
attributed to -NH stretching vibrations, where the defined peak at 3129 cm−1 is attributed to 
the -CH stretching of the methylene tail. This FTIR spectrum is in agreement with previously 
published work [5].  
The ester on the activated chitosan and the primary amine of the PHMB have reacted to 
form an amide observed with a strong peak at 1690 cm-1, corresponding to the C=O stretching 
of the primary amide. The broad peaks at approximately 3300 cm -1 – which is not present in 
the PHMB and CS molecules – could be attributed to -NH stretching in the conjugated 
structure. The remainder of the peaks of both CS and PHMB, appear to be present in the 
conjugated structure but with more intense peaks, possibly due to hydrogen bonding and a 
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variation at the size of the conjugated polymer. Finally, the CS-g-PHMB spectrum appears to 
be slightly shifted towards higher frequencies for the lower wavenumber regions  (1000 – 1800 
cm-1) compared to the PHMB and O-CMCS spectra. 
 
 
Figure C-4 FTIR spectra of the PHMB and O-CMCS pristine powders, and the CS-g-PHMB 
conjugated polymer. FTIR was performed on oven-dried samples using an FTIR 
spectrophotometer (Varian 640-IR, Varian Medical Systems, USA). The measurements were 
carried out using the ATR-crystal mode in the mid-infrared scanning range of 4200–800 cm−1 
with a spectral resolution of 2 cm−1. The spectra above represent the average of 126 scans to 
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Conclusion 
The preliminary work presented in this Appendix flourishes from the research conducted in 
Chapter 6 of this thesis. As previously observed in this thesis, the robust effect of the                       
PA6-PHMB/CS-5CLO8Q core/shell NFs relied on the release of the antimicrobial substances 
from the bicomponent NFs. The importance of this relies on the concept that by placing the 
biguanide groups of the PHMB in the surface of the CS fibres, we can attain a surface structure 
that can kill bacteria on contact. This would be a non-antibiotic-based approach that could 
ultimately prevent bacteria from adhering to surfaces and prevent colonisation and subsequent 
infection. 
Nevertheless, it is important to note that these data are preliminary and further work needs 
to be conducted to better determine the reproducibility of the process and the reliability of the 
grafting protocol under different conditions before being able to draw any definite conclusions. 
If the protocol deems to be highly consistent, additional work needs to be performed to 
establish the mechanical stability and physical properties of the subsequent electrospun fibres, 
and determine whether the antimicrobial effect is still present, and to what extent, post-
grafting. This would be an interesting alternative approach, as oppose to drug-eluting 
nanofibres, which could elicit permanent antimicrobial protection that can prevent mesh-
related surgical site infections while minimising potential toxicity due to the release of the 
antimicrobial substance in the surrounding tissue, over an extended period. However, upon 
implementation, surface proteins could entrap and coat the structure of the material and thus 
reduce its bactericidal properties. Additionally, an examination of the by-products and the 
degradation rate of the grafted compound will need to be further evaluated if developing a 
bioabsorbable hernia mesh. The proof of principle work conducted here, describing the 
grafting of the polycationic molecule, PHMB, in the surface of chitosan is described for the first 
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